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Wnt signalling is a critical cellular communication pathway controlling cell fate in all metazoan 
organisms. Timely activation of this pathway is crucial to coordinate development, control 
homeostasis of adult tissues, and to avoid cancer. 
 
Wnt signal transduction depends primarily on the activities of three multiprotein complexes; 
the ʻdegradasomeʼ, which targets the central effector β-catenin for degradation in the absence 
of Wnt; the ʻsignalosomeʼ, which is assembled by Dishevelled upon Wnt-receptor binding to 
inactivate the degradasome, thus allowing β-catenin to accumulate; and the ʻenhanceosomeʼ, 
which captures β-catenin, granting it access to target genes and relieving their transcriptional 
repression by Gro/TLE. Many of the components of these complexes have now been 
identified, but details of their regulation, and in particular the mechanisms by which they are 
switched on and off, remain poorly understood. 
 
The majority of this thesis is concerned with the mechanism by which β-catenin relieves the 
transcriptional repression imposed upon Wnt target genes, and thereby activates the Wnt 
ʻtranscriptional switchʼ. In Chapter 2, I present data showing that apposition of Gro/TLE and 
UBR5, a HECT E3 ubiquitin ligase, by β-catenin promotes Gro/TLE ubiquitylation, earmarking 
it for extraction by the VCP/p97 ATPase and ultimately leading to inactivation of its repressive 
function. In Chapter 3, I present the results of a different, ongoing study to identify the 
mechanism by which a cytoplasmic negative regulator, Naked, acts to interfere with the 
function of Dishevelled, promoting the switching of signalosomes and the termination of 
canonical Wnt signalling. 
 
These findings advance our understanding of the mechanisms by which the Wnt signalling 
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The development of a zygote into a multicellular organism with defined axes, polarity, form 
and function is an intricate process that is exquisitely dependent upon intercellular 
communication. The Wnt signalling cascade represents one of a small number of widespread 
and evolutionarily conserved signalling pathways that direct and control these developmental 
processes through the operation of transcriptional switches. These same pathways, which 
also include Notch, Hedgehog and BMP/TGF-β (bone morphogenetic protein/transforming 
growth factor-β), are later deployed to specify stem and progenitor cell populations necessary 
for homeostasis in adult tissues. Mutations in components of these pathways are therefore, 
perhaps unsurprisingly, often causative to growth-related pathologies and cancer. 
 
Compared to other signalling molecules, a unique aspect of Wnt is its ability to act as a 
directional growth factor, shaping a growing tissue whilst inducing cells to proliferate and 
divide (Nusse & Clevers, 2017). These signals can thus direct new cells to be allocated such 
that intricately organised structures are formed (Goldstein et al., 2006). The Wnt pathway was 
first identified in Drosophila when a mutagenesis screen yielded a mutant lacking wings, 
named wingless for its striking phenotype (Sharma, 1973). Seminal work in Heidelberg 
subsequently demonstrated that wingless was in fact one of a number of segment polarity 
genes crucial for patterning the developing embryo (Nüsslein-Volhard & Wieschaus, 1980), in 
the process identifying several mutations that were later traced to other components of the 
Wnt pathway (Siegfried et al., 1992; Siegfried et al., 1994). The pathway was discovered 
independently in mammals, when work in mice identified a proto-oncogene (termed 
integration 1 or Int-1) whose activation was responsible for the characteristic tumours induced 
by pro-viral insertion of the mouse mammary tumour virus (MMTV; Nusse & Varmus, 1982). 
The name ‘Wnt’ was derived as a portmanteau of ‘wingless’ and ‘Int-1’ when the two genes 
were subsequently shown to encode orthologous secreted proteins (Rijsewijk et al., 1987). 
 
Much of the early work focused on understanding Wnt signalling in developmental contexts. A 
role for Wnt in vertebrate development was first demonstrated with the finding that injection of 
Int1 mRNA causes axis duplication in Xenopus embryos (McMahon & Moon, 1989). However, 
it was not until the 1990s that a connection was made between the Wnt pathway and human 
disease. Mutations in the adenomatous polyposis coli (APC) gene were identified in patients 
with a hereditary colon cancer syndrome termed familial adenomatous polyposis (FAP; 
Groden et al., 1991; Kinzler et al., 1991; Nishisho et al., 1991). The APC protein was shown 
soon after to interact with β-catenin (Rubinfeld et al., 1993; Su et al., 1993), known as 
Armadillo in Drosophila (Peifer et al., 1992; Peifer, 1995) and now understood to be the 
central effector of the ‘canonical’ Wnt pathway. 
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Through a huge amount of meticulous study over the last three decades, the core 
components of this canonical Wnt signalling pathway have been identified, and the effects of 
pathway disruption studied in numerous systems. Despite this, many of the cellular 
mechanisms underlying signal transduction remain unclear, and certain details of these 
mechanisms constitute the focus of this thesis. 
 
1.1. The canonical Wnt signalling pathway 
Wnts are secreted, cysteine-rich proteins of approximately 40 kilodaltons (kDa), which fall into 
13 conserved subfamilies (Loh et al., 2016). All act by binding to receptors on the surface of 
nearby cells and initiating cytoplasmic signal transduction pathways. Most of this signalling 
occurs via the canonical pathway, in which β-catenin is the central effector. Different, though 
overlapping, suites of receptors, co-receptors (in particular) and cytoplasmic effectors permit 
the transduction of alternative, β-catenin-independent Wnt signals via two ‘non-canonical’ 
pathways: the planar cell polarity (PCP; Strutt, 2003; Peng & Axelrod, 2012) and Wnt/Ca2+ 
pathways (Kohn & Moon, 2005). 
 
The canonical Wnt pathway (often termed Wnt/β-catenin signalling) is controlled by the 
opposing activities of three highly dynamic multiprotein complexes (Fig. 1.1). In the off state, 
β-catenin is constitutively phosphorylated and thereby earmarked for degradation by the 
‘destruction complex’ or ‘degradasome’ (Stamos & Weis, 2013). The core degradasome 
contains two kinases, glycogen synthase kinase 3 (GSK3) and casein kinase 1α (CK1α), 
scaffolded by the key tumour suppressors Axin and APC. 
 
Upon Wnt binding to Frizzled (Fz) and LRP5/6 (low-density lipoprotein receptor-related 
protein 5/6), the ‘signalosome’ complex is assembled upon the cytoplasmic domains of these 
receptors. The signalosome is assembled by the Fz-binding protein Dishevelled (Dvl; Bilic et 
al., 2007), whose dynamic polymerization increases its avidity for Axin (Bienz, 2014). The 
whole degradasome is recruited, via Axin, to the membrane, where the intracellular tail of 
LRP5/6 becomes phosphorylated at specific residues and thus serves as a competitive 
inhibitor of GSK3 (Tamai et al., 2004; Stamos et al., 2013). Inactivation of GSK3 allows 
unphosphorylated β-catenin to accumulate and translocate into the nucleus (Peifer et al., 
1994). 
 
Transcriptional activation requires binding of this stabilised β-catenin to TCF/LEF (T-cell 
factor/lymphoid enhancer factor) proteins that are tethered at enhancers of Wnt target genes. 
Access to these transcription factors is blocked by Gro/TLE (Groucho/transducin-like 
enhancer of split), a TCF-binding transcriptional co-repressor that acts through a combination 
of chromatin compaction and histone deacetylation (Sekiya & Zaret, 2007). Gro/TLE is the 
3 
key repressive component of the ‘Wnt enhanceosome’ complex (Fiedler et al., 2015; van 
Tienen et al., 2017), which earmarks repressed target genes for inducibility and, upon capture 

































Figure 1.1 Overview of the canonical Wnt signalling pathway. 
Three multiprotein complexes are primarily responsible for the transduction of Wnt signals. In 
the absence of Wnt (left), β-catenin is constitutively earmarked for degradation via 
phosphorylation by kinases of the degradasome. Wnt triggers assembly of signalosomes 
(right), inhibiting the degradasome and allowing β-catenin to accumulate and translocate into 
the nucleus, whereupon it is captured by the enhanceosome and triggers transcriptional 
activation. See text for more details. Active components are shown in green, inactive 












































1.1.1. The degradasome 
Although it is the central effector of Wnt signalling, most β-catenin is actually found in complex 
with E-cadherin and α-catenin in adherens junctions; stable structures formed at the contact 
points of cells that facilitate their close physical interaction (Peifer et al., 1992). A distinct, 
more dynamic pool of β-catenin is responsible for transducing the Wnt signal through the 
cytosol. These pools operate independently, and indeed in some species, including C. 
elegans, these functions are carried out by distinct homologs (Korswagen et al., 2000). 
 
In the ‘Wnt off’ state, β-catenin is sequentially phosphorylated by the two constitutively active 
kinases of the degradasome at a series of N-terminal serine/threonine residues (Fig. 1.2A; 
Liu et al., 2002). A ‘priming’ phosphorylation of Ser-45 by CK1α triggers subsequent 
modification of three residues by GSK3 (Amit et al., 2002), which render N-terminal lysine 
residues of β-catenin substrates of the F-box containing E3 ubiquitin ligase β-TrCP (β-
transducin repeat containing protein), targeting it for proteasomal degradation (Aberle et al., 
1997; Kitigawa et al., 1999; Wu et al., 2003).  
 
The degradasome depends on a plethora of multivalent and partially redundant interactions 
between multiple components for its ordered assembly (Fig. 1.2B; Gammons & Bienz, 2017). 
The central and limiting component is Axin, which binds to β-catenin via a small central helix, 
as well as to APC, GSK3 and CK1α via separate domains (Hart et al., 1998; Faux et al., 
2008), coordinating these components in a spatial fashion. Mutations that destabilise the N-
terminal RGS (Regulator of G-protein signalling) domain, blocking the interaction with APC, 
exhibit dominant-negative activity, triggering formation of aberrant Axin aggregates that 
interfere with normal degradasome formation (Anvarian et al., 2016). Axin can also undergo 
reversible head-to-tail homopolymerization via its C-terminal DIX (Dishevelled/Axin) domain to 
generate short filaments (Fiedler et al., 2011), although Axin concentrations are usually 
maintained at a low level (preventing weak DIX-DIX interactions from occurring) by RNF146, 
a RING E3 ubiquitin ligase that targets it for proteasomal degradation (Lee et al., 2003; Zhang 
et al., 2011). Indeed, Axin degradasomes (unlike Dvl signalosomes) only become visible as 
cytoplasmic puncta when tankyrase, a polyADP-ribosyltransferase that activates RNF146, is 
inhibited, leading to a large increase in Axin levels (DaRosa et al., 2015; Huang et al., 2009). 
 
The other key protein involved in degradasome assembly is APC, which interacts directly with 
Axin through multiple conserved motifs (Spink et al., 2000), but also indirectly, possibly 
through β-catenin (Pronobis et al., 2015). Although it is clearly essential for degradasome 
function, the specific molecular functions of APC remain poorly understood. Like Axin, APC is 

































Figure 1.2 Structure and interactions of the degradasome. 
(A) Domain architecture, interactions and regulation of β-catenin. Priming phosphorylation of 
Ser-45 by CK1 triggers sequential phosphorylation of Thr-41, Ser-37 and Ser-33, which 
subsequently promotes polyubiquitylation of Lys-19 and Lys-49 by β-TrCP. 
(B) Domain architecture and key interactions of other core degradasome components. 
(C) Proposed model for the degradasome. Multimerization of both Axin and APC contributes 
to the assembly of these multiprotein complexes. See text for more details. Adapted from 

















































for degradasome assembly (Fig. 1.2C; Mendoza-Topaz et al., 2011; Kunttas-Tatli et al., 
2014; Pronobis et al., 2017). APC may therefore facilitate Axin homopolymerization by 
increasing its local concentration to levels permissive for DIX-DIX interaction, and/or could 
provide cross-links between Axin filaments, potentially providing an explanation for the three-
dimensional structures of degradasomes that have been observed (Thorvaldsen et al., 2015). 
APC also interacts with the central region of β-catenin through two separate repeat regions 
termed 15R and 20R (Rubinfeld et al., 1993; Spink et al., 2001), in a fashion that is enhanced 
by GSK3- and CK1α-mediated phosphorylation of the third 20R repeat (Tickenbrock et al., 
2003). A large majority of colorectal cancer-causing mutations in APC are truncations 
clustering around a small region termed the β-catenin inhibitory domain (CID), located 
between the second and third 20R repeats, demonstrating the importance of the APC/β-
catenin interaction (Kohler et al., 2009). Why full deletions of APC are rarely observed in 
cancer is unclear, although retention of partial β-catenin binding seems to promote 
tumourigenesis (Albuquerque et al., 2002), or it may be related to a separate role of APC in 
cell adhesion (Bienz & Hamada, 2004). 
 
In the absence of a Wnt signal, Axin and APC thus function to appose β-catenin with the 
kinases that earmark it for degradation, although the exact biochemical roles of these proteins 
remain somewhat elusive. Full understanding may require a complete in vitro reconstitution of 
a functional degradasome complex, and the determination of its structure, a goal that several 
labs are now working towards.  
 
1.1.2. The signalosome 
Wnt proteins are lipid modified during synthesis on a single serine residue by a 
palmitoyltransferase termed Porcupine (Willert et al., 2003; Rios-Esteves & Resh, 2013). This 
single lipid moiety is crucial for Wnt export (through binding to Wntless/Evi; Bartscherer et al., 
2006) and receptor binding (Janda et al., 2012), but it also renders the protein hydrophobic. 
The lipid may therefore tether Wnt to cell membranes, restricting its spread, and activity, to 
cells that directly contact each other. Indeed, recent evidence suggests that the role of 
Wingless in Drosophila can be largely fulfilled by a membrane-tethered form of the protein 
that cannot diffuse (Alexandre et al., 2014), though it could still be transported over longer 
distances on vesicles or filopodia (Stanganello et al., 2015). 
 
All Wnt proteins bind to heterodimeric receptor complexes, which in the canonical pathway 
consist of a Fz receptor and an LRP5/6 co-receptor (Fig 1.3A). Fz proteins, of which there are 
10 in mammals, are the archetypal members of the Frizzled (‘F’) class of G-protein coupled 
receptors (GPCRs; Hanlon & Andrew, 2015), although the importance of Fz signalling via 
heterotrimeric G-proteins remains a point of contention (see for example Nichols et al., 2013). 
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All Fzs have a large N-terminal extracellular cysteine-rich domain (CRD; Bhanot et al., 1996) 
that constitutes the primary binding site for Wnt (Dann et al., 2001). A crystal structure of the 
complex shows that Wnt ‘grasps’ the CRD via two distinct binding interfaces, one of them 
involving the palmitoylate moiety of Wnt sitting in a hydrophobic groove of the CRD (Janda et 
al., 2012). Removal of the lipid by the Wnt antagonist Notum completely blocks signalling, 
highlighting the importance of this interaction (Kakugawa et al., 2015). There is extensive 
Wnt/Fz cross-reactivity, with a single Wnt able to bind multiple Fzs, and vice versa 
(Dijksterhuis et al., 2015). Furthermore, Wnts are not the only ligands of Fz receptors: the 
cysteine-knot protein Norrin (Xu et al., 2004) and, intriguingly, Clostridium difficile toxin B 
(TcdB) can also bind and signal via Fz (Tao et al., 2016). 
 
During signalling, Fz cooperates with the single-transmembrane proteins LRP5/6 (known as 
Arrow in Drosophila; Wehrli et al., 2000), such that Wnt binding leads to coupling of the two 
receptors (Fig 1.3B; Janda et al., 2017). This mechanism leads to a conformational change in 
the receptors and triggers formation of Wnt ‘signalosome’ complexes on the cytoplasmic face 
of the active receptors, a process that is dependent on dynamic polymerization of Dvl via its 
DIX domain (Bilic et al., 2007; Schwarz-Romond et al., 2007a). This increases the avidity of 
Dvl for Axin, enabling it to recruit Axin (and with it, the degradasome) through mutual DIX 
interactions (Schwarz-Romond et al., 2007b; Fiedler et al., 2011). Dvl polymerisation also 
triggers phosphorylation of LRP5/6 by GSK3 (and subsequently CK1γ) on specific PPPSP 
motifs in the cytoplasmic tail (Bilic et al., 2007; Davidson et al., 2005), which become binding 
sites for Axin, reinforcing the interaction between the degradasome and the LRP5/6 tail 
(Tamai et al., 2004; Metcalfe et al., 2010). This proximity allows the phosphorylated motifs to 
bind the active site of GSK3 and competitively inhibit its catalytic activity, preventing 
phosphorylation of β-catenin (Stamos et al., 2014), although it has also been proposed that β-
catenin ubiquitylation is the key step that is inhibited (Li et al., 2012). Alternative mechanisms 
for GSK3 inhibition have also been suggested, including the sequestration of GSK3 and 
LRP5/6 away from β-catenin in multivesicular bodies (Taelman et al., 2010), although the 
physiological relevance of this model is dubious (Metcalfe & Bienz, 2011). As well as the key 
stabilisation of β-catenin, GSK3 inhibition has a marked effect on other Wnt components, 
including Axin itself, which is rapidly dephosphorylated and subsequently degraded during 
signalling (Willert et al., 1999; Ji et al., 2017). 
 
Whilst the role of LRP5/6 is now relatively well understood, the function of Fz in signal 
transduction is somewhat more obscure. The cytoplasmic face of Fz can bind directly to the 
Dvl DEP (Dishevelled/Egl-10/Pleckstrin) domain (Tauriello et al., 2012), potentially creating 



























Figure 1.3 Mechanisms of signalosome formation. 
(A) Domain architecture and key interactions of Dvl and Wnt receptors. 
(B) Model for Wnt-triggered signalosome formation. Fz and LRP5/6 are coupled upon Wnt 
binding, creating a high local concentration of Dvl on the cytoplasmic faces of these 
receptors and triggering signalosome assembly through polymerization of the Dvl DIX 
domain. This also requires DEP domain-swap dimerization (see inset panels), and may 
be potentiated by multimerization of Fz. LRP6 becomes phosphorylated on five C-
terminal residues (depicted as red dots), subsequently acting to competitively inhibit 




as well as DIX-DIX interactions, dimerization of the DEP domain through ‘swapping’ of an N-
terminal helix has recently been shown to be essential for Dvl polymerization (Fig 1.3B; 
Gammons et al., 2016a). The role of Fz may thus be to bring together Dvl molecules together 
to sufficient levels to trigger DEP dimerization, catalyzing an initial rate-limiting step of 
signalosome formation that is thermodynamically unfavourable to reverse (Gammons & 
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clustered so as to further potentiate this effect: LRP5/6 is reportedly associated with clathrin-
coated pits, potentially relocating Fz to these small membrane regions upon signalling 
(Hagemann et al., 2014; Gammons et al., 2016a). Alternatively, Fz multimerization could 
occur via binding of two CRDs to a single palmitoleic acid moiety on Wnt (Nile et al., 2017; 
DeBruine et al., 2017), or even directly through its transmembrane region (Petersen et al., 
2017). 
 
Like the degradasome, Wnt signalosomes represent highly complex and dynamic protein 
assemblies, reflecting the molecular properties of the constituent proteins (Gammons & 
Bienz, 2017). Many details of signalosome assembly and, in particular, disassembly, are the 
subject of current research, and aspects of these processes constitute the subject of Chapter 
3 of this thesis. 
 
1.1.3. The enhanceosome 
The key condition for canonical Wnt signal transduction to be executed is that β-catenin is 
stabilised and enters the nucleus. The exact details of how β-catenin traverses the nuclear 
pore complex (NPC) are unclear, given that it lacks an obvious nuclear localisation sequence 
(NLS), and its transport appears to be independent of the small GTPase Ran (Fagotto et al., 
1998; Yokoya et al., 1999), although the C-terminal armadillo repeat domain (ARD) of β-
catenin structurally resemble the HEAT repeats of importin-β, and can mediate direct 
interaction with nucleoporins (Lee et al., 2000; Sharma et al., 2012). It is also possible that a 
binding partner of β-catenin (perhaps APC or BCL9) may chaperone it through the NPC, 
although this has not been conclusively demonstrated (Rosin-Arbesfeld et al., 2000), and 
there is also evidence for a role of microtubular transport in some instances (Sugioka et al., 
2011). Fold change in β-catenin, rather than absolute concentration, is the critical determinant 
for transcription activation, implying that even low levels are sufficient for induction of target 
gene expression (Goentoro & Kirschner, 2009). 
 
Once it is has entered the nucleus, β-catenin effects a context-dependent cellular response 
through the transcriptional activation of TCF-bound target genes. This process occurs within 
the context of a large multiprotein complex termed the ‘Wnt enhanceosome’ (Fig 1.4). This 
complex consists of a core ‘ChiLS’ module (made up of a dimer of Chip/LIM-domain binding 
protein 1 (LBD1) and a tetramer of SSDP (single stranded DNA-binding protein)), which binds 
to Pygo, BCL9 (or its homolog BCL9-like (B9L)) and Gro/TLE, which links the complex to TCF 
and represses target genes in the absence of β-catenin (Fiedler et al., 2015; van Tienen et 
al., 2017; Cavallo et al., 1998). The enhanceosome can be tethered to DNA by lineage-
determining proteins, such as homeodomain, bHLH (basic helix-loop-helix) and GATA-binding 
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transcription factors, serving to integrate Wnt signalling with other positional information 
(Bronstein & Segal, 2011). 
 
TCF/LEF proteins are key transcription factors that employ sequence-specific DNA binding, 
as well as context-dependent interactions, to specify genes that are regulated by the Wnt 
pathway (Cadigan & Waterman, 2012). These factors are anchored on DNA via a highly 
conserved C-terminal HMG box (Giese et al., 1991), and bind directly to the central ARD of β-
catenin with high affinity (Knapp et al., 2001). Known as dTCF/Pangolin in Drosophila (van de 
Wetering et al., 1997; Schweizer et al., 2003), there are four TCF orthologs in mammals, all of 
which are extensively regulated by alternative splicing (van de Wetering et al., 1996; Cadigan 
& Waterman, 2012). Although several non-TCF proteins have been described as alternative 
transcriptional effectors of Wnt signalling, recent genome-wide approaches in mammalian 
cells and Drosophila imply that all direct activation of β-catenin target genes involves TCF 
(Schuijers et al., 2014; Franz et al., 2017). 
 
Two opposing models for the function of the essential proteins Pygo and BCL9/B9L have 
been proposed. The first of these suggests that these components are recruited to the 
enhanceosome by β-catenin only upon active Wnt signalling, during which Pygo serves to 
recruit transcriptional co-activator proteins via an NPF motif (Städeli & Basler, 2005). More 
recent evidence suggests that Pygo and BCL9 are constitutively associated with the 
enhanceosome (de la Roche & Bienz, 2007), via the concomitant interaction of Pygo with 
methylated histone tails and the ChiLS complex (Fiedler et al., 2008; Fiedler et al., 2015). 
BCL9 then interacts with multiple enhanceosome components, stabilising and scaffolding 
their assembly. Furthermore, whilst the interaction of β-catenin with TCF and APC is mutually 
exclusive, the binding site on β-catenin for BCL9 does not overlap with that for TCF 
(Hoffmans & Basler, 2004), permitting a model in which BCL9 serves to capture β-catenin and 
‘load’ it onto TCF (Fig. 1.4B; Mieszczanek et al., 2008; Fiedler et al., 2015). 
 
Once loaded onto TCF, β-catenin recruits transcriptional activators through its C-terminal-
most armadillo repeats and flexible C-terminal tail (Vleminckx et al., 1999; Mosimann et al., 
2009). These consist largely of histone acetyltransferases, including CBP/p300 (Takemaru & 
Moon, 2000; Hecht et al., 2000), and chromatin remodeling complexes such as SWI/SNF 
(Switch/Sucrose Non-Fermentable; Barker et al., 2001), which serve to reverse the repression 
exerted upon target genes by Gro/TLE. Although the exact nature of this repression is not 
fully clear, it likely involves chromatin condensation (dependent upon Gro/TLE tetramerization 
through an N-terminal Q domain), as well as histone deacetylation (Chen et al., 2000; Song et 


































Figure 1.4 Overview of the Wnt enhanceosome. 
(A) Domain architecture and key interactions of core Wnt enhanceosome components. 
(B) Model of transcriptional switching by the Wnt enhanceosome. The repressed state (top) is 
conferred by tetramerization of Gro/TLE via its Q domain (Q). Capture of β-catenin by 
BCL9 (bottom) induces a rearrangement of enhanceosome components into an active 
state permissive for transcription. The mechanism(s) by which Gro/TLE is inactivated is 







































2.1.5). The mechanism by which Gro/TLE is inactivated, such that transcriptional activation 
can occur is a further mystery, and is the principal subject of Chapter 2 of this thesis. 
Counterintuitively, β-catenin can also recruit transcriptional repressors, such as ICAT (which 
functions to displace both TCF and CBP/p300 from β-catenin through competitive binding), in 
order to terminate transcription in a timely fashion (Daniels & Weis, 2002). 
 
Just like the degradasome and signalosome, the Wnt enhanceosome depends on numerous 
multivalent and redundant interactions between individual components for its assembly and 
function. A recent study from the Bienz lab, based on proximity-labelling of endogenous 
proteins, provided evidence that the composition of the enhanceosome is not altered 
significantly during signalling, suggesting that changes in transcriptional activity are instead 
dependent on conformational rearrangements triggered by the binding of β-catenin (van 
Tienen et al., 2017). Further studies are required to decipher the intricacies of these 
rearrangements and the mechanisms by which they control the activity of this enigmatic 
complex. 
 
1.2. Wnt signalling controls development and self-renewal of adult tissues 
Wnt-operated transcriptional switches are conserved from placozoa (primitive animals lacking 
body axes and tissues) to humans, and regulate numerous aspects of development (Wodarz 
& Nusse, 1998; Ringrose et al., 2013). Cell fate specification in the C. elegans embryo, 
Drosophila larval patterning and Xenopus axes establishment have all been used as models 
for studying Wnt signalling in developmental contexts. Such complex processes invariably 
require the integration of multiple inputs, from both Wnt and other key signalling pathways 
(van Amerongen & Nusse, 2009). In particular, Wnt and Hedgehog are often secreted by 
adjacent groups of cells, for example at segment boundaries in Drosophila, where they 
establish reciprocal signalling systems in which they are mutually dependent (Ingham & 
McMahon, 2001). 
 
In addition to its key role in development, Wnt signalling persists in adult organisms and is a 
key regulator of homeostasis in self-renewing tissues such as the intestinal epithelium. The 
mammalian intestine is covered by a single sheet of epithelial cells, which is invaginated into 
a series of alternating crypts and villi (Fig. 1.5). The base of each crypt houses a stem cell 
compartment, from which proliferative ‘transit-amplifying’ cells migrate upwards towards the 
apex of the villi, terminally differentiating into specialised cell types in the process, before 
being shed into the gut lumen (van der Flier & Clevers, 2009). The rate of proliferation of the 




Figure 1.5 Wnt signalling in 
the intestinal epithelium. 
Long-lived Wnt-receptive stem 
cells, marked by LGR5, give 
rise to transit-amplifying cells 
which are displaced upwards, 
differentiating in the process 
into specialised lineages 
before being shed into the 
intestinal lumen. The entire 
epithelium is renewed 
approximately every 120 
hours. Wnt is expressed in a 
gradient, highest at the base 
of the crypt and decreasing 











approximately every 120 hours), in contrast to the extremely long-lived and slowly dividing 
stem cells. This proliferation, and the acquisition of cell fate, is coordinated by a small number 
of signalling pathways, principally Wnt and Notch (Tian et al., 2015). 
 
The defining characteristic of stem cells is their capacity to self-renew, while also producing 
specialised cells. This behaviour is primarily dictated by short-range signals, which typically 
originate from a defined stem cell ‘niche’ (Losick et al., 2011). Wnt was first implicated in 
intestinal homeostasis when it was shown that TCF4 knockout lead to loss of intestinal stem 
cells and catastrophic breakdown of the epithelium in mice (Korinek et al., 1998), and 
signalling was subsequently observed to be highest at the base of each crypt, decreasing 
gradually along the crypt-villus axis (van de Wetering et al., 2002). Conditional knockout of β-
catenin in the proliferative compartment confirmed the requirement for Wnt signalling in 
maintenance of intestinal cell proliferation (Ireland et al., 2004). Wnt is now known to be 
required for the maintenance of most, if not all, types of stem cell: indeed, pluripotent 
embryonic stem cells can be maintained in culture with the addition of just two small 
molecules, one of which (termed CHIR) potently activates Wnt signalling through inhibition of 























The exact identity of the key stem cells has historically been a matter of some contention. 
However, lineage-tracing experiments identified a small population of cycling cells, marked by 
surface expression of LGR5 (leucine-rich repeat-containing G-protein coupled receptor 5), as 
long-lived, multipotent stem cells (Barker et al., 2007). LGR5 promotes cell surface 
expression of Fz, potentiating the reception of Wnt signals by these stem cells (de Lau et al., 
2011). LGR5 has subsequently been demonstrated to mark stem cells in many other organs, 
including hair follicles, where Wnt is also known to play multiple roles (Jaks et al., 2008; 
DasGupta & Fuchs, 1999). The outcome of Wnt signalling in different tissues seems to 
depend on the developmental history of the receiving cell. For example, it promotes self-
renewal and proliferation of intestinal and haematopoietic stem cells, but dictates specific cell 
fate decisions in neural crest stem cells (Reya et al., 2003; Lee et al., 2004). 
 
More recently, organotypic cell culture has been used to study the role of Wnt signalling in 
intestinal self-renewal. These cultures (termed ‘organoids’) are self-organizing, three-
dimensional structures that contain multiple organ-specific cell types arranged in an organ-like 
fashion, and can be genetically and phenotypically stable on a timescale of years. Epithelial 
organoids (or “mini-guts’’) can be grown from a single LGR5+ stem cell (Sato et al., 2009), 
and as such are amenable to manipulation by a number of cutting-edge techniques, such as 
CRISPR/cas9-mediated genome editing (Schwank & Clevers, 2016). 
 
Despite these advances, it is still unclear whether there is a common mechanism by which 
Wnt signals maintain the ‘stemness’ of their target cells (Clevers & Nusse, 2012). Stem cells 
are destined to differentiate by default, and it seems likely that Wnt signals block this intrinsic 
step, probably by suppressing the expression of differentiation-specific genes, and various 
model systems are now being employed to test this hypothesis. 
 
1.3. Inappropriate or hyperactive Wnt signalling drives tumourigenesis 
The specific behaviours of stem cells, which characterise development and homeostasis, 
often mirror those that characterise cancer cells. Aberrations in fundamental signalling 
pathways are regularly, therefore, associated with tumourigenesis. Although frequently 
hyperactivated in numerous cancers, the Wnt pathway it is best known for its causative role in 
intestinal tumourigenesis. Colorectal cancers are amongst the most common neoplasms in 
humans, with approximately 5% of Western populations expected to develop some form of 
colorectal malignancy during their lifetime (Bienz & Clevers, 2000). 
 
A small fraction of colorectal cancers occur in an inherited fashion, giving clues as to the 
underlying molecular causes. The APC gene was first characterised as a tumour suppressor 
when it was identified as being mutated in familial adenomatous polyposis (FAP), a rare 
hereditary colon cancer syndrome characterised by the development of numerous 
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adenomatous polyps during early adulthood, which invariably develop into carcinomas 
(Kinzler et al., 1991; Nishisho et al., 1991). FAP patients typically inherit one mutant copy of 
APC, and polyps develop upon spontaneous mutation of the second copy. The vast majority 
of these mutations are truncations, located in the mutation cluster region (MCR) between the 
second and third 20R repeats, which preclude binding of APC to Axin and thus prevent 
formation of the degradasome, leading to massive stabilisation of β-catenin (Nagase & 
Makamura, 1993; Kohler et al., 2009). Colorectal cancers that are APC wt (i.e. do not carry 
APC mutations) often carry inactivating mutations in Axin, or point mutations of β-catenin that 
prevent its phosphorylation by GSK3 or CK1α (Morin et al., 1997; Liu et al., 2000). 
Interestingly, over 10% of colorectal adenocarcinomas have mutations in FBXW7 (F-box/WD 
repeat-containing protein 7), a component of an E3 ubiquitin ligase complex that is not 
required for Wnt-dependent transcriptional activation by β-catenin, but is central to a novel 
arm of Wnt-signalling termed Wnt-dependent stabilisation of proteins (Wnt/STOP), whose 
targets include prominent oncogenes such as c-Myc (Acebron et al., 2014; Zhan et al., 2017). 
 
As well as the core pathway components, several regulators that ‘fine-tune’ Wnt signalling 
have also been implicated in cancer. For example, inactivating mutations in the RNF43 (RING 
finger protein 43) and ZNRF3 (Zinc RING finger protein 3) E3 ubiquitin ligases (negative 
regulators of Wnt signalling which promote endocytosis and hence limit cell-surface levels of 
Fz; Hao et al., 2012; Koo et al., 2012) have been identified in pancreatic cancer and 
adrenocortical carcinoma, respectively (Wu et al., 2011; Assié et al., 2014), whilst 
chromosomal fusions involving R-spondin can be found in colon cancer (Seshagiri et al., 
2012). Several studies have also suggested a link between Wnt and non-coding RNAs; 
microRNA-146a can stabilise β-catenin, leading to maintenance of Wnt signalling and 
symmetric division of colorectal cancer stem cells (Hwang et al., 2014).  
 
Polyp formation occurs at the boundary between crypts and villi, where cells from the 
proliferative zone grow into a neighbouring villus to form a microadenoma (Fig. 1.6A). This 
process is dependent upon APC mutation, but is only an early step towards malignancy 
(Powell et al., 1992). Development from a benign polyp into a severely dysplastic carcinoma 
requires additional mutations which drive aggressive tumour formation, often in well-
characterised oncogenes or tumour suppressors such as K-RAS, SMAD4 and/or p53 (Fig. 
1.6B; Kinzler & Vogelstein, 1996). Wnt signalling is also thought to contribute to metastasis of 
colorectal cancer cells through the activation of genes that promote the epithelial to 
mesenchymal transition (EMT; the process by which polarised epithelial cells transform into 
migratory cells with invasive capacity) such as SNAI2 (Wu et al., 2012). Indeed, 
overexpression of B9L results in morphological changes, accompanied by increased 

















Figure 1.6 Multistep models of intestinal tumourigenesis. 
(A) Adenomatous polyp formation in the intestinal epithelium. Cells expand from the crypt into 
a villus, forming a microadenoma (2-4). This microadenoma can expand into multiple 
neighbouring villi, eventually forming a large adenomatous polyp (5-8). Adapted from 
Oshima et al., 1997. 
(B) Genetic progression of colorectal cancer tumourigenesis. Neoplastic development is 
initiated by activating mutations in Wnt pathway components (e.g. in APC), which can be 
inherited or spontaneous. This is followed by various mutations that drive the progression 
from an early adenoma to a malignant carcinoma. Components commonly mutated in a 





Although less common, Wnt-related pathology is not restricted to cancer. Mutations in Wnt 
signalling components, either inherited or spontaneous, are known to also contribute to the 
development of numerous degenerative diseases. Well-characterised mutations in LRP6 or 
SOST (an LRP6-binding Wnt antagonist; Semënov et al., 2005) cause sclerosteosis and 
hereditary osteoporosis (Baron and Kneissel, 2013), whilst diseases such as familial 
exudative vitreoretinopathy can be caused by mutation of LRP5, Fz4, or Norrin (Nusse & 
Clevers, 2017). Furthermore, increased risk for type 2 diabetes has been linked to single 
nucleotide polymorphisms (SNPs) in gene coding for Wnt5b, Wnt10b and TCF4, suggesting a 
link between Wnt signalling and metabolic disease (Grant et al., 2006; Clevers & Nusse, 
2012). 
 
Conditional knockout strategies in the mouse have been central to investigating the effect of 






























recently, intestinal organoids have been used to model colorectal cancer and examine the 
requirements for different mutations in growth and invasion (Matano et al., 2015). Despite 
this, many of the interactions between Wnt components in the pathological context of 
colorectal cancer are yet to be fully understood. Numerous mutations have been found 
enriched in colorectal cancer patients, and in many cases it is unclear whether these are key 
‘drivers’ of tumourigenesis, or merely bystanders to the process. For example, both 
amplification and loss-of-function mutations of UBR5 and Naked (the subject of chapters 2 
and 3 of this thesis, respectively) have been found in colorectal tumours. Non-canonical Wnt 
signalling pathways may also contribute to the development of pathology (see, for example 
Zhan et al., 2017). A fuller understanding of these interactions is required if therapeutic 
targeting of the Wnt pathway is to be achieved. 
 
1.4. Therapeutic targeting of the Wnt pathway 
The undisputed role of Wnt signalling in numerous human diseases implies that it has strong 
potential as a target for therapeutic intervention. Indeed, whilst adenomas with Wnt-activating 
APC mutations often reach severe dysplasia, those with only K-RAS mutations usually fail to 
progress to large tumours (Jen et al., 1994). Despite this, there are no Wnt-targeting 
therapeutic agents currently in use in the clinic. An overarching aim of the Bienz lab, and thus 
of this thesis, is to identify and understand Wnt pathway components, so as to determine their 
potential as targets for therapeutic intervention. 
 
Extensive efforts from multiple groups, using a number of different approaches, have been 
made to identify or design small molecules that interfere with Wnt signal transduction. Some 
compounds that reduce signalling have been successfully identified; for example, the stability 
of Axin, which is controlled by tankyrase-mediated ADP-ribosylation, is one aspect of the 
pathway that appears to be targetable. Treatment of non-cancerous cells with tankyrase 
inhibitors, such as XAV939, leads to increased Axin, and concomitantly lowered β-catenin 
levels, inhibiting signalling (Huang et al., 2009; Kulak et al., 2015). However, tankyrase 
inhibitors are ineffective under conditions of chronic Wnt signalling in colorectal cancer cell 
lines (de la Roche et al., 2014). Specific inhibitors of Porcupine, the acyltransferase that 
catalyzes palmitoylation of Wnt, have also been identified. These molecules, which include 
IWP2 and LGK974, lead to a complete block in Wnt secretion and receptor binding, and may 
have efficacy in treatment of metastatic lesions that appear to require the presence of Wnt 
itself (Lu et al., 2009; Madan et al., 2016). Wnt-receptor interactions have also been probed 
as potential targets, with antibodies directed at Fzs and R-spondins (a family of Wnt agonists) 
both showing promise in certain model systems (Steinhart et al., 2017; Storm et al., 2016). 
Perhaps most successfully, a monoclonal antibody targeting SOST (known as 
Romosozumab) has proven useful in treating Wnt-related osteoporosis in clinical trials 
(Cosman et al., 2016). 
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Despite these successes, therapeutic agents that would be expected to function in the 
majority of colorectal tumours (which carry mutations of APC or β-catenin) have yet to be 
identified. One obvious target is the complex formed between TCF and β-catenin, which is 
absolutely required for signalling, and acts at a node in the pathway that is downstream of 
almost all activating mutations (Clevers & Nusse, 2012). Like many protein-protein 
interactions, however, targeting this complex has proven fraught with difficulty. The large, 
shallow groove of the β-catenin armadillo repeat domain, which binds to numerous positive 
and negative regulators of signalling, seems to be difficult to target selectively (Huber et al., 
1997; Daniels et al., 2001). A unique difficulty with targeting the Wnt pathway seems to be 
that much of the signal transduction process relies on changes in the oligomeric state and 
interactions of protein components, rather than the post-translational modifications that are 
pervasive in other pathways, and which necessitate modifying enzymes that constitute 
potential targets for therapeutic intervention. Despite this, post-translational modification does 
occur on numerous Wnt pathway components, and enzymatic positive regulators of the 
pathway are sought after as potential targets (a theme explored in more detail in Chapter 2 of 
this thesis).  
 
As well as blocking signalling, there is also potential clinical value in stimulating the Wnt 
pathway for tissue regrowth and regeneration. Wnt itself is unsuitable for use as a drug, due 
to its hydrophobicity, which complicates delivery (and also because producing significant 
quantities is currently challenging). Recently, however, soluble protein agonists of Wnt have 
been shown to activate signalling in vivo, whilst several small molecule inhibitors of GSK3 
have been identified that induce Wnt target gene expression (Janda et al., 2017; Licht-Murava 
et al., 2016). A more detailed understanding of physiological and pathological Wnt signalling 
pathways, both canonical and non-canonical, is required for us to be able to identify the most 
likely points for therapeutic intervention, and to predict the efficacy and side-effects of the Wnt 













1.5. Outstanding questions in the Wnt signalling field 
Through the efforts of a large number of different labs over almost three decades, the core 
components of the Wnt pathway have now been identified, and many of their individual 
interactions defined. The next goal of the Bienz lab, and thus of this thesis, is to understand 
the Wnt-induced molecular changes that trigger the assembly and disassembly of the three 
multiprotein complexes that govern Wnt signal transduction (the degradasome, signalosome 
and enhanceosome), and their switching between inactive and active states. This represents 
a significant challenge, given that these transitions involve numerous and often subtle 
changes in the activities, conformations and/or oligomeric states of the constituent proteins of 
these complexes. 
 
This thesis covers progress towards answering two key questions, each of which relate to the 
switching of one of these complexes from one state to another: 
 
In Chapter 2, I examine the mechanisms underlying the switching of the Wnt enhanceosome 
from a poised to an active state upon docking of β-catenin. Crucially, this transition requires 
inactivation of Gro/TLE, a key co-repressor of Wnt target genes. I outline our progress 
towards understanding this inactivation, and the essential role that ubiquitylation of Gro/TLE 
by a HECT E3 ubiquitin ligase, termed UBR5, plays in this process. 
 
In Chapter 3, I investigate the mechanisms by which signalosomes are switched off in a 
timely fashion to effect the cessation of canonical Wnt signalling. I focus in particular on the 
role of a key cytoplasmic negative regulator of the pathway, Naked, which acts at the level of 
Dishevelled, but whose mechanism of action is largely unknown.  
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A key step in Wnt signal transduction is the conversion of the nuclear enhanceosome 
complex from a poised, silent state into an active one that is permissive for transcription. 
Operating this transcriptional switch involves binding of the central effector, β-catenin, to TCF, 
and the concomitant release of transcriptional repression imposed on the Wnt target genes by 
TCF-associated Gro/TLE. Despite the central importance of this step, which occurs 
downstream of almost all Wnt pathway-activating mutations, it remains poorly understood. In 
this chapter we identify a new mechanism within this transcriptional switch, whereby a HECT 
ubiquitin ligase, UBR5, ubiquitylates and subsequently inactivates Gro/TLE during Wnt 
signalling. 
 
2.1.1 The ubiquitin system 
The ubiquitin system is responsible for the post-translational, covalent addition of a highly 
conserved protein termed ubiquitin (Ub) onto intracellular substrates. This system, which is 
involved in controlling almost all processes in eukaryotic cells, provides an essential 
mechanism for communication between cellular pathways (Yau & Rape, 2016). It can target 
damaged, misfolded or otherwise abnormal proteins in a constitutive fashion, but it can also 
regulate protein stability or activity in a switch-like manner (Varshavsky et al., 2012). 
 
Ubiquitin is a highly stable protein of 76 amino acids, consisting of a single β-grasp fold 
(Vijay-Kumar et al., 1987). The sequence of ubiquitin is almost invariant from yeast to man, 
suggesting a strong evolutionary pressure to conserve the structure, and implying that much 
of its surface is involved in recognition by ubiquitin-binding domains (UBDs; Dikic et al., 
2009). Substrate modification with ubiquitin is known as ‘ubiquitylation’. In the simplest 
version of the process, monoubiquitylation, a single ubiquitin moiety is covalently conjugated 
via its flexible C-terminal tail to the ε-amino group of a target lysine residue, yielding a 
‘branched’ protein conjugate with multiple exposed N-termini (the initial observation that led to 
the discovery of ubiquitin; Goldknopf & Busch, 1977). Multi-monoubiquitylation, where a 
single ubiquitin is conjugated to multiple lysine residues on a substrate, can also occur (Fig. 
2.1A). 
 
Furthermore, ubiquitin itself contains eight primary amines (seven lysine residues and an N-
terminus) that constitute sites for additional of further ubiquitin, permitting the formation of 
polyubiquitin ‘chains’ (Fig. 2.1A; Hershko & Heller, 1985). In most of these polyubiquitin 
(polyUb) conjugates, each ubiquitin moiety is linked to the next via the same lysine (or 
methionine) residue, creating chains that adopt distinct, dynamic conformations that can be 
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specifically recognised by specialised UBDs (Ye et al., 2012). The idea that different types of 
chain, such as K48-, K63- and Met1-linked polyubiquitin, can serve as distinct signals has 
lead to the proposal of a ‘ubiquitin code’, whereby ubiquitin chains encode information that is 
deciphered by UBDs to effect specific biological outcomes (Fig. 2.1B; Komander & Rape, 
2012; Yau & Rape, 2016). 
 
All of the different possible chain types have been identified in cells, although their proportions 
vary drastically (Meierhofer et al., 2009). K48-linked chains constitute the majority of 
polyubiquitin found in cells, and have been known for a long time to promote 26S-
proteasome-mediated degradation of modified substrates (Chau et al., 1989). Accordingly, 
these chain types are known to be the product of several E3 ligases associated with 
degradation, such as the cell-cycle associated E3 ligase SCF (Skp, Cullin, F-box containing), 
and their levels increase upon proteasome inhibition (Petroski & Deshaies, 2005; Xu et al., 
2009). In some cases, proteins destined for degradation can be escorted to the proteasome 
by chaperones, such as VCP/p97 (valosin-containing protein/protein of 97 kDa), that 
specifically recognize K48-linked polyubiquitin (van den Boom & Meyer, 2017; see also 
Section 2.1.4). The ubiquitin system is also able to act independently of this ‘ubiquitin-
proteasome system’ (UPS), by recruiting proteins to participate in signalling, controlling 
substrate localisation via trafficking factors, or by directly controlling substrate activity (Hoege 
et al., 2002; Terrell et al., 1998; Rahighi et al., 2009). These functions often depend upon 
monoubiquitylation or Met1- and Lys63-linked polyubiquitin modifications (Chen & Sun, 2009). 
Work to identify the physiological roles of other ‘atypical’ ubiquitin chain types, including K27-, 
K29- and K33-linked polyubiquitin, is ongoing (Kulathu & Komander, 2012). 
 
In some cases, multiple linkage types are present on a single substrate, either as separate 
chains, or in the form of mixed or branched heterotypic chains (Fig. 2.1A). Binding of IL-1 to 
its cognate receptor triggers the assembly of both K63- and Met1-linked polyubiquitin on 
IRAK1, much of which is in the form of hybrid chains (Emmerich et al., 2013). The extent to 
which the context of a single ubiquitin linkage produces a specific response remains unclear, 
although it is thought that some ubiquitin branch points can be specifically recognised by 
certain UBDs (Ohtake et al., 2016). In some cases, polyubiquitin can be released from 
substrates and the unanchored chains act as second messengers (Xia et al., 2009). Further 
expanding the complexity of the code, ubiquitin itself has recently been found to be subject to 
(non-ubiquitin) post-translational modifications, including phosphorylation and acetylation 
(Koyano et al., 2014; Ohtake et al., 2015). The ubiquitin kinase PINK1 generates Ser-65-
modified phosphoubiquitin, a potent signalling molecule that promotes mitophagy through 
allosteric activation of the E3 ligase Parkin (Wauer et al., 2015). Furthermore, there are 




















Figure 2.1 Summary of the ubiquitin system. 
(A) Diversity of potential ubiquitin modifications. Blue and pink moieties represent ubiquitin 
linked via different lysine residues. Red dots indicate phosphorylated ubiquitin. 
(B) Structure of ubiquitin, highlighting (in bold) the 8 potential sites for further ubiquitin 
modification, and the known cellular roles of some of these polyubiquitin chains. 
(C) The ubiquitylation cascade. Ubiquitin is activated by an E1 ubiquitin-activating enzyme in 
an ATP-dependent fashion, and transferred to a catalytic cysteine residue of an E2 
ubiquitin-conjugation enzyme. This in turn transfers ubiquitin directly or indirectly onto the 
substrate with the aid of an E3 ligase. 
(D) Mechanisms of E3 ubiquitin ligases. RING ligases (left) catalyse the direct transfer of 
ubiquitin from E2 to substrate. In contrast, HECT/RBR ligases (right) operate via a two-
step mechanism, involving transfer of ubiquitin onto a catalytic cysteine residue of the E3, 




operate in parallel with ubiquitin, often but not exclusively employing components of the 
ubiquitin system for their own conjugation (van der Veen & Ploegh, 2012). In some cases, 
these different modification systems can act on substrates in simultaneous and even 
coordinated fashion (Prudden et al., 2007).  
 
Ubiquitylation is executed via a three-step cascade involving ATP-dependent activation of 
ubiquitin by an E1 ubiquitin activating enzyme, conjugation of ubiquitin to an E2 ubiquitin 
conjugating enzyme, and the transfer of ubiquitin to substrate mediated by the E3 ubiquitin 
ligases that have already been touched upon (Fig. 2.1C). There are two E1s, approximately 
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(Schulman & Harper, 2009). This cascade allows the system to be tightly regulated at several 
stages of ubiquitin transfer, and can also be reversed through the activity of deubiquitylating 
enzymes (DUBs). E3 ligases and DUBs are focal points of study within ubiquitin research, 
since they impart the majority of the substrate and linkage-type specificity. 
 
Three classes of E3 ubiquitin ligases have been identified to date: RING (really interesting 
new gene), HECT (homologous to E6-AP C-terminus) and RBR (RING-Between-RING; 
Zheng & Shabek, 2017). The HECT and RBR families have different characteristic catalytic 
folds but share a common mechanism, in which ubiquitin is accepted from the E2 enzyme 
onto a catalytic cysteine before transfer onto the substrate (Fig. 2.1D, see also Section 
2.1.3). In contrast the RING family, which contains the vast majority of known E3 ligases, do 
not contain a catalytic cysteine, and ubiquitin is transferred directly from E2 to substrate in a 
fashion facilitated by the RING domain. Within each family of E3 ligases there are numerous 
subfamilies; the HECT family is subdivided into the NEDD4, HERC and ‘other HECT’ 
subfamilies, for example (Rotin & Kumar, 2009). Similarly, there are several families of 
deubiquitylases, with a remarkable variety of different catalytic folds and mechanisms, 
displaying numerous determinants of substrate and ubiquitin linkage specificity (Komander et 
al., 2009; Mevissen et al., 2013). Based on the current rate of advance, further classes of 
both E3 ligase and DUB are likely to be identified in the future (see for example Pau et al., 
2018). As enzymes that modulate a myriad of signalling pathways through regulation of 
protein ubiquitylation, these proteins represent attractive targets for therapeutic intervention 
(Huang & Dixit, 2016). 
 
2.1.2 Ubiquitylation in the Wnt pathway 
As in many intracellular pathways, ubiquitin-dependent mechanisms operate at multiple steps 
of Wnt signalling, targeting both positive and negative components of the pathway, and 
providing addition layers of control through the regulation of protein stability, activity and 
localisation (Tauriello & Maurice, 2010a).  
 
Wnt signalling hinges on the crucial step of ubiquitin-mediated degradation of the key 
transcriptional regulator β-catenin. In the off state, the RING E3 ligase β-TrCP targets 
phosphorylated β-catenin for degradation through the assembly of K48-linked polyubiquitin 
chains on N-terminal lysine residues (Wu et al., 2003). Interestingly, other E3 ligases have 
been implicated in ubiquitylation and degradation of β-catenin, including Jade-1 and HUWE1 
(HECT, UBA and WWE domain-containing protein 1; Chitalia et al., 2008; Dominguez-Brauer 
et al., 2017), whilst one report proposed that assembly of atypical ubiquitin chains by the 
HECT E3 ligase UBR5 could stabilise β-catenin and thereby promote Wnt signalling (Hay-
Koren et al., 2011). 
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Whilst components of the degradasome function to earmark β-catenin for degradation, they 
are themselves subject to ubiquitin-dependent regulation. Recall that Axin is constitutively 
targeted for degradation by the poly-ADP-ribose activated RING E3 ligase RNF146, keeping 
its concentration low (Zhang et al., 2011; Section 1.1.1). Moreover, Wnt-treatment of cells 
leads to a further reduction in Axin levels, which was recently shown to be mediated by an E3 
ligase termed SIAH (Ji et al., 2017). The SIAH binding site on Axin overlaps with that of 
GSK3, meaning that SIAH-dependent Axin degradation only occurs upon Wnt-induced 
degradasome disassembly. Knockout of SIAH-1 attenuates β-catenin stabilisation and Wnt 
signalling, seemingly at odds with previous reports implicating it in ubiquitylation of β-catenin 
(Liu et al., 2001; Dimitrova et al., 2010). On the other hand, K63-linked polyubiquitylation of 
APC by HECTD1 is reported to negatively regulate signalling through promotion of the APC-
Axin interaction, although the role of the ubiquitin chains in this process is unclear (Tran et al., 
2013). Confusingly, UBR5 has also been identified as an APC-associated E3 that decreases 
levels of active β-catenin (Ohshima et al., 2007), although this mechanism is reportedly 
independent of E3 ligase activity and contradicts the report mentioned above (Hay-Koren et 
al., 2011). 
 
Positive regulators of the Wnt pathway are also subject to regulation via ubiquitylation.!The 
transmembrane RING E3 ligases RNF43 and ZNRF3 inhibit Wnt signalling by promoting the 
ubiquitylation and subsequent lysosomal degradation of Frizzled and LRP6 in a fashion 
dependent upon the Dvl DEP domain (Mukai et al., 2010; Koo et al., 2012; Jiang et al., 
2015b). This cycle is in turn inhibited by R-spondins, which bind to LGR4/5 receptors and 
promote the internalization of RNF43 and ZNRF3, thereby acting as potent Wnt agonists (de 
Lau et al., 2011; Hao et al., 2012). Dvl itself is also heavily ubiquitylated by a number of E3 
ligases, including several from the NEDD4 (Neuronal precursor cell-expressed 
developmentally downregulated 4) subfamily of HECT E3s, although the function of these 
modifications has not been fully elucidated. ITCH and NEDD4L each negatively regulate Dvl 
levels in a manner dependent on a conserved PPxY motif in Dvl (Wei et al., 2012; Ding et al., 
2013). HUWE1 can also modify Dvl, reportedly with K63-linked non-proteolytic polyubiquitin 
(de Groot et al., 2014). These modifications, which can be removed by the deubiquitylase 
CYLD, may function by modulating the ability of Dvl to polymerize through the DIX domain 
(Tauriello et al., 2010b; Madrzak et al., 2015, see also Chapter 3).  
 
Despite this plethora of reported modifications, relatively few roles for ubiquitylation have 
been identified at downstream steps of Wnt signal transduction. The DUB Uch37 binds 
TCF/LEF and promotes Wnt signalling, but this is seemingly independent of catalytic activity 
(Han et al., 2017). Monoubiquitylation of the N-terminal Q domain of Gro/TLE by XIAP (X-
linked inhibitor of apoptosis protein) has been reported to activate Wnt signalling, by 
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promoting the dissociation of Gro/TLE from TCF, but this ubiquitylation is not Wnt-dependent 
(Hanson et al., 2012). Intriguingly, the scaffolding protein BCL9 contains a PPxY motif, similar 
to that of Dvl, which could recruit E3 ligases to the enhanceosome, although none have been 
conclusively demonstrated as physiologically relevant ligands at this stage. 
 
It is clear that ubiquitin is a key regulatory protein in the Wnt pathway, controlling the stability 
of crucial components through proteasomal degradation, as well as protein localisation, 
trafficking and activity through non-proteolytic mechanisms (Tauriello & Maurice, 2010a). 
Although a few of these ubiquitin-dependent mechanisms have been outlined in some detail, 
in many cases the literature is unclear, largely due to the relatively subtle effects that many 
modifications have, and the fact that conclusive identification of E3 ligase-substrate pairs is 
technically very challenging (Iconomou & Saunders, 2016). For example, whilst UBE3C has 
been implicated in Wnt pathway activation in cancer, no mechanistic details or substrates 
have so far been identified (Wen et al., 2015). The case of UBR5 further highlights this, with 
two completely different substrates, chain types and corresponding effects on the pathway 
reported (Ohshima et al., 2007; Hay-Koren et al., 2011). 
 
2.1.3 UBR5 is an unusual HECT E3 ubiquitin ligase 
UBR5 was first identified in Drosophila as the gene hyperplastic discs (hyd), mutation of 
which causes massive overgrowth of somatic tissue in larval wing discs. Cloning of the hyd 
gene identified a large protein, subsequently shown to be homologous to a mammalian 
protein termed UBR5 (Mansfield et al., 1994; Callaghan et al., 1999).  
 
UBR5, also known as EDD1 (E3 identified by differential display 1), is a 309 kDa HECT E3 
ubiquitin ligase (of the ‘other HECT’ subfamily) found exclusively in metazoa. HECT ligases 
have a well-characterised mechanism for ubiquitin transfer, involving formation of a thioester 
linkage between ubiquitin and a conserved catalytic cysteine within the HECT domain 
(Komander & Rape, 2012). The HECT domain is located at the extreme C-terminus of UBR5 
and consists of archetypal N- and C-lobes, separated by a flexible linker, but displays several 
unique features. The HECT domain itself does not appear to contain a binding site for 
ubiquitin (usually located within the C-lobe), instead relying on a distant UBA domain (Kozlov 
et al., 2007). UBR5 also contains a UBR zinc finger required for recognition of substrates with 
destabilising N-terminal residues (N-end-rule substrates; Tasaki et al., 2005; Sriram et al., 
2011), and a MLLE domain (containing a characteristic MLLE motif), separated by large 
regions presumed to be natively unstructured (Fig. 2.2A). Intriguingly, sequence comparisons 
reveal homology between the region immediately upstream of the MLLE domain and N-
terminal portions of certain extended HECT domains, such as that of HUWE1, implying that 
the MLLE domain is present as an insert within the HECT domain (Fig. 2.2B). Accordingly, a 
minimal UBR5 HECT construct lacking this N-terminal region is not capable of polyubiquitin 
26 
synthesis in vitro (Kristariyanto et al., 2015). The MLLE domain is thought to be principally 
involved in recruitment of substrates (such as PAIP2; Kozlov et al., 2004), but may also 
regulate ubiquitin transfer catalyzed by the adjacent HECT (Munoz-Escobar et al., 2015). The 
full architecture of the MLLE-HECT region is not known, although a crystal structure of the 





























Figure 2.2 UBR5 domain architecture and cellular functions. 
(A) Domain architecture and key interactions of UBR5. 
(B) Sequence alignment of HUWE1 and UBR5 HECT domains. Note the region of HECT 
domain homology N-terminal of the UBR5 MLLE domain (shown in crimson). Alpha 
helices (H) are shown as cylinders, β-strands (S) as arrows. See text for more details. 
(C) Reported substrates and cellular roles of UBR5. Red arrows indicate proteins that are 
destabilised or inactivated by UBR5 activity, green indicates stabilisation or activation. 
Adapted from Shearer et al., 2015. 
 
Fig. 2.2!





















































UBR5 is predominantly localised to the nucleus, as a result of two nuclear localisation 
sequences (Henderson et al., 2002), and has been implicated it in a wide variety of cellular 
processes including DNA damage repair, translation and cell cycle regulation, as well as Wnt 
signalling (Munoz et al., 2007; Yoshida et al., 2006). As mentioned, identification of 
substrates of E3 ligases is technically challenging, and many interacting partners appear to 
be independent of UBR5 catalytic activity, suggesting that UBR5-mediated ubiquitylation is 
context dependent and tightly regulated. Reported substrates of UBR5 include DNA damage 
repair factors TopBP1, RNF168 and ATMIN (Honda et al., 2002; Zhang et al., 2014), 
translational machinery proteins CDK9 and PAIP2 (Cojocaru et al., 2011), and the KATNA1 
subunit of the cell cycle-related protein KATANIN (Maddika et al., 2009; see Fig. 2.2C for 
more details). In some cases, these substrates are destabilised by UBR5-dependent 
ubiquitylation, but this certainly does not seem to be an exclusive mechanism by which UBR5 
acts, and the polyubiquitin chain type(s) assembled by UBR5 remains a point of contention 
(Hay-Koren et al., 2011). In several cases, UBR5 cooperates with other E3 ligases, including 
TRIP12, and its activity may also be counteracted by associated deubiquitylases acting as 
part of ubiquitin chain-editing complexes (Gudjonsson et al., 2012; Rutz et al., 2015). 
 
Numerous studies have implicated UBR5 in various facets of cancer biology, and many of the 
reported molecular functions of UBR5 are consistent with a role in cancer (Shearer et al., 
2015). hyd was originally labelled as a tumour suppressor gene in Drosophila, but the most 
common genetic changes in UBR5 associated with cancers are amplifications, often in the 
form of allelic imbalances that result in increased levels of UBR5 mRNA, implying an 
oncogenic nature (Mansfield et al., 1994; Clancy et al., 2003). Indeed, UBR5 amplification 
correlates with negative outcomes in breast cancer, was identified in a mutagenesis screen 
for cooperative mutations in pancreatic adenocarcinomas, and has been shown to mediate 
therapeutic resistance in ovarian cancers (Mann et al., 2012; O’Brien et al., 2008). Clearly, 
the specific mechanisms by which UBR5 contributes to carcinogenesis remain poorly 
understood. This controversy also applies in the Wnt field, with conflicting reports labelling 
UBR5 as both a tumour suppressor (Ohshima et al., 2007) and an oncogene (Hay-Koren et 
al., 2011) with respect to colorectal cancer. Despite a plethora of research, there thus remains 
a lack of understanding of UBR5 activity in various physiological and pathological states, and 
any potential development of this E3 ligase as a therapeutic target is dependent on the 
identification of bona fide substrates in the context of carcinogenesis. The findings presented 
in this chapter are the results of a study initiated to clarify the literature with respect to UBR5 






2.1.4 VCP/p97 is a cellular unfoldase/segregase 
As briefly mentioned, an important feature of the ubiquitin-proteasome system (UPS) is the 
capacity to specifically recruit chaperones to polyubiquitylated proteins in order to execute 
particular functions related to protein folding and/or unfolding. One example, highly relevant 
for this thesis, is the abundant hexameric ATPase known as VCP/p97 (van den Boom & 
Meyer, 2017). 
 
VCP/p97 was originally discovered in yeast genetic screens as Cdc48 (Moir et al., 1982), and 
the mammalian homolog was later identified as a 97 kDa precursor of the small peptide 
valosin, hence termed valosin-containing protein (VCP) or p97 (although it subsequently 
emerged that valosin is actually unrelated to p97; Koller & Brownstein, 1987). VCP/p97 
belongs to the AAA+ family of ATPases, members of which function in all three domains of 
life, and is now understood in intricate structural detail (Zhang et al., 2000). VCP/p97 is a 
symmetrical hexamer, with each subunit consisting of a regulatory N-terminal domain and 
tandem ATP-binding domains, D1 and D2 (Fig 2.3A). ATP hydrolysis by the D2 domain 
allows VCP/p97 to impose conformational changes on substrate proteins, underlying 
VCP/p97’s diverse ability to unfold proteins for proteasomal degradation, or to segregate 
them from binding partners, membranes or protein complexes (Xia et al., 2016). VCP/p97 is 
assisted in these functions by over 25 cofactor proteins, which are recruited via dedicated 
domains that bind either the N domain or the C-terminal tail of VCP/p97. These cofactors 
often act as substrate or ubiquitin adapters, but in some cases confer additional enzymatic 
activities such as deubiquitylation (Meyer et al., 2002; Buchberger et al., 2015). 
 
VCP/p97 is localised throughout the cell, including large nuclear and organelle fractions, and 
has many reported functions that cover all aspects of cellular physiology (Fig 2.3B; Song et 
al., 2015; Ye et al., 2017). VCP/p97 clearly plays a critical role in the UPS, binding to a large 
number of polyubiquitylated proteins in various cellular locations and facilitating their 
proteasomal degradation, and also appears to be essential for autophagy-mediated 
degradation in lysosomes (Meyer et al., 2012; Papadopoulos et al., 2017). However, in some 
cases, VCP-associated deubiquitylases appear to act immediately upon segregation, 
potentially preventing degradation of the substrate (Rumpf & Jentsch, 2006; Bodnar & 
Rapoport, 2017). VCP/p97 has crucial regulatory roles in various signalling pathways, 
including NF-κB (Li et al., 2014), either through the proteasomal degradation of key 
regulators, or through the release of proteins from macromolecular complexes or membranes. 
Furthermore, VCP/p97-mediated segregation of ubiquitylated proteins from chromatin is now 
known to be essential for diverse DNA-related processes including replication, repair and 
transcription (Maric et al., 2014; van den Boom et al., 2016). Most of these processes involve 
recognition of K48-linked polyubiquitin, although other chain types, including K6- and K11-
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linked, have also been reported to recruit VCP/p97 (van den Boom & Meyer, 2017; Locke et 
































Figure 2.3 Structure and function of VCP/p97. 
(A) Domain architecture and key interactions/functions of VCP/p97.  
(B) Structure of a VCP/p97 hexamer, with key domains colour as in (A). Adapted from Meyer 
et al., 2012. 









































Unsurprisingly, given its manifold cellular functions, mutation of VCP/p97 is associated with 
various diseases. Though homozygous knockout in mice is lethal, dominant mutations in 
regulatory regions cause a late-onset multisystem proteinopathy (MSP-1), also known as 
IBMPFD! (Inclusion Body Myopathy with Paget’s Disease and Frontotemporal Dementia; 
Johnson et al., 2010). On the other hand, VCP/p97 is upregulated in certain cancers, 
apparently in response to increased proteotoxic stress (Deshaies, 2014). Small-molecule 
inhibitors of VCP/p97 are now are now available as research tools, and several are also in 
clinical trials (Chapman et al., 2015; Anderson et al., 2015). However, a detailed 
understanding of many aspects of VCP/p97 function is still lacking. In particular, the features 
of ubiquitylated proteins that define them as substrates of VCP/p97 and/or the proteasome 
are unclear, although particularly stable, folded proteins often seem to require VCP/p97. 
Specific features of the ubiquitin chain, including branching, may also be relevant (Blythe et 
al., 2017). Understanding of these basic biochemical questions will be required for the 
success of therapeutic strategies designed to target VCP/p97. In this chapter we identify the 
co-repressor Gro/TLE as a client of VCP/p97, and hence outline a key role for VCP/p97 in 
Wnt pathway regulation. 
 
2.1.5 Gro/TLE maintains transcriptional repression at Wnt enhanceosomes 
As discussed, the Wnt enhanceosome is a protein complex poised for transcriptional 
activation upon docking of β-catenin, but maintained in an inactive state by the co-repressor 
Groucho (Gro) in Drosophila, or its ortholog TLE in mammals (see Section 1.1.3). For the 
purposes of this thesis it is pertinent to give a more detailed introduction to the mechanisms 
by which Gro/TLE exerts transcriptional repression upon Wnt target genes, and to discuss 
some of the mechanisms proposed as means by which this repression is removed upon 
signalling, although both of these remain very much open questions. 
 
Gro/TLE proteins are broadly expressed and highly pleiotropic. Alongside Wnt, they regulate 
other developmental signalling pathways, including Notch, playing crucial roles in body 
segmentation, neurogenesis and sex determination (Paroush et al., 1994; Nagel et al., 2005). 
The primary structure of Gro/TLE includes five regions, of which the N-terminal Q domain and 
C-terminal WD-repeat (WD40) domain are most highly conserved (Fig 2.4A, B). The Q 
domain contains two coiled-coil motifs that facilitate oligomerisation, whilst the WD40 domain 
folds to form a β-propeller that mediates numerous protein-protein interactions (Jennings & 
Ish-Horowicz, 2008). These structured domains are linked by a flexible region containing the 
GP, CcN and SP motifs (Fig 2.4A). 
 
The repressive function of Gro/TLE is dependent on a combination of histone modifications 





























Figure 2.4 Structure and function of Gro/TLE. 
(A) Domain architecture and key interactions of TLE3. 
(B) Structure of TLE, incorporating crystal structures of the tetrameric N-terminal Q domain 
(monomer shown in orange; Chodaparambil et al., 2014) and C-terminal WD40 (Pickles 
et al., 2002). No structures have been solved for the largely unstructured linker between 
the Q and WD40 domains, although it contains several regions of interest. Adapted from 
Buscarlet & Stifani, 2007. PDB: 4OM3, 1GXR. 
(C) Model of Gro/TLE-dependent transcriptional repression. Gro/TLE recruits HDAC 
complexes which remove activatory modifications to histone tails, whilst also contributing 
to the generation of a repressive chromatin state through physical interaction of Gro/TLE 
tetramers with multiple nucleosomes. See text for more details. 
 
 
directly, and instead is localised to Wnt-responsive enhancers via the interaction of its Q 
domain with TCF/LEF (Cavallo et al., 1998; Chodaparambil et al., 2014). Histone deacetylase 
(HDAC) complexes are then recruited via the GP region to mediate transcriptional repression 
TLE3! 1! 772!Q! WD40!


















(Chen et al., 1999; Arce et al., 2009). However, Gro/TLE is also able to directly bind to 
histones, potentially leading to nucleosome clustering (due to the oligomeric nature of 
Gro/TLE). The determinants of this interaction remain controversial, with conflicting reports 
both implicating and dismissing a role for the Q domain in histone binding (Flores-Saaib & 
Courey, 2000; Sekiya & Zaret, 2007). Whatever the mechanism, it is clear that Q domain 
tetramerization is absolutely required for transcriptional repression, even though dimerisation 
appears to be sufficient for interaction with TCF/LEF (Chen et al., 1998; Song et al., 2004). 
The WD40 domain, meanwhile, assists in anchoring Gro/TLE to the Wnt enhanceosome 
through multivalent interactions with the ChiLS complex, as well as BCL9/B9L (Fiedler et al., 
2015; van Tienen et al., 2017). This domain also interacts with transcription factors containing 
characteristic WRPW or eh1 motifs (such as Engrailed and Goosecoid) via the central pore 
region of the propeller, integrating Gro/TLE-dependent repression with other positional inputs 
and providing a means for cross-talk between pathways (Jimenez et al., 1999; Jennings et 
al., 2006). Interestingly, a large number of WD40 domains are able to bind ubiquitin 
(Pashkova et al., 2010), although this has not been demonstrated for Gro/TLE. 
 
The Wnt transcriptional switch is thus controlled by the opposing effects of β-catenin and 
Gro/TLE. Transcriptional activation by β-catenin requires the inactivation of Gro/TLE, but how 
this takes place is largely unknown. Early models, based on in vitro data, suggested that β-
catenin might simply outcompete Gro/TLE for binding to TCF (Daniels & Weis, 2005), but this 
is inconsistent with the lack of overlap between the β-catenin and Gro/TLE binding sites on 
TCF/LEF (van de Wetering et al., 1997; Brantjes et al., 2001). Indeed, a subsequent study 
from the same group demonstrated that β-catenin and a Gro/TLE Q domain construct can 
bind LEF1 simultaneously (Chodaparambil et al., 2014). Moreover, very recent evidence from 
the Bienz lab, employing proximity labelling methods throughout the course of Wnt induction, 
suggests that Gro/TLE is not removed from the enhanceosome at any stage of signalling (van 
Tienen et al., 2017).  
 
One potential mechanism proposed for Gro/TLE inactivation involves the RING E3 ligase 
XIAP (X-linked inhibitor of apoptosis), which was reported to monoubiquitylate the Gro/TLE Q 
domain, promoting its dissociation from TCF (Hanson et al., 2012). However, this 
ubiquitylation was found to be independent of Wnt signalling. The authors proposed a model 
in which XIAP limits the amount of ‘free’ (non-ubiquitylated) Gro/TLE available to repress 
TCF, thereby maintaining a β-catenin-inducible switch. Other factors have also been 
implicated, including Lbx2, which activates Wnt transcriptional readouts in zebrafish, 
reportedly by directly binding Gro/TLE and blocking its ability to associate with TCF (Lu et al., 
2014). However, the mechanism by which the Wnt transcriptional switch is activated is very 
much an open question, and one on which this chapter is focused. 
33 
2.2 Results 
2.2.1 A screen for HECT E3 ligases modulating Wnt signalling 
Given the somewhat confusing state of the literature regarding the roles of HECT E3 ubiquitin 
ligases in control of Wnt signal transduction, I decided to clarify the roles of several candidate 
proteins from the enigmatic ‘other HECT’ subfamily (Fig. 2.5A) that have previously been 
implicated in Wnt regulation, using a small-scale deletion screen.  
 
Employing the CRISPR/Cas9 genome editing system, I designed single-guide RNAs 
(sgRNAs) to induce double-strand breaks in early exons of the genes coding for these E3 
ligases (Ran et al., 2013). Using Western blot analysis and DNA sequencing, I confirmed that 
these ligases were deleted from clonal HEK293T (human embryonic kidney 293 T-antigen) 
cell lines (Fig. 2.5B; Appendix 1). I then sought to test Wnt responses in these edited cell 
lines, using a luciferase-based TCF-dependent reporter assay (SuperTOP; Veeman et al., 
2003) to monitor Wnt transcriptional activity in the KO cell lines after stimulation of the 



















Figure 2.5 CRISPR/Cas9 screen for HECT E3 ubiquitin ligases modulating Wnt signal 
transduction. 
(A) Domain architectures of candidate E3 ligases selected for CRISPR/Cas9 knockout. 
(B) Western blots of cell lysates from KO lines (see also Appendix 1), probed with 
antibodies as indicated, to confirm absence of protein expression. 
(C) SuperTOP assays to measure Wnt signalling activity in KO cell lines stimulated with 
Wnt3a-conditioned media or LiCl. Values are presented as mean ± SEM (n=3), relative to 







wt! HUWE1! UBR5! TRIP12! HECTD1! UBE3C!





















































HEK293T cell lines in which one HECT E3 ligase, UBR5, was deleted, showed significantly 
reduced transcriptional responses upon both Wnt3a and LiCl stimulation (Fig. 2.5C). 
Contrastingly, deletion of the other ligases (HUWE1, TRIP12, HECTD1 and UBE3C) did not 
reduce the response, although HUWE1 deletion caused hypersensitivity to Wnt3a, perhaps 
expectedly since HUWE1 has been reported to negatively regulate the upstream signalosome 
component Dvl!(de Groot et al., 2014). UBR5, uniquely among the ligases studied, is thus a 
candidate positive regulator of Wnt-induced transcription in human cells. 
 
2.2.2 UBR5 is a positive regulator of Wnt signal transduction 
Given my results, and the contradictory previous literature linking UBR5 to Wnt signalling 
(Ohshima et al., 2007; Hay-Koren et al., 2011), I sought to confirm the suggestion from the 
CRISPR/Cas9 deletion screen that UBR5 acts as a positive regulator of Wnt signal 
transduction. 
 
Repeating the SuperTOP assays used for the initial screen, I found that the Wnt 
transcriptional output was again significantly reduced in UBR5 KO cells treated with Wnt3a or 
LiCl, compared to wt cells. This transcriptional response can, however, be rescued toward 
normal by re-expression of a GFP (green fluorescent protein)-tagged UBR5 (Fig. 2.6A), but 
not a catalytically dead UBR5 (UBR5-CS, bearing a cysteine-to-serine substitution, C2768S, 
in its catalytic site). Additionally, overexpression of a stabilised β-catenin construct (Δ45-β-
catenin, carrying a Δ45 deletion of a key phosphodegron residue that was identified in 
colorectal cancer cell lines; Morin et al., 1997) induces hyperactive signalling in wt cells, but 
this activity is significantly reduced in the UBR5 KO cells (Fig. 2.6B), suggesting that UBR5 
functions downstream of β-catenin in human cells. Furthermore, using RT-qPCR I found that 
endogenous mRNA levels of the Wnt target genes NKD1, AXIN2, and SP5 (Hanson et al., 
2012; Lustig et al., 2002; see also Appendix 2) are less inducible in LiCl-stimulated UBR5 
KO cells compared to wt controls (Fig. 2.6C).  
 
In order to minimise potential off-target effects of the CRISPR/Cas9 editing process (which 
involves the growth of clones from single cells), I further confirmed that an independently 
isolated UBR5 KO line behaves the same way in SuperTOP assays (Fig. 2.6D). Taken 
together, these results confirm that UBR5 does indeed function as a positive regulator of Wnt 
signalling, at a downstream step of signal transduction, and that this function is dependent 












































Figure 2.6 UBR5 is a positive regulator of Wnt signal transduction. 
(A) Overexpression of UBR5 rescues the signalling defect in UBR5 KO cells. Top: Western 
blots of lysates from wt and KO cells, expressing proteins as indicated above, and probed 
with antibodies as indicated on the right. Bottom: SuperTOP assays to measure signalling 
activity in these conditions upon (left) Wnt3a or (right) LiCl stimulation. Values are 
presented as mean ± SEM (n=3), relative to unstimulated cells (set to 1). 
(B) SuperTOP assays measuring signalling responses to Wnt3a, LiCl and overexpressed 
Δ45-β-catenin in wt and UBR5 KO cells. Values are presented as mean ± SEM (n=3), 
with wt cells set to 100 in each case. 
(C) RT-qPCR assays to quantify mRNA levels of Wnt target genes in wt and UBR5 KO cells 
treated with LiCl. Values were normalised to PMM1 levels and presented as mean ± SEM 
(n=3), relative to NaCl treated cells (set to 1). 
(D) Top: Western blots of lysates from wt and two different UBR5 KO cell lines. Bottom: 
SuperTOP assays, as above, in these cell lines. Values are presented as mean ± SEM 
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2.2.3 UBR5 function is conserved in Drosophila melanogaster 
Given my results implying a role for UBR5 in Wnt signalling in cells, we looked to confirm 
these findings in an animal model by studying the role of the UBR5 homolog, Hyd in Wnt 
pathway regulation in Drosophila melanogaster. All fly genetics, crosses, and analyses were 
carried out by Juliusz Mieszczanek. 
 
We examined the consequences of loss of Hyd on Wnt (termed Wingless (Wg) in the fly) 
responses by generating hyd mutant clones in wing imaginal discs (see Section 4.3 for 
details of fly genetic analyses). hyd is essential for viability and germline development 
(Mansfield et al., 1994), precluding analysis of Wg responses in embryonic stages. Imaginal 
discs bearing hyd mutant clones produce wings with significant margin defects and ectopic 
bristles, similar to the phenotype observed with pygopus (pygo) mutant clones (Fig. 2.7A).  
 
In order to further assess the role of Hyd in Wg target gene expression, we stained clone-
bearing wing discs for Senseless (Sens) and Wg. Wg is normally expressed in a stripe along 
the prospective wing margin, where it activates Sens expression in neighbouring cells, whilst 
inhibiting its own expression through a negative feedback loop (Fig. 2.7B; Rulifson et al., 
1996). Sens expression is lost in hyd mutant clones near the wing margin, while Wg is 
derepressed within these clones, similar to the pattern seen in pygo mutant clones (Fig. 2.7C, 
D; Parker et al., 2002). We also stained for Vestigial (Vg), encoded by a Wg target gene 
expressed in a broad region straddling the margin (Schweizer et al., 2003), which is 
downregulated in pygo mutant clones in the prospective wing blade (Fiedler et al., 2015), and 
likewise in hyd mutant clones (Fig. 2.7E). In other words, hyd mutant clones phenocopy pygo 
mutant clones, causing a loss of Wg responses in the wing disc.  
 
Finally, given the similarities in the hyd and pygo mutant phenotypes, we asked whether hyd 
blocks the activity of a stabilised Armadillo construct similar to Δ45-β-catenin (called ArmS10; 
Pai et al., 1997), as pygo has been shown to (Thompson et al., 2002). Indeed, hyd mutant 
clones expressing ArmS10 lack Sens expression and show ectopic Wg (Fig. 2.7F). Taken 
together, these Drosophila analyses demonstrate that hyd is a positive regulator of Wg 

































Figure 2.7 UBR5 homolog Hyd is required for Wingless signalling in Drosophila. 
(A) Wings with mutant clones (as labelled), showing margin defects (boxed; higher 
magnification on the right) and overgrowths in the hinge (arrows). A wt wing is shown on 
the left for comparison. 
(B–F) Sections of wing discs from late third-instar larvae, fixed and co-stained with DAPI  
(blue) and antibodies as indicated above panels: (B) wt disc (as boxed in low-
magnification view on the right); discs bearing (C, E, F) hydK7-19 mutant clones (marked 
by absence of GFP, green), or (D) pygoS123 mutant clones. (F) also expressing ArmS10. 
Note the lack of Vg and Sens within clones near the margin (asterisks), which also show 
derepressed wg (arrows), leading to ectopic Sens in adjacent wt cells (arrowheads). Size 
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2.2.4 TLE is a substrate of UBR5 upon Wnt signalling 
Having confirmed that UBR5 is a positive regulator of Wnt signalling, and that its catalytic 
activity is required for this function, we next wanted to identify its relevant physiological 
substrate(s). Identification of E3 ligase substrates has traditionally been challenging, due to 
the weak and transient nature of ligase-substrate interactions (Iconomou & Saunders, 2016). 
However, we reasoned that a proteomics approach, combined with our epistasis analysis of 
UBR5/Hyd function and prior knowledge of Wnt enhanceosome components, could yield 
candidate substrates for further study. The mass spectrometry and subsequent experiments 
detailed in this section were carried out in collaboration with Nikola Novčić. 
 
Our proteomics approach was based on co-immunoprecipitation (coIP) of proteins associated 
with UBR5, using a Flag-tagged catalytically dead version (Flag-UBR5-CS) as bait with the 
aim of stabilising ligase/substrate interactions and thus maximizing substrate capture (Fig. 
2.8A, see Section 4.11 for further details). Mass spectrometry analysis of factors co-eluted 
with this bait revealed a number of proteins consistently associated with UBR5, but not with 
the empty vector control (Fig. 2.8B). UBR5-specific hits identified in two independent 
experiments included known UBR5 substrates, including BUB1 and RANGAP1 (Jiang et al., 
2015a), proteins containing PAM2 motifs (known to interact with MLLE domains; Kozlov et al., 
2010) such as ATXN2L, as well as several proteins previously unlinked to UBR5. The only 
known Wnt enhanceosome component identified was TLE3, albeit with low counts. This 
potential association was intriguing given the essential role TLE plays as a co-repressor of 
Wnt-dependent transcription. Although there are four isoforms of TLE in humans (known as 
TLE1-4) with different expression patterns (see for example Cloonan et al., 2008), these 
proteins are very closely related in sequence and significant differences in their molecular 
function would not be expected (Gasperowicz & Otto, 2005). I thus focused on TLE3 for the 
majority of the subsequent experiments. 
 
Immunofluorescence experiments to study the subcellular localisation of UBR5 confirmed that 
both endogenous and overexpressed GFP-UBR5 are confined to the nucleus (Fig. 2.8C), as 
expected (Henderson et al., 2002), suggesting that most physiological substrates of UBR5 
ought to be nuclear proteins. In order to confirm the association indicated by our proteomics 
analysis, I performed coIP assays in UBR5 KO HEK293T cells expressing GFP-tagged 
UBR5-CS and HA-tagged TLE3 (Fig. 2.8D). A weak, but seemingly robust interaction was 
detected between GFP-UBR5-CS and HA-TLE3, but not with GFP alone. Intriguingly, this 



























Figure 2.8 Proteomics identifies TLE3 as a UBR5-interacting protein. 
(A) Outline of the Flag-affinity purification strategy used to identify candidate interacting 
proteins/substrates of UBR5. 
(B) Table of selected proteins identified by mass spectrometry. Values represent total 
unweighted spectral counts (>95% probability). 
(C) Confocal sections through HeLa cells, with or without co-expression of GFP-UBR5, co-
stained with DAPI (blue) and antibodies as labelled. Size bars, 10 µm. 
(D) CoIP assays examining binding of UBR5 to TLE3; shown are Western blots of UBR5 KO 
cell lysates after co-expression of proteins, treatments, and immunoprecipitation (IP) as 




Given these results, we next wanted to test whether TLE is a substrate of UBR5-dependent 
ubiquitylation during Wnt signalling. To this end, I conducted in vivo ubiquitylation assays in 
UBR5 KO cells, expressing Myc-tagged TLE3, GFP-UBR5 (or GFP-UBR5-CS as a control) 
and His-tagged Ub, and following TLE3 ubiquitylation after affinity purification of ubiquitylated 
proteins (see Section 4.8 for details). GFP-UBR5, but not GFP-UBR5-CS, generated a high 
molecular weight smear of TLE3, indicating conjugation with multiple ubiquitin moieties (Ub-
TLE3). Notably, this activity was very significantly enhanced upon LiCl treatment, whilst 
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Interestingly, I also detected substantial levels of LiCl-dependent Ub-TLE3 in wt HEK293T 
cells, but not UBR5 KO cells, in the absence of UBR5 overexpression, suggesting that 
endogenous UBR5 is also able to modify TLE3 with ubiquitin. Indeed, re-expression of GFP-
UBR5 to near-endogenous levels restores the LiCl-induced Ub-TLE3 in these KO lines (Fig. 
2.9B). Furthermore, endogenous TLE can also be ubiquitylated in LiCl-treated cells in a 
UBR5-dependent fashion, although this is technically challenging to detect (Fig. 2.9C). 


























Figure 2.9 UBR5 binds and ubiquitylates TLE3 upon Wnt signalling. 
(A) Assays for Ub-TLE3; shown are Western blots of UBR5 KO cell lysates, after co-
expression of proteins and treatments as indicated above, and affinity purification of His-
tagged ubiquitin with Ni-NTA, probed with antibodies as indicated on the right, to reveal 
Ub-TLE3 (highlighted with a bracket). 
(B) As (A), but assaying for Ub-TLE3 by endogenous UBR5 by comparison of wt and UBR5 
KO cell lines. 
(C) As (A), but assaying for ubiquitylation of endogenous TLE. 






































































































experimental point of view, I also wanted to confirm that a physiologically relevant ligand also 
has the same effect on TLE3 ubiquitylation. Indeed, treatment of cells with Wnt3a does 
induce Ub-TLE3, although the level of ubiquitylation is less pronounced, potentially reflecting 
the reduced levels of active-β-catenin in Wnt3a-stimulated compared to LiCl-stimulated cells 
(Fig. 2.9D).  
 
One potential corollary of these findings is that TLE (and presumably its Drosophila homolog, 
Groucho) is inactivated during Wnt signalling by Hyd/UBR5-dependent ubiquitylation. If so, 
one would expect that genetic inactivation of Gro/TLE should restore Wnt responses in cells 
lacking Hyd/UBR5. Due to time constraints, I did not attempt to generate human cell lines in 
which all four TLE isoforms were deleted. However, we were able to test this in Drosophila, in 
collaboration with Juliusz Mieszczanek, by studying wing disc clones double mutant for Hyd 
and Gro. Indeed, we observed partial restoration of Sens expression in hyd gro double mutant 
clones (Fig. 2.10). Furthermore, the clones with restored Sens expression do not exhibit 
ectopic Wg, in contrast to hyd mutant clones. Hyd therefore seems to be dispensable to a 
significant extent for Wg responses in the absence of Gro, suggesting that Gro is indeed a 
functionally relevant substrate of Hyd in Wg-stimulated cells. Taken together, the striking Wnt-
induced E3 ubiquitin ligase activity of Hyd/UBR5 towards Gro/TLE indicates that Gro/TLE is a 











Figure 2.10 UBR5 and Groucho act antagonistically in Drosophila. 
hydK7-19 groMB36 double mutant clones, with Sens expression and Wg repression (arrows) 
restored within clones by Groucho loss (compare to hydK7-19 single mutant clones, Fig. 2.7). 













2.2.5 β-catenin apposes UBR5 and TLE 
Having established that Gro/TLE is a substrate of UBR5, I next wished to investigate the 
mechanism underlying the remarkable Wnt-dependency of TLE ubiquitylation. Our epistasis 
analyses in human cells and Drosophila indicated that UBR5 acts below β-catenin in the Wnt 
pathway (Fig. 2.6B, 2.7F). I therefore asked whether β-catenin alone could induce UBR5-
dependent Ub-TLE3, by overexpressing Δ45-β-catenin in UBR5 KO cells, with or without 
GFP-UBR5, and monitoring Ub-TLE3. TLE3 ubiquitylation was indeed induced by expression 
of Δ45-β-catenin to a similar level as by LiCl treatment (Fig. 2.11B).  
 
I initially considered two models that could explain these data. The first, ‘activation’ model, 
supposes that UBR5 is somehow autoinhibited, and that its activation directly or indirectly 
requires β-catenin. However, UBR5 is perfectly able to modify other substrates, such as 
PAIP2, in the absence of Wnt signalling (Shearer et al., 2015, Yoshida et al., 2006). I 
confirmed that Flag-UBR5 can efficiently ubiquitylate HA-PAIP2 in the presence or absence of 
LiCl stimulation (Fig. 2.11C), suggesting that UBR5 is intrinsically catalytically active and 



























Figure 2.11 β-catenin activates UBR5 towards TLE. 
(A) Domain architectures and mutagenesis of proteins expressed in these experiments.  
(B) Assays for Ub-TLE3 as previously; shown are Western blots of UBR5 KO cell lysates, 
after co-expression of proteins and treatments as indicated above, and affinity purification 
of His-tagged ubiquitin with Ni-NTA, probed with antibodies as indicated on the right. 






































































































In contrast, the ‘recruitment’ model 
supposes that stabilised β-catenin binds to 
UBR5 and apposes it to TLE3, thereby 
directing its E3 ubiquitin ligase activity 
toward its substrate. If this was the case, 
one would expect that the interaction of 
UBR5 with TLE3 should be enhanced upon 
Wnt signalling, as previously observed (Fig. 
2.8D). In support of this model, endogenous 
β-catenin coIPs with GFP-UBR5-CS, but 
transient depletion of β-catenin by 
CRISPR/Cas9 completely blocks this 
interaction, and also abrogates binding of 
UBR5 to TLE3 (Fig. 2.12A). Furthermore, 
this ‘recruitment’ would appear to occur 
within the context of the Wnt 
enhanceosome: Flag-UBR5-CS coIPs with 
GFP-tagged enhanceosome components 
TCF4 and PYGO1, regardless of LiCl 
stimulation (Fig. 2.12B, C).  
 
 
Figure 2.12 β-catenin binds UBR5 and 
apposes it to TLE. 
(A) CoIP assays examining binding of UBR5 
to β-catenin; shown are Western blots of 
UBR5 KO cell lysates, after transient 
knockdown of β-catenin by 
CRISPR/Cas9 (or control treatment), co-
expression of proteins, treatments, and 
IP as indicated above and below panels, 
probed with antibodies as indicated on 
the right. 
(B-C) CoIP assays as previously, 
      examining (B) binding of TCF4 or 
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2.2.6 UBR5 decorates the TLE WD40 domain with K48-linked polyubiquitin 
Having established how Wnt signalling triggers the ubiquitylation of TLE by UBR5, I sought to 
understand how this modification might lead to inactivation of TLE, a key requirement for 
activation of Wnt target genes. I thus looked to characterise the ubiquitylation of TLE by 
UBR5, hoping that this might provide insight into such a mechanism. 
 
I first mapped the domain of TLE3 that is the substrate of UBR5-dependent ubiquitylation by 
expressing different TLE3 truncations (Fig. 2.13A) and testing them for UBR5-dependent 
ubiquitylation in LiCl-stimulated cells. These experiments revealed that the C-terminal WD40 
domain is both necessary and sufficient for ubiquitylation (Fig. 2.13B). Furthermore, HA-
tagged WD40 domain coIPs with GFP-UBR5-CS at a similar level to wt TLE3, in contrast to a 
ΔWD40 construct, and this interaction is enhanced by LiCl (Fig. 2.13C). TLE3 thus appears to 
interact with UBR5 via the WD40 domain, which becomes ubiquitylated as a result. 
 
I next wondered what polyubiquitin 
linkage types were assembled on the 
WD40 domain by UBR5, given that 
previous analysis of UBR5 linkage 
specificity was not definitive (Hay-Koren 
et al., 2011; Section 2.1.3). In 
collaboration with Nikola Novčić, I carried 
out in vitro autoubiquitylation assays 
(see Section 4.15 for details) with 
bacterially expressed UBR5 HECT 
domain (UBR52217-2799, either wt, or 
bearing a C to S catalytic site mutation; 
Fig. 2.14A) and K-only Ub mutants 
(bearing arginine-to-lysine substitutions 
of all but one lysine). Catalytically active  
 
 
Figure 2.13 UBR5 ubiquitylates the 
WD40 domain of TLE3. 
(A) Domain architecture of TLE3 wt and 
mutant constructs used in these 
experiments. 
(B) Assays for Ub-TLE3 as previously, 
using the TLE3 constructs illustrated 
in (A). 
(C) CoIP assays as previously, again 












































UBR5 HECT domain autoubiquitylated with wt or K48-only Ub, but not with any of the other K-
only Ub mutants (Fig. 2.14B). Consistent with this, pilot analysis of affinity-purified Flag-TLE3 
by mass spectrometry revealed di-Ub peptides derived exclusively from K48-linked Ub in 
addition to unlinked Ub peptides (data not shown). Finally, I used ‘UbiCRest’ deubiquitylation 
assays (Hospenthal et al., 2015), to interrogate the polyubiquitin chain types assembled by 
UBR5 on TLE3 itself. Attempts to cleave Ub-TLE3 with K11-, K29-, K33-, K48-, and K63-
linkage specific deubiquitylases (DUBs) revealed that only the K48-specific DUB OTUB1 is 
significantly active toward Ub-TLE3 (Fig. 2.14C). Taken together, these data demonstrate 























Figure 2.14 UBR5 decorates the TLE WD40 domain with K48-linked polyubiquitin. 
(A) Catalytic domain constructs of UBR5 expressed in bacteria for use in these experiments. 
(B) In vitro ubiquitylation assay with bacterially expressed GST-UBR52217-2799 or catalytically-
inactive GST-UBR5-2217-2799-CS, incubated for 2 hrs with wt or methylated Ub, or with K-
only Ub mutants (as indicated above), and supplemented with E1 and E2 (UBE2L3) 
enzymes. Shown is a Western blot probed with α-GST to recognise Ub-GST-HECT. 
(C) UbiCREST assays of Ub-TLE3; shown are Western blots of UBR5 KO lysates after co-
expression of proteins, treatment and IP as indicated, followed by in vitro treatment of IPs 
with linkage-specific DUBs (specificity in brackets), or USP2 (non-linkage specific control) 




























2.2.7 TLE is not destabilised by UBR5-dependent ubiquitylation 
A likely implication of the K48-linkage specificity of UBR5 is that TLE is earmarked for 
degradation by this ubiquitylation. I thus sought to ask whether TLE levels change during Wnt 
signalling, and, if so, whether the presence or absence of UBR5 affects these changes. 
However, experiments using cycloheximide to block protein synthesis during Wnt stimulation 
did not reveal any differences in the steady-state levels of endogenous TLE upon LiCl 
stimulation, in either wt or UBR5 KO cells (Fig. 2.15A). The same was also true upon 
overexpression of GFP-tagged UBR5 (or a catalytically dead mutant as control, Fig. 2.15B). 
 
These steady-state experiments corroborate with the data presented earlier, showing that the 
levels of Ub-TLE3 are only mildly elevated after proteasome inhibition (Fig. 2.9A), and the 
observation that Gro levels (as estimated by antibody staining) are unaltered within hyd 
mutant clones (Juliusz Mieszczanek, data not shown). While these data would suggest that 
proteasomal degradation is not the primary mechanism by which UBR5 inactivates Gro/TLE, 
it is possible that these assays are not sensitive enough to detect UBR5-dependent 
destabilisation of the TCF-associated Gro/TLE (which represents only a small proportion of 




Figure 2.15 TLE is not 
destabilised by UBR5-
dependent ubiquitylation. 
Cycloheximide (CHX) chase 
experiments to examine the 
stability of endogenous TLE 
under different conditions; 
shown are Western blots of 
lysates from (A) UBR5 KO 
cells or parental controls, or 
(B) UBR5 KO cells 
overexpressing GFP-UBR5-wt 
or CS, lysed 0-10 hrs after 
treatment with 50 µg ml-1 
cycloheximide and 20 mM LiCl 
(or NaCl as control), probed 
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2.2.8 Ubiquitylation does not interfere with WD40-ligand interactions 
Given that TLE does not seem to be targeted for degradation by UBR5, I attempted to test 
other possible mechanisms by which TLE ubiquitylation could lead to its inactivation. The 
WD40 domain is primarily a protein-protein interaction domain, employed to both anchor TLE 
at the enhanceosome and recruit ligands that exert a repressive function on the associated 
genes. I thus sought to determine which residues within the WD40 domain are modified with 
Ub, and test whether these individual modifications might have an effect on the capacity of 
the WD40 domain to bind to its cognate ligands. The TLE3 WD40 domain contains 16 lysine 
























Figure 2.16 UBR5 ubiquitylates multiple WD40 residues. 
(A) Sequences of WD40 domains from human TLE1-4, with conserved K residues highlighted 
in red.  
(B) In vivo Ub assay in LiCl-treated UBR5 KO cells co-expressing wt or K-only HA-WD40 
mutants with His-Ub, ± Flag-UBR5 as indicated; note the varying levels of ubiquitylation of 
the K-only mutants. KallR indicates a mutant in which all 16 K residues were substituted 
with R.  
(C) Heat-maps of the WD40 domain (Jennings et al., 2006; left, ligand-binding surface; right, 
reverse side), indicating Ub levels of K-only mutants shown in (B). Selected highly 































I attempted to identify sites of Ub modification within the WD40 domain using a proteomics 
approach but was largely unsuccessful, likely due to my inability to obtain significant 
quantities of ubiquitylated material from an in vitro WD40 ubiquitylation assay. I therefore 
examined the ubiquitylation of single K-only WD40 mutants (bearing arginine-to-lysine 
substitutions of all but one lysine) by UBR5 in vivo, which showed that most of the lysine 
residues within the WD40 domain can be efficiently ubiquitylated, with K520, K632 and K720 
proving the strongest ubiquitin acceptors (Fig. 2.16B, C). Notably, K720 is located close to 
the pore region of the WD40 propeller, and is critical for binding to short C-terminal motifs in 
HES and RUNX proteins (Jennings et al., 2006). I thus asked whether WD40 modified at 
these residues is still able to associate with known WD40 binding partners, HES1 and the 
ChiLS complex (Jiménez et al., 1997; Fiedler et al., 2015). However, WD40 domain 
ubiquitylated in vivo at K520, K632 or K720 coIPs efficiently with GFP-HES1 and GFP-ChiLS 
(Fig. 2.17A, B respectively). Thus, ubiquitylation of the WD40 does not seem to interfere with 














Figure 2.17 WD40 ubiquitylation does not seem to interfere with its interaction with 
binding partners. 
CoIP assays, as previously, after co-expression of K-only HA-WD40 mutants with His-Ub and 
GFP-tagged (A) HES1, or (B) LDB1 and SSDP, showing comparable associations of these 
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2.2.9 Ubiquitylated TLE is a substrate of VCP/p97  
During my unsuccessful proteomics attempt to identify ubiquitylated residues within the C-
terminus of TLE (using a Flag-tagged WD40 domain as bait), I identified peptides 
corresponding to VCP/p97 associated with the ubiquitylated WD40 (Fig. 2.18B). VCP/p97 is 
an AAA+ family ATPase implicated in the extraction of ubiquitylated proteins from chromatin 
during various nuclear processes (Dantuma et al., 2014; Xia et al., 2016, Section 2.1.4). I 



















Figure 2.18 Ubiquitylated TLE3 is a substrate of 
VCP/p97. 
(A) Domain architecture and mutagenesis of 
VCP/p97 constructs used in these experiments. 
(B) Table of selected proteins identified by mass 
spectrometry after Flag-affinity purification of 
TLE3 WD40 domain. Values represent total 
unweighted spectral counts (>95% probability). 
(C) CoIP assays examining binding of VCP/p97 and 
TLE3, using the VCP-EQ construct illustrated in 
(A). 
(D), (E) Assays for Ub-TLE3 as previously, after (D) 
        treatment with small molecule inhibitors of 
        VCP/p97, NMS-873 and CB-5083 (DMSO as a 
        negative control, MG132 for comparison), or (E) 





In order to confirm the association indicated by our proteomics analysis, I performed coIP 
assays between a GFP-tagged catalytically dead VCP/p97 (with a point mutation, E578Q, in 
its D2 ATPase domain; VCP-EQ-GFP) and Myc-TLE3 (Fig. 2.18C). TLE3 did indeed coIP 
with VCP/p97, although unexpectedly this did not seem to fully depend on TLE3 being 
ubiquitylated. I thus asked whether VCP/p97 catalytic function is required for the removal of 
Ub-TLE, using two small molecule inhibitors, NMS-873 and CB-5083, with differing 
mechanisms of VCP/p97 inhibition (allosteric and competitive, respectively). Treatment of 
cells with these inhibitors indeed lead to an increase in levels of Ub-TLE3, more so than 
proteasome inhibition with MG132 (Fig. 2.18D). Inhibiting VCP/p97 function in a different way, 
through overexpression of VCP-EQ (which has a dominant-negative effect), was even more 
effective in stabilising Ub-TLE3, whilst overexpression of wt VCP/p97 had no effect (Fig. 
2.18E). These data thus suggest that TLE becomes a substrate of VCP/p97 upon 
ubiquitylation. 
 
2.2.10 VCP/p97 activity is required for Wnt signal transduction 
I next asked whether the association identified between VCP/p97 activity and TLE 
ubiquitylation is functionally relevant for Wnt signalling. I therefore measured Wnt 
transcriptional output, using SuperTOP assays, in wt and UBR5 KO cells, with or without 
treatment with VCP/p97 inhibitors. LiCl-induced SuperTOP activity is indeed strongly reduced 
in wt cells upon treatment with either NMS-873 or CB-5083, but only slightly in UBR5 KO cells 
(Fig. 2.19A), as would be expected if VCP/p97 acted downstream of UBR5. SuperTOP 
activity is also sensitive to VCP/p97 inhibition by NMS-873 when induced by overexpression 
of Δ45-β-catenin (Fig. 2.19B), further implying that VCP/p97 activity is required for a 
downstream step of signal transduction. Finally, NMS-873 treatment also blocks the 
expression of the endogenous Wnt target genes NKD1, AXIN2 and SP5 upon LiCl treatment 
in wt cells, but has a reduced effect upon UBR5 KO cells (Fig. 2.19C). These results, and 
those from Section 2.2.9 therefore implicate VCP/p97 in the inactivation of TLE by UBR5, 

































Figure 2.19 VCP/p97 activity is required for Wnt signal transduction. 
(A), (B)  SuperTOP assays, as previously, measuring (A) Wnt signalling activity in wt and KO 
cell lines stimulated with LiCl and treated with small molecule inhibitors of VCP/p97, 
NMS-873 and CB-5083, or (B) wt cells stimulated with LiCl or Δ45-β-catenin and treated 
with NMS873. Values are presented as mean ± SEM (n=3) relative to wt cells treated with 
DMSO (set to 100). 
(C) RT-qPCR assays to quantify mRNA levels of Wnt target genes in wt and UBR5 KO cells 
stimulated with LiCl and treated with NMS-873 (or DMSO control). Values were 
normalised to PMM1 levels and presented as mean ± SEM (n=3), relative to cells treated 




2.2.11 Ubiquitylation of TLE3 by UBR5 is XIAP-independent 
Previous reports have implicated the RING E3 ligase XIAP in TLE ubiquitylation and Wnt 
signal transduction (Hanson et al., 2012, see also Section 2.1.5). Given this similarity with 
our data, I sought to ask whether XIAP and UBR5 might act on TLE in a cooperative fashion, 
by generating cell lines in which XIAP was deleted by CRISPR/Cas9 (as employed previously; 
Section 2.2.1). However, I found that UBR5-dependent polyUb of TLE3 is normal in XIAP KO 
cells, suggesting that the two ligases act independently (Fig. 2.20A). These data corroborated 
siRNA knockdown experiments previously conducted in the Bienz lab (Nikola Novčić, 






































































































XIAP KO cells, as measured by SuperTOP assays, is significantly reduced in comparison to 
that observed in UBR5 KO cells (Fig. 2.20B). These data would suggest that XIAP plays a 
less significant role than UBR5 in promoting Wnt responses, although compensation (perhaps 
in terms of upregulation of another E3 ligase) during the process of establishing the XIAP KO 
















Figure 2.20 UBR5-dependent ubiquitylation of TLE3 is independent of XIAP. 
(A) Ub-TLE3 assays, as previously, in wt and XIAP KO cells, showing that the UBR5-
dependent ubiquitylation of TLE3 is independent of XIAP.  
(B) SuperTOP assays, as previously, showing that UBR5 KO reduces the Wnt- and LiCl-
inducibility of HEK293T more severely than XIAP KO. Values are presented as mean ± 































































2.2.12 UBR5 is a potential therapeutic target in Wnt-driven cancers 
Given our data suggesting that UBR5 is a crucial component of the Wnt transcriptional switch 
in HEK293T cells, which have an inducible Wnt signalling pathway, I wondered whether 
UBR5-dependent ubiquitylation of TLE3 also occurs in colorectal cancer cell lines that carry 
constitutively activating mutations of Wnt pathway components. I therefore used the 
CRISPR/Cas9 system to delete UBR5 in the HCT116 colorectal cancer cell line, whose Wnt 
pathway activity is elevated due to a Δ45 mutation of an allele of β-catenin (Morin et al., 
1997). Indeed, ubiquitylated TLE3 is detectable in wt HCT116 cells in the absence of any 
additional Wnt stimulation, but not in the UBR5 KO derivatives (Fig. 2.21A). Furthermore, β-
catenin-dependent transcription is significantly reduced in the UBR5 KO cells, as measured 
by SuperTOP assays (Fig. 2.21B). These data suggest that, in this cell line at least, UBR5 





Figure 2.21 UBR5 is a potential 
therapeutic target in Wnt-driven 
cancers. 
wt or UBR5 KO HCT116 cells, 
assayed for (A) Ub-TLE3 (as 
previously) or (B) SuperTOP 
activity. Values are presented as 
mean ± SEM (n=3), relative to wt 









































A crucial downstream step of Wnt signal transduction is the inactivation of the transcriptional 
co-repressor Gro/TLE. In this chapter, I have presented evidence demonstrating a 
requirement for the HECT E3 ubiquitin ligase UBR5 in this process. Our data suggest that β-
catenin binds to UBR5 upon Wnt signalling and directs the activity of this E3 ligase toward 
Gro/TLE. We further suggest that the ATPase VCP/p97 is involved in this UBR5-dependent 
Gro/TLE inactivation. Nevertheless, several aspects of the mechanism outlined are somewhat 
speculative, and numerous of features of Wnt enhanceosome regulation require further study. 
Alongside the discussion, suggestions for further experiments to expand on the data 
presented are outlined below. 
 
2.3.1 UBR5 is a conserved positive regulator of Wnt signalling  
I initially set out to identify HECT E3 ubiquitin ligases of the ‘other HECT’ subfamily that 
regulate the Wnt signalling pathway, with a particular interest in those that act at downstream 
steps of the pathway, using a CRISPR/Cas9 deletion screen. The rationale behind this 
decision was twofold. Firstly, numerous HECT ligases from this subfamily have been reported 
to modulate Wnt signalling, and the use of cutting-edge genome editing techniques offers an 
opportunity to clarify the literature regarding these large and (often) enigmatic proteins. 
Secondly, as enzymatic regulators of a key cancer pathway, such ligases might constitute 
attractive targets for therapeutic intervention in human diseases. I selected five candidate E3 
ligases for deletion in HEK293T cells, based on previous reports implicating them in Wnt 
pathway regulation (de Groot et al., 2014; Hay-Koren et al., 2011, Tran et al., 2013; Wen et 
al., 2015). 
 
My deletion screen immediately highlighted one E3 ligase, UBR5, as an interesting candidate 
for further study (Fig. 2.5). When this protein was deleted, cells showed significantly reduced 
responses to both Wnt3a and LiCl stimulation, thus resolving the previous inconsistency 
regarding the effects of UBR5 depletion on Wnt/β-catenin responses in human cell lines 
(Ohshima et al., 2007; Hay-Koren et al., 2011). UBR5 KO cells showed no changes in β-
catenin levels, but consistently reduced Wnt transcriptional responses. These data parallel 
our results from hyd mutant clones in flies, which display a lack of expression of the Wnt 
target genes sens and vestigial (reminiscent of the phenotype observed in pygo clones; 
Parker et al., 2002), and providing unequivocal evidence for UBR5 as a positive regulator of 
Wnt signalling in human and fly cells. A previous report suggesting that UBR5 might 
negatively regulate Wnt signalling was based largely on the observation that overexpression 
of UBR5 leads to increased levels of co-expressed APC (Ohshima et al., 2007). However, we 
noted that upregulation of proteins co-expressed with UBR5 was a general phenomena, not 
specific to APC or any other factor (Joshua Flack & Nikola Novčić, data not shown). We 
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hypothesise that this expression artefact could be due to titration of the general translation 
inhibitor PAIP2 by the UBR5 MLLE domain, although this requires confirmation. 
 
Interesting, we also found that deletion of HUWE1 caused hypersensitivity to Wnt3a, but not 
LiCl, in agreement with published findings that HUWE1 negatively regulates the upstream 
component Dvl (de Groot et al., 2014). HUWE1 KO HEK293T cell lines show somewhat 
abnormal growth phenotypes (notably a slower rate of division), potentially complicating 
analyses, as we and other studies have noted (Choe et al., 2016). However, HUWE1 clearly 
represents an interesting candidate for further study in the context of Wnt signalling, 
particularly in light of its reported role in stem cell niche maintenance and tumour suppression 
(Dominguez-Brauer et al., 2016; Dominguez-Brauer et al., 2017). In contrast, despite previous 
reports implicating HECTD1 and UBE3C in regulation of Wnt signalling, we did not find any 
evidence in our deletion screen for a significant role of either of these ligases. There are 
several potential reasons for these inconsistencies. The report implicating HECTD1 was 
largely based upon siRNA knockdown experiments (Tran et al., 2013), which can be 
complicated by off-target effects (Echeverri et al., 2006). Indeed, in the Bienz lab, siRNA 
knockdown of UBR5 itself proved highly unreliable (Nikola Novčić, data not shown). However, 
the CRISPR/Cas9 editing process itself is not risk-free, with its own problems of off-target 
effects, as well as the possibility of adaptation during the expansion process (which takes 
several weeks). Differences in the behaviour of different cell lines is also a distinct possibility, 
particularly in the case of UBE3C, where the previous study was conducted only in cancer 
cells (Wen et al., 2015). 
 
2.3.2 Groucho/TLE is a substrate of UBR5 
Having identified UBR5 as a positive regulator of Wnt signal transduction, we next wanted to 
identify the relevant physiological substrate(s) of the E3 ubiquitin ligase activity of UBR5. 
Using a Flag-IP-based proteomics approach, we isolated candidate interactors of UBR5, 
including several previously reported substrates, although the only Wnt component identified 
was TLE3, a homolog of the Drosophila co-repressor Groucho (Fig. 2.8B). The mechanism 
by which Gro/TLE is inactivated, though crucial for Wnt signalling, is unknown, and we were 
intrigued by a previous report that Gro/TLE ubiquitylation regulates Wnt responses (Hanson 
et al., 2012). We thus proceeded to study Gro/TLE, and found that it was robustly 
ubiquitylated by UBR5 upon Wnt stimulation (Fig. 2.9A).  
 
Several corroborating lines of evidence suggest that Gro/TLE is indeed the physiologically 
relevant substrate of UBR5 during Wnt signalling. Firstly, epistasis experiments in Drosophila 
demonstrate that Hyd/UBR5 acts below Armadillo/β-catenin in the pathway (Fig. 2.7), 
implying that substrates are likely nuclear proteins (and consistent with the nuclear 




























































the absence of Gro (as shown by hyd gro double mutant clones; Fig. 2.10), suggesting that 
Hyd acts by antagonizing Gro. Finally, and crucially, the enzymatic activity of UBR5 towards 
Gro/TLE in human cells is highly specific, in that it only occurs upon Wnt stimulation of cells 
(with either Wnt3a or LiCl; Fig. 2.9). Our data are the first to propose Gro/TLE as a substrate 
of UBR5. One report previously suggested that β-catenin itself may be a substrate of UBR5 
(Hay-Koren et al., 2011). However, whilst we did find robust binding of UBR5 to β-catenin 
(either endogenous or overexpressed), we observed no UBR5-dependent ubiquitylation of β-
catenin in any of our assays. It is possible that the use of a HECT domain construct tagged at 
the C-terminus (which is known to inactivate HECT catalytic function; Salvat et al., 2004) may 
have affected the conclusions made by these authors. Nevertheless, we do not discount the 
possibility that there are other substrates of UBR5 that might contribute to its role in Wnt 
regulation. Indeed, Sens expression is not fully rescued in all hyd gro double mutant clones, 
implying that there might be further repressive factors that are targeted by UBR5. 
 
2.3.3 β-catenin triggers Wnt enhanceosome rearrangements that promote UBR5-
dependent modification of TLE 
The β-catenin-dependency of Gro/TLE ubiquitylation by UBR5 was immediately intriguing to 
us, given that such mechanisms are unusual in the pathway, and indicate functional 
relevance. We initially considered two possible mechanisms by which β-catenin might activate 
UBR5 toward Gro/TLE during Wnt signalling (Fig. 2.22A, B). The ‘activation’ model supposes 
that UBR5 can access TLE at all times, but is normally autoinhibited, and β-catenin somehow 
activates the catalytic activity of UBR5. Such a mechanism would be reminiscent of the 
NEDD4 subfamily of HECT ligases, which are relieved from autoinhibitory interactions by the 
binding of NDFIP proteins (Wiesner et al., 2007; Mund & Pelham, 2009; Mari et al., 2014). 
However, the strong activity of UBR5 toward other substrates, such as PAIP2, in the absence 




Figure 2.22 Models for Wnt-dependent 
ubiquitylation of Gro/TLE. 
(A) ‘Activation’ model, in which β-catenin 
activates or derepresses the catalytic 
activity of UBR5, permitting 
ubiquitylation of TLE. 
(B) ‘Recruitment’ model, in which β-catenin 
binds UBR5 and recruits it to the Wnt 
enhanceosome. 
(C) ‘Rearrangement’ model, whereby β-
catenin triggers conformational changes 
in the Wnt enhanceosome that leads to 
apposition of UBR5 and TLE. See text 
for more details. 
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In contrast, the ‘recruitment’ model proposes that β-catenin is required to appose an initially 
separate enzyme and substrate, bringing together UBR5 and Gro/TLE upon Wnt signalling. 
CoIP assays show that β-catenin promotes the association of UBR5 with TLE, as would be 
predicted by the recruitment model (Fig. 2.11). Unexpectedly, however, I also found that 
UBR5 is associated with Wnt enhanceosome components, including TCF4 and PYGO1, in a 
constitutive fashion. These data are in agreement with those of a recent study from the Bienz 
lab, which employed proximity-dependent biotin labelling methodology (BioID) to investigate 
the composition and structure of the enhanceosome, and which also identified UBR5 as 
associated with this complex in the absence of signalling (van Tienen et al., 2017). Taken 
together, these data thus imply that UBR5 is constitutively associated with the 
enhanceosome, and suggest that a variation of the recruitment model, termed here the 
‘rearrangement’ model, in fact most accurately reflects the biological mechanism. This model 
supposes that the recruitment and docking of β-catenin triggers conformational 
rearrangements within the Wnt enhanceosome that results in proximity between UBR5 and 
Gro/TLE (Fig. 2.22C). Indeed, numerous other conformational changes are also likely to 
occur, and further experiments are needed to understand the mechanisms by which β-catenin 
alters the transcriptional complexes regulating Wnt target genes. 
 
2.3.4 VCP/p97 contributes to remodeling of the Wnt enhanceosome 
Prior to this study, the mechanisms underlying the inactivation of Gro/TLE were largely 
unknown, in part because the methods that Gro/TLE employs in order to repress transcription 
are themselves unclear (Ramakrishnan et al., 2017). The identification of UBR5 as a 
Gro/TLE-targeted E3 ligase offers a significant insight into this process, and how UBR5-
dependent ubiquitylation of Gro/TLE leads to inactivation of its transcriptional co-repressor 
function is thus a question of critical importance. 
 
A previous study employing single point-mutants of ubiquitin had suggested UBR5 generates 
atypical ubiquitin chains, linked via K11 or K27 (Hay-Koren et al., 2011). However, our 
rigorous in vitro and in vivo ubiquitylation assays both show that UBR5 assembles 
predominantly K48-linked polyubiquitin (Fig. 2.14). The most obvious mechanism for UBR5-
dependent inactivation therefore involves degradation of ubiquitylated TLE (Fig. 2.23A), given 
that these chain types constitute the archetypal signal for proteasomal targeting (Chau et al., 
1989). Levels of UBR5-dependent Ub-TLE3 are somewhat elevated after treatment with the 
proteasome inhibitor MG132, but no destabilisation of endogenous TLE was observed in 
cycloheximide chase experiments (Fig. 2.15), arguing against rapid proteasomal degradation 
being the primary mechanism underlying Gro/TLE inactivation. Furthermore, the proximity 














































Figure 2.23 Models for inactivation of Gro/TLE by 
ubiquitylation. 
(A) Ubiquitylation of TLE by UBR5 promotes its 
proteasomal degradation. 
(B) Ubiquitylation of the WD40 domain prevents the 
interaction of this domain with binding partners, 
such as Wnt enhanceosome components or 
transcriptional co-repressors. 
(C) Ubiquitylation serves to recruit an ATPase such 
as VCP/p97, which ‘extracts’ TLE from the 
enhanceosome or disrupts its tetrameric 







enhanceosome is not altered upon Wnt signalling (van Tienen et al., 2017), although it is 
unclear whether this methodology is sufficient time-resolved to fully answer this question, 
given that certain proteins, including β-catenin, are reported to ‘cycle’ on and off the 
enhanceosome on relatively rapid timescales (Sierra et al., 2006). 
 
I was thus forced to consider alternative mechanisms by which Gro/TLE may be inactivated 
by ubiquitylation. Mapping experiments demonstrated that the C-terminal ligand-binding 
WD40 domain of Gro/TLE is the target for ubiquitylation (Fig. 2.13). I therefore envisaged that 
modification of the WD40 domain might interfere with its binding to protein partners, such as 
the Chip/LDB1-SSDP (ChiLS) complex, weakening the association of Gro/TLE with the Wnt 
enhanceosome, or with other transcriptional co-repressors (Fig. 2.23B). However, Ub-TLE3 
appears to bind to its ligands just as efficiently as the unmodified protein. I reasoned that our 
samples of ubiquitylated WD40 would contain domains ubiquitylated at many different lysines, 
which could complicate the interpretation. Nevertheless, a single-lysine WD40 mutant that 
can only be ubiquitylated at K720 (a pore residue crucial for binding to WRPW/eh1 motifs; 
Jennings et al., 2006) still binds to ChiLS and HES1, suggesting that the ubiquitin C-terminus 
is flexible enough to accommodate ligand binding (Fig. 2.17). I have thus far been unable to 
test whether ubiquitylation of TLE directly affects its ability to promote chromatin compaction 
(Sekiya & Zaret, 2007), although it seems plausible that the attachment of multiple ubiquitin 
chains to the WD40 domain could directly or indirectly ‘loosen’ the binding of Gro/TLE to 
nucleosomes, attenuating its ability to compact chromatin into repressive structures. 
 
During a proteomics experiment designed to identify ubiquitylation sites within the WD40 
domain, I identified peptides corresponding to VCP/p97 associated with the ubiquitylated 
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WD40, which was confirmed by coIP (Fig. 2.18). VCP/p97 is a hexameric AAA+ family 
ATPase known to regulate numerous ubiquitylated proteins (including components of DNA 
repair and chromatin complexes) by promoting their unfolding and segregation from large 
cellular structures (van den Boom & Meyer, 2017). I found that VCP/p97 inhibition 
dramatically stabilised Ub-TLE, suggesting that VCP/p97 might contribute to Gro/TLE 
inactivation by UBR5 (Fig. 2.18D, E). A recent proteomic screen for VCP/p97-associated 
proteins identified TLE1 and TLE3, along with several adaptor proteins and other known 
substrates, consistent with our proposal of Gro/TLE as a novel substrate of this ATPase (Xue 
et al., 2016). VCP/p97 activity on individual monomers is likely to trigger the destabilisation of 
Gro/TLE oligomers, in the similar fashion to the mechanism by which VCP/p97 promotes 
disassembly of a hexameric CMG helicase complex during DNA replication (Maric et al., 
2015). Since Q domain-mediated tetramerization is absolutely required for transcriptional 
repression (Song et al., 2004; Chodaparambil et al., 2014), this would lead to Gro/TLE 
inactivation. This proposed ‘extraction’ mechanism (Fig. 2.23C) is also consistent with a 
recent proposal that the relief of Gro-dependent repression is based on kinetic destabilisation 
(Chambers et al., 2017), which could be facilitated by unfolding of ubiquitylated Gro/TLE by 
VCP/p97. Notably, this mechanism would predict that only a subset of all enhanceosome-
associated Gro/TLE molecules would need to be modified by UBR5 in order that all Gro/TLE 
repressive function is inactivated, allowing for rapid transcriptional switching. 
 
It is important to note that the different mechanisms discussed here are certainly not mutually 
exclusive, and could well be acting in a co-operative fashion. For example, VCP/p97 
dependent extraction could occur rapidly upon ubiquitylation, whereas degradation might 
occur on a slower timescale. Furthermore, it is possible that UBR5 is not the only E3 ligase 
that regulates Gro/TLE. Overexpression of BCL9/B9L triggers Gro/TLE ubiquitylation in a 
fashion that is independent of UBR5 (Moore van Tienen, unpublished data), whilst the role of 
XIAP is uncertain, given that XIAP KO has little effect on Wnt responses in HEK293T cells 
(Fig. 2.20). Whatever the mechanism, we propose that disassembly of the Gro/TLE tetramer 
is likely to be a crucial step required for inactivation. Further experiments, designed to 
characterise the oligomeric state of Gro/TLE during different stages of Wnt signalling, will be 
required to confirm this hypothesis. 
 
2.3.5 A model for Wnt transcriptional switching 
In light of the data presented in this chapter, along with recent advances from our lab and 
others, we would like to present an updated model for Wnt transcriptional switching (Flack et 
al., 2017; van Tienen et al., 2017; Fig. 2.24). 
 
In the off state, Gro/TLE tetramers are stably anchored to the Wnt enhanceosome through 
multivalent interactions with TCF (via the Q domain), ChiLS and BCL9/B9L (via the WD40 
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domain), and maintain a compact chromatin state that is non-permissive for transcription. The 
enhanceosome is primed for Wnt responsiveness, however, by BCL9/B9L, which is able to 
capture β-catenin via its free HD2 domain. Several crucial cofactors, including UBR5, as well 
as chromatin modifying and remodeling complexes, are located at or near the enhanceosome 
and are poised for activity. Upon Wnt signalling, the captured β-catenin triggers 
conformational rearrangements that appose UBR5 with the C-terminal WD40 domain of 
Gro/TLE, allowing ubiquitylation to proceed. This ubiquitylation leads to disruption of Gro/TLE 
tetramerization via the activity of VCP/p97, which is recruited to the K48-linked polyubiquitin. 
At the same time, chromatin remodeling complexes present at the enhanceosome such as 
SWI/SNF are activated to alleviate the repressive chromatin structure imposed by Gro/TLE, 














Figure 2.24 Updated model of the Wnt transcriptional switch. 
In the absence of Wnt signalling, Gro/TLE tetramers represses transcription of TCF-bound 
Wnt target genes (nucleosomes in crimson). Upon Wnt signalling, stabilised β-catenin docks 
the Wnt enhanceosome and induces a conformational change (van Tienen et al., 2017) 
resulting in the apposition of UBR5 to TCF-bound Gro/TLE, enabling it to modify this 
substrate with K48-linked polyUb. This renders it a substrate for VCP/p97-dependent 
unfolding, destabilising the Gro/TLE tetramer and relieving chromatin compaction 
(nucleosomes in light green), allowing transcriptional activation. See text for more details. 
Adapted from Flack et al., 2017. 
 
 
Despite advances in our understanding of this process, several aspects of this model remain 
unclear. Fig. 2.24 depicts Gro/TLE molecules as remaining at the enhanceosome, as 
suggested by proximity-labelling experiments (van Tienen et al., 2017), but in an inactive 
(perhaps monomeric or dimeric) state. Further experiments to determine the oligomeric state 
of endogenous Gro/TLE (or that expressed at near-endogenous levels) at different stages of 
the Wnt transcriptional cycle will be required to shed light on this issue. In similar fashion, the 
mechanisms that anchor UBR5 at Wnt enhancers also require further study. Interestingly, 
Wnt OFF! Wnt ON!
Fig. 2.24!
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although UBR5 is named for its characteristic UBR domain, our studies did not identify a 
specific role for this domain in Wnt regulation. It seems likely that regions within the UBR5 N-
terminus, whether folded or not, are responsible for recruiting UBR5 to the enhanceosome, 
but the details of such interactions are yet to be confirmed. It would also be useful to develop 
new techniques to determine the constitution of the enhanceosome at a single point in time, 
given the low resolution that the BioID methodology has in this respect. The development of 
chromatin immunoprecipitation (ChIP)-quality antibodies for key enhanceosome factors will 
assist in this respect. 
 
Furthermore, many questions currently remain as to how transcriptional repression is 
reestablished upon the cessation of Wnt signalling, and what role Gro/TLE might play in this 
process. In Drosophila, one potentially important factor might be the transcriptional repressor 
Brinker, which has been shown to bind the WD40 domain of Groucho through an FKPY motif 
and imposes silencing on Wnt-responsive elements in cooperation with another factor, 
Teashirt (Hasson et al., 2001; Saller et al., 2002). This could fit with a model in which Gro/TLE 
remains at the enhanceosome throughout the period of active Wnt signalling, and is then 
switched back on in order to effect transcriptional repression. How Gro/TLE might be 
‘reactivated’ is unclear, but could involve removal of UBR5-dependent ubiquitylation by an as-
yet unidentified deubiquitylase, or the ‘replacement’ of the ubiquitylated subset of Gro/TLE 
with freshly translated, unmodified molecules. Although several deubiquitylases are 
associated with VCP/p97, none have so far been implicated in regulation of Wnt signalling 
(Liu & Ye, 2012).  
 
2.3.6 Implications for cancer therapeutics 
From the data in this chapter, and our revised model for Wnt transcriptional switching, we 
propose that UBR5 and VCP/p97 represent candidates for further study in terms of 
therapeutic intervention in the Wnt pathway. As introduced (Section 2.1.3), UBR5 has been 
heavily implicated in cancer, although it is somewhat unclear whether it promotes or prevents 
tumour progression, and its effect may be context-dependent (Shearer et al., 2015). However, 
amplification is the predominant genetic alteration of UBR5 identified in many types of 
cancers (far more so than loss-of-function mutations; Clancy et al., 2003), implying a tumour-
promoting role that is consistent with the new role we propose it plays in relieving Gro/TLE-
dependent transcriptional repression of Wnt target genes. Given our results, it will be 
therefore be important to test whether loss-of-function or inhibition of UBR5 inhibits Wnt-
dependent tumourigenesis, as might be expected given our results in colorectal cancer cells. 
Proliferation of wt HCT116 cells is slowed by VCP/p97 inhibition (Magnaghi et al., 2013), 
whilst cells in which UBR5 is knocked out show attenuated Wnt-dependent transcription (Fig. 
2.21B). It will be interesting to test whether this applies generally to other cancer cell lines that 
are dependent upon hyperactive Wnt signalling, colon or otherwise.  
62 
 
There is certainly a precedent for designing drugs that could target either UBR5 or VCP/p97. 
A small molecule has been identified that acts as a general inhibitor of HECT E3 ligases 
through oxidation of the catalytic cysteine (Mund et al., 2014). The unusual architecture of the 
UBR5 HECT domain could allow for development of a more specific therapeutic. On the other 
hand, CB-5083 is an orally bioavailable VCP/p97 inhibitor that is already in clinical trials (Zhou 
et al., 2015). The current rationale behind CB-5083 use is that cancer cells are under 
increased proteotoxic stress, and are thus highly sensitive to VCP/p97 inhibition, although 
how this effect would synergise with a reduction in Wnt-dependent transcription is unknown. 
Whether targeting these enzymes could actually have therapeutic benefits, without significant 
side-effects, is another matter. Organoid cultures, in which the UBR5 or VCP genes could be 
easily manipulated using genome-editing techniques, and genetically engineered mouse 
models are potential tools that could be used to understand the effect of UBR5 or VCP/p97 
inhibition in carcinogenesis. Indeed, one recent study hints that knockdown of UBR5 reduces 
the growth of colorectal tumours in a xenograft assay (Xie et al., 2017). Further studies using 
applicable models such as these will be required to validate UBR5 and VCP/p97 as new 










The ability to rapidly terminate Wnt/β-catenin signal transduction is an absolute requirement 
for accurate, timely signalling to occur. Several negative regulators which work to inactivate 
Wnt receptors, including Dickkopf and RNF43 (Niehrs, 2006; Koo et al., 2012), or function at 
the level of Wnt itself, such as WIF-1 (Wnt inhibitory factor 1) and Notum (Malinauskas et al., 
2011; Kakugawa et al., 2015), are now understood in structural detail. However, this transition 
from active to inactive signalling also requires the disassembly, or switching, of Wnt 
signalosome complexes, such that key components of the degradasome, including Axin, are 
released and can resume their function in marking β-catenin for degradation. Surprisingly, 
although it has been a significant focus of research in the Wnt field, how this key event occurs 
is not well understood. In this chapter, we investigate the mechanism of action of a 
cytoplasmic negative regulator of Wnt signalling, Naked, which acts at the level of the Wnt 
signalosome. Despite extremely clear genetic experiments implicating Nkd as part of a crucial 
negative feedback loop in the canonical Wnt signalling pathway (Zeng et al., 2000), no 
convincing mechanistic basis for its function has thus far been identified. 
 
3.1.1 Dishevelled is the central cytoplasmic Wnt signal transducer 
In order to understand signalosome function, it is essential to understand Dishevelled (Dvl), 
the lynchpin of cytoplasmic Wnt signalling which assembles signalosomes, and provides the 
crucial link between the receptor complexes and components of the degradasome (Mlodzik et 
al., 2016). Dvl was first identified as a segment polarity gene in Drosophila, a mutant of which 
showed a characteristic ‘dishevelled’ phenotype as a result of loss of body and wing hair 
orientation (Fahmy & Fahmy, 1959). Cloning of the fly dishevelled (dsh) gene identified a 
novel protein, which acts as an essential positive component of the Wnt signalling pathway 
(Klingensmith et al., 1994). Subsequently, three mammalian homologs were identified 
(termed Dvl1-3; Sussman et al., 1994; Sokol et al., 1995), all of which share a characteristic 
conserved domain architecture (Fig. 3.1). Dvl contains an N-terminal DIX (Dishevelled and 
Axin) domain, shared uniquely with Axin, a central PDZ (Postsynaptic density 95, Discs 
Large, Zona-occludens-1) domain which binds to numerous signalling partners, and a C-
terminal DEP (Dvl, Egl-10, Pleckstrin) domain whose role has previously been controversial 
(Boutros & Mlodzik, 1999). 
 
Through a large number of comprehensive studies, we now have a detailed molecular 
understanding of the mechanism by which Dvl enables Wnt signal transduction. An interesting 
and highly unusual property of the DIX domain is its ability to homopolymerize in a 
concentration-dependent manner, both in vitro and in vivo (Schwarz-Romond et al., 2005). 
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Overexpression of Dvl is sufficient to drive this polymerization and activate Wnt signalling, but 
mutations in the DIX domain that abolish polymerization completely block this effect 
(Schwarz-Romond et al., 2007a). As well as forming homopolymers, Dvl can 
heteropolymerize with Axin to recruit the central degradasome component via its own DIX 
domain,!the key step that initiates degradasome inhibition and thus stabilisation of β-catenin 
(Fiedler et al., 2011; see also Section 1.1.2). The specific triggering of DIX polymerization 
upon Wnt binding to its receptors is thus crucial, and involves the generation of a high local 
concentration of Dvl molecules. This depends on recruitment of Dvl to Wnt receptor 
complexes through interaction of the Dvl DEP domain with the cytoplasmic face of Fz 
(Tauriello et al., 2012). Once concentrated, Dvl subsequently undergoes dimerization via the 
DEP domain which occurs, unusually, through domain-swapping of a single α-helix from one 
DEP moiety to another,!a process that is energetically unfavourable to reverse and could thus 
impose unidirectionality on signalosome assembly (Rousseau et al., 2003; Gammons et al., 
2016a). In the absence of signalling the DEP domain also plays a key role, binding to and 
facilitating the ubiquitylation of Fz by the E3 ligases RNF43/ZNRF3, leading to its clathrin-




















Figure 3.1 Structure and mechanisms of Dvl. 
(A) Domain architecture and key interactions of Dvl.  
(B) Structure of folded domains of Dvl, including polymerized DIX domain (Madrzak et al., 
2015), PDZ domain with bound peptide (Zhang et al., 2009) and domain-swapped DEP 
dimer (Gammons et al., 2016a). PDB: 4WIP, 3CBZ, 5SUY. 
Fig. 3.1!
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Whilst the DIX and DEP domains are thus clearly required for canonical Wnt signal 
transduction, the PDZ domain is more enigmatic. Although originally thought to play a key 
role, more recent data demonstrated that the PDZ domain is completely dispensable for 
canonical signalling (Gammons et al., 2016b). This domain is, however, known to bind 
numerous proteins, including Dvl inhibitors Dapper and Frodo (Wong et al., 2003), often 
through C-terminal motifs, although it can also bind internal motifs, or even folded domains, 
such as that of Naked (Rousset et al., 2001; see also Section 3.1.2). The PDZ domain also 
binds to the C-terminus of Dvl itself, promoting a ‘closed’ conformation of Dvl that may be 
autoinhibitory (Lee et al., 2015; Qi et al., 2017), in a similar fashion to that proposed for Axin 
(Kim et al., 2013). It therefore seems likely that the PDZ domain represents a primary region 
for regulation of Dvl function. Furthermore, the multitude of ligands for the PDZ suggests that 
it may be able to dictate the choice of downstream signalling effectors activated, and hence 
control the transition from canonical to non-canonical Wnt outputs (Axelrod et al., 1998). 
Indeed, planar cell polarity (PCP) signalling in Drosophila has been shown to involve the 
formation of signalosome-like structures by Dsh, triggered by complexes of Fz and the non-
canonical co-receptor Flamingo (Strutt et al., 2016). 
 
As well as polymerization, a further notable feature of Dvl is the extent to which it is post-
translationally modified. Numerous modifications, including phoshorylation and ubiquitylation, 
occur extensively in the unstructured linker regions between domains (as well as occasionally 
within the domains themselves). Dvl becomes heavily phosphorylated upon Wnt signalling by 
a number of kinases, including CK1ε and γ isoforms, although the timing of these events 
(relative to polymerization) and their functions are somewhat unclear (González-Sancho et al., 
2004; Mlodzik, 2016). A number of E3 ubiquitin ligases have been shown to regulate the 
stability of Dvl, including KLHL12 (Angers et al., 2006), through the promotion of proteasomal 
degradation. However, Dvl behaviour may also be regulated more subtly, through conjugation 
of non-degradative K63-linked ubiquitin chains (Tauriello et al., 2010b; de Groot et al., 2014; 
see also Section 2.1.2). Polymerized Dvl itself is able to activate a number of NEDD4 family 
E3 ligases, including WWP2, potentially providing a mechanism whereby ubiquitylation of 
substrates can be specifically triggered at active Wnt signalosomes (Mund et al., 2015; Mund 
et al., 2018). 
 
Much remains to be discovered regarding Dvl function. As mentioned, the monomeric and 
domain-swapped dimeric conformations of the DEP domain are separated by a large 
energetic barrier, suggesting that once triggered, signalosome formation is not easily 
reversed. The mechanism by which Dvl signalosomes are thus inactivated upon the cessation 
of Wnt signalling is unknown, but it is likely that negative regulators of the Wnt pathway which 
target Dvl, such as Naked, might play a key role.  
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3.1.2 Naked proteins are negative regulators of Dvl 
Alongside the components described so far that are essential for core signalosome function, 
there are numerous accessory factors that can impart regulation upon the process of 
signalosome assembly and, presumably, disassembly. One of these factors is Naked (Nkd), a 
segment polarity gene first described over 30 years ago (Ju ̈rgens et al., 1984; Martinez Arias 
et al., 1988; McEwen & Peifer, 2001). Whilst wt embryos display bands of hair-like denticles, 
nkd mutants instead display a characteristic ‘naked’ cuticle, a phenotype representing a 
potent activation of Wnt signalling. Consistent with Nkd functioning as a negative regulator of 
Wnt signalling, misexpression of Drosophila Nkd phenocopies loss-of-function of Wingless, 
whilst injection of nkd RNA from flies into Xenopus embryos disrupts anterior-posterior axis 
specification and blocks induction of secondary axes, events that are exquisitely dependent 
on canonical Wnt signalling (Zeng et al., 2000). Two mammalian homologs of Nkd (Nkd1 and 
Nkd2) were soon identified (Wharton et al., 2001), and Nkd transcripts are upregulated by 
Wnt signalling in both flies and mammals, implying that Nkd acts as part of a negative 
feedback loop to attenuate Wnt signals (Zeng et al., 2000; Yan et al., 2001). Recall that there 
are, in fact, several well described negative feedback regulators of Wnt signalling, including 
Dickkopf and Notum (Niida et al., 2004; Gerlitz & Basler, 2002), but Nkd and Axin2 are the 
only known examples that act cytosolically, and hence could directly affect the signalosome. 
Both Nkd1 and 2 are recurrently mutated in several cancers, including colorectal, 
underscoring the importance of these Wnt pathway brakes as key tumour suppressors, and 
Nkd mRNA expression has been used as a prognostic marker for tumours displaying aberrant 
Wnt signalling (Guo et al., 2009; Stancikova et al., 2015). 
 
Drosophila Nkd and mammalian Nkd1/2 share a broadly similar domain architecture, 
including a single EF-hand motif and a highly unusual C-terminal histidine-rich region 
(henceforth referred to as the histidine-rich domain; HRD), although the poorly conserved 
linker between these regions is significantly larger in the fly protein (Fig. 3.2). The EF-hand is 
a Ca2+-binding domain found in many calcium regulated proteins, although they are more 
usually found in tandem, making Nkd somewhat unusual (Lewit-Bentley & Réty, 2000). 
Furthermore, despite containing a near-optimal consensus motif (of four acidic residues) for 
Ca2+ binding, it is unclear whether the Nkd EF-hand actually binds Ca2+, with one report 
suggesting that the domain instead recruits a Zn2+ ion for binding to Dvl (Rousset et al., 
2002). No detailed study has been made of the HRD, nor a role proposed for it, although 
similarly histidine-rich regions can be found in other proteins. The regions between these 
domains are not highly conserved, although there are several sequences that resemble Ca2+ 
binding motifs, suggesting that Nkd may once have contained tandem EF-hands. 












Figure 3.2 Domain structure of Naked proteins. 
Comparison of domain architectures of Drosophila Naked with mammalian Nkd1 and Nkd2. 
Note the extended C-terminus in the fly protein, and the lack of an N-terminal myristoylation 




as a result of N-terminal signal sequences, which serves to localise Nkd to the plasma 
membrane, whilst fly Nkd is also membrane-localised, despite lacking a consensus 
myristoylation sequence (Li et al., 2004; Chan et al., 2007). 
 
Early genetic experiments in Drosophila defined the epistatic relationships between Nkd and 
other components of the canonical Wnt signalling pathway. Nkd functions cell autonomously, 
and overexpression can suppress the effect of overexpressing Wingless or Dishevelled, 
although not of constitutively active Armadillo. Furthermore, they showed that Nkd 
antagonises Wnt signalling upstream of Zw3 (the Drosophila homolog of GSK3), implying that 
Nkd functions above the level of the degradasome (Rousset et al., 2001). Epistasis 
experiments in mammalian cells similarly placed murine Nkd1 upstream of β-catenin 
(Wharton et al., 2001). Through yeast two-hybrid and in vitro coIP experiments, Dvl was 
identified as an interacting partner of Nkd, and a series of Dvl fragments used to demonstrate 
that Nkd, like many Dvl regulators, binds to the PDZ domain (Rousset et al., 2001).  
 
However, despite nearly two decades of study, the mechanism(s) by which Nkd functions to 
reduce Wnt signalling remains mysterious. Several reports have suggested that Nkd 
promotes the proteasomal degradation of Dvl, a plausible model, although no E3 ubiquitin 
ligases have been reported, nor a clear mechanistic basis outlined (Hu et al., 2010; Schneider 
et al., 2010). Others have suggested that Nkd engages nuclear import receptors, inhibiting a 
downstream step of signal transduction, such as β-catenin import (Chan et al., 2008). These 
models for Nkd function suppose that the Nkd/Dvl interaction serves to somehow activate 
Nkd, which then acts on a step of the pathway distinct from the signalosome, although this 
would not seem to be consistent with myristoylation locating Nkd to the plasma membrane in 
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including β-catenin (Larraguibel et al., 2015) and Axin (Gao et al., 2016), have been mooted. 
There is also evidence that Nkd might function to redirect Wnt signal transduction towards 
non-canonical outputs (Yan et al., 2001; Marsden et al., 2018), although loss of Nkd function 
in the Drosophila wing fails to disrupt planar cell polarity, suggesting Nkd is not essential for 
non-canonical signalling in this particular instance (Zeng et al., 2000). A role for Nkd in 
Wnt/Ca2+ signalling could also be plausible, if it was determined conclusively that the Nkd EF-
hand binds to Ca2+ ions. Clearly, the mechanism of Nkd function has clearly not been 
conclusively identified, and our work towards understanding this enigmatic protein is the topic 
of this chapter. 
 
3.1.3 The autophagy system 
For reasons that will become clear in this chapter, it is relevant to give an introduction to a 
cellular degradation pathway, alternative to the proteasome, known as autophagy. Autophagy 
is a conserved cellular recycling pathway that engulfs intracellular material, including protein 
complexes, aggregates and entire organelles, within a double membrane and targets it for 
lysosomal degradation (Mizushima et al., 2011). Autophagy thus constitutes a highly versatile 
process that has multiple roles in the cell, including the provision of nutrients during 
starvation, maintenance of homeostasis, protein quality control and pathogen defence (Kaur 
& Debnath, 2015). Autophagy initiates with the formation of a phagophore (also known as 
isolation membrane), which subsequently elongates and seals to generate a mature 
autophagosome capable of fusion with endosomes and lysosomes, which contain hydrolytic 
enzymes. Various cellular organelles, including the endoplasmic reticulum, Golgi apparatus 
and plasma membrane can supply membrane to the growing autophagic structure. 
Deregulation of autophagy is known to play a role in numerous diseases, including cancer 
and various degenerative conditions, although the mechanisms remain controversial 
(Mizushima et al., 2008). Beclin1 (the mammalian homolog of ATG6) is deleted in over half of 
breast, ovarian and prostate cancers, implying a tumour suppressive role (Aita et al., 1999), 
but in some cases autophagy seems to favour cancer cell survival. Autophagy is also known 
to be deployed against certain bacterial infections (Randow, 2011), and can protect against 
pathogenic protein aggregates such as those formed by tau (Falcon et al., 2017). 
 
Autophagy is a complex and tightly regulated process that is executed by a large number of 
autophagy-related genes (ATGs; Fig. 3.3A). Originally identified in yeast genetic screens, 
most of these have conserved orthologs in mammals (Tsukada & Ohsumi, 1993; Ohsumi, 
2014). These factors form several complexes that control sequential steps of autophagosome 
formation (Fig. 3.3B). Biogenesis begins at the phagophore assembly site, where proteins of 
the UNC51-like kinase (ULK) complex assemble to initiate formation of the isolation 
membrane (Jung et al., 2009). In the nucleation stage, the activated ULK complex targets a 
class III PI3K (phosphoinositide 3-kinase) complex to promote production of a phagophore-
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specific pool of phosphatidylinositol 3-phosphate (PI3P; Obara et al., 2006). This phospholipid 
assists in recruitment of the ATG12–ATG5–ATG16 complex to the isolation membrane, 
where it directs lipidation of MAP1LC3 (also known simply as LC3) family proteins with 
phosphatidylethanolamine, a process that is absolutely required for LC3-directed 
autophagosome expansion (Dooley et al., 2014; Nakatogawa et al., 2007). The isolation 
membrane continues to expand until a mature autophagosome is formed upon closure of the 
double membrane, a process that is not fully understood (Fujita et al., 2008). 
 
Autophagosome formation is thus the key step that regulates autophagy. Formerly considered 
to be a largely non-selective degradation pathway, more recent studies have revealed a high 
degree of selectivity in autophagy, conferred by specialised autophagy receptors that specify 
cellular material and physically link it with the autophagy machinery through simultaneous 
interactions with the cargo and LC3 proteins on autophagosomes (Stolz et al., 2014). Many of 
these autophagy receptors, including p62 and NBR1, contain ubiquitin-binding domains (often 




















Figure 3.3 Summary of the autophagy pathway. 
(A) Domain architecture and interactions of the key autophagy receptors p62 and NBR1.  
(B) Overview of the canonical autophagy pathway: initiation takes place at the ER membrane, 
with recruitment of the ULK1 initiation complex. Subsequent recruitment of the VPS34 
PI3K complex generates PIP3 required for recruitment of downstream effectors that 
promote autophagosome formation (lower left) and are responsible for the selection of 




















































fundamental role for ubiquitin in marking substrates for selective autophagy (Pankiv et al., 
2007; Kirkin et al., 2009; Rogov et al., 2014). This may be related to the ability of long 
ubiquitin chains to induce aggregation of substrates (Morimoto et al., 2015). In some cases, 
the AAA+ ATPase VCP/p97 (discussed in detail in Chapter 2) appears to be required for the 
autophagic degradation of ubiquitylated proteins (Ju & Weihl, 2010; Papadopoulos et al., 
2017). However, in other circumstances autophagy can be initiated in a ubiquitin-independent 
fashion, particularly if substrates are already aggregation-prone (Khaminets et al., 2016). One 
prominent autophagy adaptor is ALFY (autophagy-linked FYVE protein), which can interact 
with PI3P-containing membranes to facilitate degradation of model aggregation-prone 
proteins (Filimonenko et al., 2010). In some cases autophagy receptors that contain UBDs, 
including p62, have been implicated in ubiquitin-independent autophagy (Watanabe & 
Tanaka, 2011). 
 
Autophagy has previously been reported to regulate the Wnt pathway. One report found that 
autophagy negatively regulates signalling through the promotion of Dvl degradation (Gao et 
al., 2010). These authors proposed that ubiquitylation of Dvl by the Von Hippel-Lindau (VHL) 
E3 ligase promotes the binding of Dvl2 to p62, which in turn facilitates aggregation and LC3-
mediated autophagosome recruitment under conditions of starvation. Interestingly, p62 
contains an N-terminal PB1 domain (Fig. 3.3A), the closest structural relative to the DIX 
domain, and is able to mediate self-association in a similar fashion, but cannot bind directly to 
Dvl in the absence of modification (Bienz et al., 2014; Ciara Metcalfe, PhD thesis). 
Autophagy-dependent Dvl degradation may be promoted by other factors, including the 
negative regulator Dapper (Zhang et al., 2006), and a negative correlation was observed 
between autophagy and Dvl expression in late stages of colon cancer, suggesting that 
autophagy may contribute to the aberrant activation of Wnt signalling during carcinogenesis 
(Gao et al., 2010). Autophagy is a complex set of processes, integrating multiple membrane 
trafficking pathways, regulatory factors and mechanisms. Whilst this pathway seems to play a 
role in Wnt regulation, this has not been fully explored, and many of the mechanisms 
underlying specificity within the autophagy system are yet to be understood. 
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3.2 Results 
3.2.1 Nkd inhibits signal transduction at the level of Dvl 
In order to determine the mechanism(s) by which Nkd acts to inhibit Wnt signalling, I first set 
about confirming previous data and establishing our own assays of Nkd function in the lab. 
Mammalian Nkd1 has been well characterised as a Wnt target gene (Zeng et al., 2000), and I 
confirmed by Western blot analysis and RT-qPCR that Nkd1 protein and mRNA levels, 
respectively, are significantly increased when transcription of Wnt target genes is stimulated 
with LiCl in HEK293T cells (Fig. 3.4). Interestingly, this analysis showed that Nkd1 protein 
levels do not increase until around six hrs after initial stimulation, and continue to increase 
post-12 hrs of treatment, in contrast to active β-catenin levels, which rapidly increase within 
two hrs, but peak around 12 hrs after stimulation. This timeframe would certainly fit the 
purported role of Nkd1 as a negative feedback regulator, through reducing β-catenin activity 











Figure 3.4 Nkd1 is a Wnt target gene.   
(A) Western blots of wt HEK293T cell lysates, after indicated treatments, probed with the 
indicated antibodies. 
(B) RT-qPCR assays to quantify Nkd1 mRNA levels in HEK293T cells treated with NaCl or 
LiCl. Values were normalised to PMM1 levels, and presented as mean ± SEM (n=3). 
 
 
I therefore asked whether expression of Nkd1 leads to a reduction of Wnt transcriptional 
responses in these cells. Using SuperTOP assays, I found that the Wnt transcriptional output 
was significantly reduced in cells treated with Wnt3a upon overexpression of HA-tagged 
Nkd1, in comparison to HA-GFP (Fig. 3.5). The same result was obtained when stimulating 
the Wnt pathway by overexpression of the key signalosome component Dvl2 (recall that this 
is sufficient to activate Wnt signalling in the absence of stimulation), but not by LiCl treatment 
or expression of stabilised β-catenin (Δ45-β-catenin, as employed in Chapter 2), both of 
which act epistatically to Dvl (Fig. 3.5B). These data confirm that Nkd1 functions as a 
negative regulator of canonical Wnt signal transduction, at the level of the signalosome. 
 
A! B!




















































Figure 3.5 Nkd1 inhibits Wnt signalling at the level of Dvl2. 
(A) Western blots of HEK293T cell lysates, after the expression of proteins and treatments 
indicated above, probed with the indicated antibodies. Note that, for reasons which are 
unclear, expression of Dvl2 does not lead to a significant stabilisation of active β-catenin. 
(B) SuperTOP assays to measure Wnt signalling activity in cells treated as in (A). Values are 
presented as mean ± SEM (n=3), relative to untreated cells. 
 
 
3.2.2 Nkd1 EF-hand and histidine-rich domains are required for Wnt inhibition 
Given the lack of insight into the mechanism by which Nkd1 functions, I sought to undertake a 
detailed structural and functional study of Nkd1. Analysis of the domain architecture, and 
conservation between Nkd orthologs, highlighted several potential regions of interest, namely 
the central EF-hand fold and C-terminal HRD (Fig. 3.6A; see also Section 3.1.2). I therefore 
decided to examine whether these domains play an important role, using our established 
SuperTOP assays of Nkd1 function. Point mutation of four essential ion-coordinating residues 
within the EF-hand to alanine (‘4A’; predicted to disrupt the fold of the EF-hand), and deletion 
of the HRD (‘ΔHRD’; through introduction of a premature stop codon after Ala-449) both 
significantly reduced the ability of Nkd1 to attenuate canonical Wnt transcriptional responses 
induced by either Wnt3a treatment, or expression of Dvl2, indicating that both of these 
regions are required for full Nkd1 function (Fig. 3.6B). Interestingly, whilst the 4A mutant 
seemed to express at levels similar to the wt protein, the ΔHRD mutant was expressed at 






























































































Figure 3.6 Nkd1 EF-hand and histidine-rich domain are required for inhibition of Wnt 
signalling. 
(A) Nkd1 wt and mutant constructs used in these experiments. 
(B) SuperTOP assays to measure Wnt signalling activity in cells after co-expression of 
proteins and treatments indicated. Values are presented as mean ± SEM (n=3), relative 
to untreated cells. 
(C) Western blots of HEK293T cell lysates, after expression of Nkd1 constructs as in (A), 




3.2.3 Nkd1 EF-hand interacts with the Dvl PDZ domain 
I next sought to determine the mechanistic basis for the requirement of the EF-hand and HRD 
in the ability of Nkd1 to inhibit Wnt signalling. Previous work suggested Nkd1 binds directly to 
Dvl, and that the EF-hand may be key to this interaction, although a role for other regions 
close downstream of the EF-hand was also mooted (Rousset et al., 2002). Indeed, Nkd1 
colocalises with Dvl puncta when both proteins are overexpressed and visualised by 
immunofluorescence in COS-7 cells (Fig. 3.7A).  Using ‘BioIP’ proximity labelling assays (see 
Section 4.12), I found that stably expressed wt and ΔHRD Nkd1 both associate efficiently 
with endogenous Dvl2, whilst 4A Nkd1 associates only weakly (Fig. 3.7B). These data were 
in contrast to coIP assays between overexpressed proteins, which showed no clear difference 
between binding of wt and 4A Nkd1 to Dvl2 (data not shown). Previous studies have mapped 
the Nkd-interacting region to Dvl to the PDZ domain (Rousset et al., 2001). Using coIP 
assays, I found that wt, but not ΔPDZ, Dvl interacted robustly with Nkd1, indeed suggesting 
the PDZ domain constitutes the sole binding site for Nkd1 (Fig. 3.7C). Furthermore, the ability 



















































was stimulated by expression of ΔPDZ Dvl, as would be expected if Nkd1 could no longer 
bind (Fig. 3.7D).  Note that the ΔPDZ Dvl construct is not as active as wt Dvl in SuperTOP 
activation, although we believe this to be an artefact of overexpression, since ΔPDZ Dvl 
signals to the same level as the wt protein when expressed at endogenous levels in Dvl KO 























Figure 3.7 Nkd1 EF-hand interacts with the Dvl PDZ domain. 
(A) Confocal sections through COS-7 cells after co-expression of indicated proteins, co-
stained with DAPI (blue) and antibodies as labelled. Size bars, 10 µm. 
(B) Proximity biotinylation (‘BioIP’) assays investigating binding between Nkd1 and Dvl2; 
shown are Western blots of HEK293T cell lysates stably expressing BirA*-tagged Nkd1 
bait proteins, after treatment with biotin and immunoprecipitation (IP) as indicated above 
panels, probed with antibodies as indicated on the right. 
(C) Top: wt and mutant Dvl2 constructs used in these experiments. Bottom: coIP assays 
investigating binding between Nkd1 and Dvl2; shown are Western blots of HEK293T cell 
lysates, after co-expression of proteins and IP as indicated above panels, probed with 
antibodies as indicated on the right.  
(D) SuperTOP assays to measure Wnt signalling activity in cells after co-expression of 
constructs (shown in (C)) indicated. Values are presented as mean ± SEM (n=3), relative 
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Having demonstrated an interaction between the EF-hand and PDZ domain in vivo, I next 
sought to further characterise this interaction in vitro using purified proteins, in collaboration 
with Miha Renko. Expression of a number of different EF-hand constructs (with variable N- 
and C-terminal boundaries) was trialled (data not shown), with a construct containing 
approximately 20 residues downstream of the predicted EF-hand fold yielding significant 
quantities of folded, soluble protein (Fig. 3.8A, see Section 4.13 for details). Using the same 
boundaries, expression of a ‘4A’ mutant EF-hand did not yield soluble protein, likely due to 
this mutation disrupting protein folding. Dvl2 PDZ domain was expressed using the same 























Figure 3.8 Nkd1 EF-hand interacts with the Dvl PDZ in vitro. 
(A) Minimal Nkd1 EF-hand and Dvl2 PDZ constructs expressed for use in these experiments.  
(B) Top: gel filtration profile of untagged EF-hand-PDZ complex after mixing. Bottom: 
fractions from the indicated peak are resolved on SDS-PAGE. 
(C) NMR experiments demonstrating direct binding between purified EF-hand and PDZ 
domains. Shown are overlays of HSQC spectra of 100 µM 15N-labelled PDZ domain when 
alone (black), or when probed with 200 µM RFP-tagged EF-hand (red). 
(D) SEC-MALS of RFP-tagged EF-hand (red), or EF-hand-PDZ complex (blue). Solid lines 
indicate the elution profile as detected by the Refractive Index detector; dashed lines 
indicate the measured molecular mass; cartoons below indicate stoichiometries 
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al., 2016b). Gel filtration analysis, after mixing of wt EF-hand and PDZ domain, yielded a 
single, symmetrical peak containing both proteins, although the stoichiometry was not clear 
(Fig. 3.8B). 
 
We next asked whether a binding site (or sites) for the EF-hand on the PDZ domain could be 
identified using an NMR approach (for which a full assignment of the Dvl PDZ has previously 
been obtained; Gammons et al., 2016b). In collaboration with Trevor Rutherford, we recorded 
heteronuclear single-quantum correlation (HSQC) spectra of 15N-PDZ before and after 
incubation with purified RFP (red fluorescent protein)-tagged EF-hand (Fig. 3.8C). Significant 
line broadening and chemical shift of a majority of peaks were observed upon addition of EF-
RFP, suggesting that the EF-hand interacts with a large surface of the PDZ domain, and/or 
causes significant changes in the PDZ structure upon binding.  
 
Finally, we wanted to determine the stoichiometry of the complexes formed by the EF-hand 
alone, and when bound to the PDZ domain. Size exclusion chromatography coupled to multi-
angle light scattering (SEC-MALS, carried out in collaboration with Chris Johnson) revealed 
an apparent molecular mass of approximately 75 kDa for EF-RFP alone, corresponding to a 
dimer (Fig. 3.8D), as has previously been observed for EF-hand folds (Huang et al., 2009b). 
When mixed in an equimolar ratio with Lip (lipoyl)-tagged PDZ domain, the complex formed is 
approximately 100 kDa, suggesting the EF-hand dimer binds a single PDZ domain, and a 
smaller peak corresponding to the excess monomeric PDZ (approximately 25 kDa) can also 
be observed. These data would seem to fit with the stoichiometry observed upon SDS-PAGE 
analysis of the untagged complex (Fig. 3.8B). Taken together, these data show that the Nkd1 
EF-hand is able to stably interact with the Dvl PDZ domain, with a stoichiometry of 2:1. 
Mutations of the EF-hand that abrogate binding to Dvl also abolish the ability of Nkd1 to inhibit 
Wnt signalling, explaining the requirement for the EF-hand in SuperTOP assays. 
 
3.2.4 The Nkd1 HRD forms stable clusters in vivo and in vitro 
Having characterised the mechanism underlying the requirement for the Nkd1 EF-hand in 
Wnt inhibition, I next focused on the histidine-rich domain (HRD). When re-analysing samples 
from cells expressing Nkd1 by Western blot analysis, I observed protein bands corresponding 
to high molecular weight (HMW; greater than 250 kDa) species of wt, but never ΔHRD, Nkd1 
(Fig. 3.9A). This observation accounts for the apparent lower expression of wt and 4A Nkd 
noted earlier (Fig. 3.6C). The slow migration of these species was not due to polyUb of Nkd1, 
as no signal was observed with an α-ubiquitin antibody (data not shown). I reasoned that 
these HMW species might instead correspond to insoluble clusters or aggregates of Nkd1, 

























Figure 3.9 Nkd1 HRD 
promotes the formation of 
high molecular weight 
species. 
(A) Western blots of HEK293T 
cell lysates, after the 
expression of proteins 
indicated, probed with α-HA 
antibody. 
(B) Confocal sections through 
COS-7 cells after co-
expression of indicated 
proteins, co-stained with 
DAPI (blue) and a-HA 
antibody as labelled. Size 
bars, 10 µm. 
(C) Western blots as in (A), 
after treatment of cell lysate 
samples with the indicated 




HRD-dependent clustering of Nkd1 is observable in cells. Indeed, wt Nkd1 forms distinct 
puncta (not dissimilarly to Dvl, though the puncta are usually larger and fewer) when 
visualised by immunofluorescence in COS-7 cells, whilst ΔHRD Nkd1 is diffuse (Fig. 3.9B).   
 
My observation of HMW species by Western blot implies that these species are resistant to 
solubilisation by boiling in 1% LDS (lithium dodecyl sulphate), as this was present in the 
sample buffer. Unexpectedly, treatment of Nkd1 lysates with other sample buffers, or addition 
of various harsh denaturants including SDS, Urea or GuHCl, did not reduce the proportion of 
Nkd1 found in the HMW bands (Fig. 3.9C), suggesting the presence of unusually strong 
intermolecular interactions between HRDs.  
 
Given this unusual tendency of the Nkd1 HRD to form HMW species, I sought to further 
investigate this behaviour in vitro using bacterially-expressed HRD constructs, in collaboration 
with Miha Renko. A Lip-tagged minimal HRD also formed HMW species, indicating that the 
HRD alone is fully sufficient for this clustering process to occur (Fig. 3.10A, B). Analysis of 
several HRD mutants revealed that maximal formation of HMW species is dependent upon 
the presence of numerous histidine residues, including those in the N-terminal part of the 
HRD (compare mutants 1 and 2), and two residues either side of a highly conserved tyrosine 
(mutant 5). Mutation of specific hydrophobic (in a conserved YHHF motif, mutant 6) or 
glutamate (mutant 7) residues had a reduced, though still observable effect on formation of 





























Figure 3.10 Nkd1 HRD forms distinct HMW species in vitro. 
(A) Top: minimal Nkd1 HRD construct expressed for use in these experiments. Bottom: 
amino acid sequence of HRD domain of wt and seven mutant constructs, tested for their 
ability to form HMW species at neutral pH (indicated on right). 
(B) pH dependency of the formation of HMW species. Shown is SDS-PAGE analysis of Nkd1 
HRD samples treated in buffer at the indicated pH.  
(C) Gel filtration profiles of Lip-Nkd1 HRD run at acidic (red) and neutral (blue) pH. At neutral 
pH, the protein elutes as a single peak of approximately 250 kDa; At acidic pH, a single 
peak corresponding to approximately 20 kDa (Lip-Nkd1 HRD = 17 kDa). 
(D) Estimating the stoichiometry of HMW species. Shown is SDS-PAGE analysis of samples 
in which (small) Lip-tagged Nkd1 HRD is mixed with (large) MBP-tagged Nkd1 HRD in 
differing ratios. ‘Steps’ upwards from the lower band indicate complexes containing 
incrementally more MBP-Nkd1-HRD. 
(E) Mass spectrometry analysis of purified Lip-tagged Nkd1 HRD. Shown is a portion of a 
MALDI-TOF spectrum with peaks indicating stable complexes formed from the indicated 































































































Given that the formation of HMW species presumably involves close proximity between 
histidine residues of different HRDs, and considering that the pKa for histidine protonation is in 
a physiologically relevant range (approximately 6.5 in most proteins; Edgcomb & Murphy, 
2002), we wondered whether this behaviour of the HRD might vary in a pH-dependent 
fashion. SDS-PAGE analysis of Lip-Nkd1 HRD boiled in sample buffer of varying pH revealed 
that whilst most protein resides in the HMW band at pH 6.4, this band is almost entirely 
absent at pH 6.2 (Fig. 3.10B). The same trend was also observed by gel-filtration; Lip-HRD 
forms a broad peak (representing a range of high molecular weight stoichiometries) at pH 7.2, 
but collapses to a sharp peak of monomer at pH 5.0 (Fig. 3.10C). This pH dependency of 
HRD clustering could have implications for Nkd function (see Section 3.3.3). 
 
Finally, we wished to more accurately assess the stoichiometry of Nkd1 HMW complexes 
formed under various conditions. Gel filtration analysis at pH 7.2 suggested an approximate 
molecular weight of 250 kDa for the centre of the peak, indicating a mean stoichiometry of 
around 14-16 HRD moieties (Fig. 3.10C). In contrast, resolution of HMW species formed after 
boiling, by mixing ‘small’ Lip-HRD with ‘large’ MBP (maltose-binding protein)-tagged HRD 
suggested a maximum stoichiometry of only 10 monomers (Fig. 3.10D), although MALDI-
TOF mass spectrometry analysis was able to detect species corresponding to a 17-mer of 
Nkd1 (Fig. 3.10E). Unfortunately, pilot experiments aiming to investigate the structure of the 
HMW species by electron microscopy were complicated by a large degree of sample 
heterogeneity. Overall, these data show that the Nkd1 HRD is a unique domain displaying 
some highly unusual properties, and the propensity of this region to aggregate, forming stable 
HMW species of defined stoichiometry, may be required for Nkd1 function. 
 
3.2.5 Axin interacts with Nkd1 through mutual HRD binding 
Intrigued by the observed behaviour of the Nkd1 HRD, we wondered whether the formation of 
high molecular weight species might be a more general property of proteins containing 
histidine-rich sequences. Employing a bioinformatic analysis (conducted by Miha Renko) to 
identify such proteins, we found approximately 60 proteins with HRD motifs (containing at 
least eight histidine residues within a span of 14) in the human genome, a selection of which 
are shown (Fig. 3.11A, see Appendix 3 for complete list). Interestingly, this list contained 
human Axin1 (the central component of the β-catenin destruction complex and thus a major 
Wnt component; see Section 1.1.1) as a protein containing a histidine-rich domain. The 
Axin1 HRD is slightly smaller than that of Nkd1, consisting of 9 histidine residues (within a 
span of 12), and is located centrally within the protein (Fig. 3.11A, B). No functions have 
been clearly assigned to the Axin1 HRD, although this region of the protein has previously 
been implicated in an autoinhibitory interaction with the Axin DIX domain (Kim et al., 2013). 







































Figure 3.11 Nkd1 HRD interacts with the Axin HRD. 
(A) Summary of selected HRD-containing proteins (see also Appendix 3). 
(B) Domain architecture of Axin1 wt and mutant constructs used in these experiments. 
(C) CoIP assays, as previously, investigating binding between Nkd1 and Axin1. Two slices 
are shown for α-GFP and α-HA blots, to show high and low molecular weight species. 
(D) Formation of Nkd1-Axin1 HMW species in vitro. Shown is SDS-PAGE analysis of 
samples in which Lip-tagged Nkd1 HRD is mixed with MBP-tagged Axin1 HRD in differing 
ratios. The banding pattern at high molecular weight indicates species containing both 
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terms of formation of HMW species. GFP-tagged Axin1 did not yield any HMW bands upon 
overexpression and analysis by SDS-PAGE (as can be seen in Fig. 3.11C). However, coIP 
assays between Nkd1 and Axin1 revealed that wt, but not ΔHRD Axin1 (carrying either a 
larger, Δ510-594, or more minimal, Δ530-541, deletion) was able to associate with Nkd1 
HMW species in vivo (Fig. 3.11C). As expected, no association was observed with Nkd1 
ΔHRD. The equivalent result was also obtained between minimal Nkd1 and Axin1 HRDs in 
vitro, where MBP-Axin1 HRD is incorporated into HMW species with Nkd1 HRD, but cannot 
form them by itself (Fig. 3.11D). 
 
One simple model for how Nkd could function to reduce Wnt signalling, given its ability to bind 
both Dvl (through its EF-hand) and Axin1 (through their respective HRDs), is that it could 
somehow block the interaction between Dvl and Axin, thereby releasing Axin to reform the β-
catenin destruction complex. We thus wondered whether expression of Nkd1 would interfere 
with the binding of Dvl to Axin1. However, coIP assays showed that the interaction between 
Dvl2 and Axin1 is actually enhanced, not reduced, upon expression of Nkd1, and the robust 
presence of Nkd1 in these immunoprecipitates indicates that the three proteins are apparently 
able to form a ternary complex (Fig. 3.12A). Corroborating this, Nkd1 and Axin1 both 
colocalise in the same Dvl2 puncta when visualised by immunofluoresence (Fig. 3.12B). 
These data suggest that, whilst Nkd1 is able to associate with Axin1, via mutual interaction of 
their HRDs, this interaction does not immediately explain the mechanism of Nkd function (for 
example by competing with the Dvl/Axin interaction), and could serve simply as a second 














Figure 3.12 Nkd1 forms a ternary complex with Dvl2 and Axin1. 
(A) CoIP assays, as previously, investigating binding between Nkd1, Dvl2 and Axin1. For 
clarity, only low molecular weight species are shown. 
(B) Confocal sections through COS-7 cells after co-expression of indicated proteins, co-
stained with DAPI (blue) and antibodies as labelled. Size bars, 10 µm. 
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3.2.6 BioID-MS reveals candidate interactors of the Nkd1 HRD 
Although we identified Axin1 as an interactor of the HRD, I wondered whether further hitherto 
unidentified binding partners of the Nkd1 HRD might explain the absolute requirement of this 
domain for the ability of Nkd to inhibit cytoplasmic β-catenin dependent signal transduction. I 
thus set out to use a proximity-dependent biotin labelling technique (termed BioID; Roux et 
al., 2012) to identify novel ligands of the HRD, and other domains, of Nkd1. This method 
relies on the generation of a ‘cloud’ of reactive biotin moieties by a promiscuous biotin ligase 
(E. coli BirA, carrying an R118G mutation, termed BirA*) that is fused to the protein of 
interest, leading to biotinylation of proximal endogenous proteins and allowing their selective 
isolation by biotin-affinity capture (Fig. 3.13A). One important consideration when using this 
method is the design of the BirA*-bait fusion protein, in order to mimic the interactions of the 





















Figure 3.13 BioID methodology and construct design. 
(A) Outline of BioID proximity labelling methodology (Roux et al., 2012). 
(B) Nkd1-BirA* fusion constructs used in these experiments. 
(C) SuperTOP assays to measure Wnt signalling activity in cells after co-expression of 
proteins indicated. The pathway was stimulated by overexpression of Dvl2. Values are 
presented as mean ± SEM (n=3), relative to cells in which Dvl2 was not expressed. 
(D) Validation of Flp-in HEK293 cell lines inducibly expressing Nkd1-BirA* fusions. Shown are 
Western blots of cell lysates indicating the extent of biotin labelling after the treatments 
indicated above, probed with the antibody or reagent shown on the right. 
(E) Time course of biotinylation. Shown are Western blots, as in (D), indicating the extent of 






















































kDa). I therefore designed several Nkd1-BirA* fusions and tested their ability to reduce Wnt 
transcriptional output using SuperTOP assays (Fig. 3.13B). An N-terminal BirA* would be 
unsuitable, as it would interfere with membrane localisation of Nkd1, whilst a C-terminal 
fusion of BirA* rendered Nkd1 inactive in reducing SuperTOP (Fig. 3.13C), potentially 
because the BirA* somehow interferes with a function of the HRD. In contrast, with an 
internally fused BirA* (located after Gln-333, referred to as Nkd1-333BirA*), Nkd1 remained 
able to reduce Wnt signalling output. This location of the tag was selected as it is proximal to 
the site of a large insertion in the Drosophila Nkd protein relative to human Nkd1 (see 
Section 3.1.2). 
 
HEK293 cell lines stably expressing this Nkd1-333BirA* bait were generated using the Flp-In 
system (O’Gorman et al., 1991; see Section 4.12). These cells contain a recombinase site 
allowing for a single integration of the fusion construct at a defined genomic locus, such that 
the expression levels are controllable by a tetracycline-inducible promoter. I confirmed that 
the bait was expressed in tetracycline-inducible fashion by Western blotting with an α-BirA 
antibody, and that this bait triggered a smear of biotinylation of endogenous proteins (Fig. 
3.13D). Conducting a time course, I established that significant biotinylation occurs within 12 
hrs of biotin treatment (Fig. 3.13E). This time point, although shorter than the recommended 
24 hrs of labelling (Roux et al., 2013), fits more closely with the physiological duration of Wnt 
signalling events, and so was used during the proteomics screen. Having confirmed the 
labelling methodology was working, I proceeded to generate stable cell lines for three Nkd1 
mutants (constructs shown in Fig. 3.14A). In addition to the 4A and ΔHRD mutations 
previously identified, I included a glycine-to-alanine substitution of the second amino acid of 
Nkd1 (G2A). Mutation of this glycine residue blocks N-terminal myristoylation and hence 
prevents targeting of Nkd1 to the plasma membrane (Li et al., 2004). An N-terminally GFP-
tagged BirA* was used to generate a background proteomics profile for comparison. 
 
The BioID cells lines were treated with Wnt3a-conditioned media and biotin for 12 hrs, after 
which biotinylated proteins were affinity purified and resolved by SDS-PAGE (Fig. 3.14B, see 
Section 4.12). Mass spectrometry analysis of purified proteins revealed a number of 
interesting candidate interacting proteins of Nkd1 (which were enriched 5-fold or greater, 
relative to GFP; Fig. 3.14C). I was pleased to note that all three orthologs of Dvl were 
identified at high spectral counts with wt Nkd1, but were reduced with the 4A mutation. Other 
cytoplasmic Wnt signalling components identified included APC, Axin1 (notably with fewer 
counts with the ΔHRD bait), CK1ε and β-catenin, as well as the transmembrane co-receptor 
LRP6. As expected, almost all of the plasma membrane proteins identified were significantly 
reduced in their association with the G2A mutant. Of particular interest were a number of Nkd- 
associated proteins, several of which were previously unlinked to Wnt signalling, which were 
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significantly reduced with the ΔHRD mutant. These included two related to K63-linked polyUb 
signalling (N4BP1 and CYLD), as well as several related to the autophagy pathway (including 
NBR1, KEAP1 and p62). The BioID labelling approach was thus successful in identifying 




Figure 3.14 BioID screen for 
interactors of Nkd1. 
(A) GFP- and Nkd1-BirA* fusion 
constructs used in this screen. 
(B) SDS-PAGE gel, prior to cutting 
into slices, showing biotin 
pulldowns from Flp-In HEK293 
cell lines expressing the 
indicated BioID baits. 
(C) Table of selected proteins 
identified by mass 
spectrometry. Values represent 
total unweighted spectral 

























3.2.7 Autophagy adapters interact with Nkd1 
One group of proteins that particularly stood out from the BioID analysis were those involved 
in the autophagy pathway, including p62, NBR1 and KEAP1, all of which seemed to be fully 
dependent on the HRD of Nkd1 for association (Fig. 3.15A, B). Autophagy has previously 
been implicated in Wnt signalling (Gao et al., 2010), and although a conclusive demonstration 
of a role is lacking, the HMW aggregates formed by the Nkd1 HRD could constitute a 
substrate for selective autophagy (see Section 3.1.3). I thus sought to validate the findings of 
the BioID experiment, focusing on p62 and NBR1, both key adapter proteins involved in the 
selection of cargo for autophagy-mediated degradation. 
 
Using BioIP proximity labelling assays, I confirmed that endogenous p62 and NBR1 are both 
efficiently biotinylated by wt Nkd1-BirA*, but are completely untouched by ΔHRD Nkd1 (Fig. 
3.15C). I further wanted to confirm the results of these proximity-labelling experiments using 
an alternative methodology: ‘Lumier’ assays allow direct quantification of binding by 
comparing the enrichment of luciferase-tagged preys in immunoprecipitates of control and 
protein-of-interest baits (Fig. 3.15D; Blasche & Koegl, 2013). Using this assay, I found that 
















Figure 3.15 Autophagy adapter proteins identified by BioID interact with Nkd1. 
(A) Domain architectures of autophagy related proteins used in these experiments. 
(B) Table of selected proteins from Fig. 3.14C. Values represent total unweighted spectral 
counts (>95% probability). 
(C) Proximity biotinylation assays, as previously, investigating binding between Nkd1 and 
autophagy proteins. 
(D) Outline of Lumier assay methodology (Blasche & Koegl, 2013). 
(E) Binding of Nkd1 and LC3C baits to autophagy adapter proteins. Shown are Lumier assay 
data indicating the binding of luciferase-tagged preys to Flag-Nkd1 and Flag-LC3C, 
relative to Flag-GFP (set to 1). Values are presented as mean ± SEM (n=3). 
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p62 and NBR1 associated with a known binding partner, LC3C, NBR1 did not bind Nkd1 at 
above-background levels, suggesting that NBR1 does not bind Nkd1 directly, but comes into 
close proximity later, perhaps after delivery to autophagosomes is initiated by p62. 
 
3.2.8 Autophagy is not required for the function of overexpressed Nkd1 
Having established that autophagy adapter proteins bind to Nkd1, either directly or indirectly, 
it was crucial to establish whether activity of any of these proteins, or indeed the autophagy 
pathway in general, is required for Nkd1 to inhibit cytoplasmic Wnt signal transduction. I 
therefore chose to test the effect of Nkd1 in cell lines in which p62 and NBR1 had been 
deleted. Given that these proteins are somewhat redundant with each other, and other 
autophagy adapters, I also wanted to generate a cell line in which autophagy is completely 
blocked, by deleting the essential component ATG5 (Tsukada & Ohsumi, 1993). Furthermore, 
given previous reports that Dvl ubiquitylation might be a crucial moderator of Wnt signal 
transduction, and a reported role for DUBs in this process (Tauriello et al., 2010b), I also 
elected to delete N4BP1 and CYLD, both identified as HRD-associated proteins, in the same 
screen. 
 
I thus employed the CRISPR/Cas9 system, designing sgRNAs to induce double-strand 
breaks in 5’-proximal exons of the genes coding for these proteins, and confirmed their 
deletion from clonal HEK293T cell lines using Western blot analysis and DNA sequencing 
(Fig. 3.16A, B). ATG5 KO cells showed a marked increase in levels of p62 and NBR1, as 
would be expected when autophagy is completely abrogated (Bjørkøy et al., 2005). However, 
using SuperTOP assays I found no significant reduction in the ability of Nkd1 to inhibit Wnt3a-
induced transcriptional responses in any of these cell lines (Fig. 3.16C). In all cell lines, as in 
wt cells, Nkd1 ΔHRD showed a greatly reduced ability to inhibit signalling. Similar results were 
observed when signalling was induced by overexpression of Dvl2 in the same cell lines (Fig. 
3.16D). These data would suggest that none of these autophagy- or K63 polyUb-related 
proteins are cofactors essential for Nkd1 to function. However, it is important to note that 
Nkd1 is overexpressed in these assays, a major caveat in interpreting these results (see 
Section 3.3.3 for discussion). Further work is clearly required to elucidate the mechanism(s) 













































Figure 3.16 Knockout of candidate Nkd1 interactors does not interfere with Nkd1 
function. 
(A) Domain architectures of candidate interactors from BioID screen selected for further study 
by CRISPR/Cas9 knockout. 
(B) Western blots of lysates from KO lines, probed with antibodies as indicated, to 
demonstrate absence of protein expression (see also Appendix 1). 
(C) SuperTOP assays to measure Wnt signalling activity in KO cell lines (as indicated below) 
expressing the indicated proteins, and stimulated with Wnt3a. Values are presented as 
mean ± SEM (n=3), relative to control-treated cells. 




The timely cessation of β-catenin dependent Wnt signal transduction is essential for normal 
development and physiology, and for the prevention of pathologies including cancer. 
However, how this key event occurs remains poorly understood. In this chapter, I set out to 
perform a detailed structural and functional analysis of Nkd, a conserved cytoplasmic 
negative regulator of canonical Wnt signal transduction, aiming to understand the mechanism 
by which it inhibits signalling. This study is still ongoing and, as such, all our conclusions 
remain tentative at this stage. Alongside the discussion, suggestions for further experiments 
that would help to consolidate and expand on our preliminary data are also outlined. 
 
3.3.1 Conserved domains within Nkd are required for function 
Wanting to begin the study with no preconceived ideas of how Nkd might function 
biochemically to reduce Wnt signalling, I sought to confirm previous genetic evidence 
suggesting that Nkd acts at the level of Dvl (Rousset et al., 2001; Rousset et al., 2002), using 
Wnt signalling assays in human cell lines. Overexpression of Nkd1 reduced Wnt 
transcriptional output in cells stimulated with either Wnt3a or Dvl2 overexpression, but not 
with LiCl or β-catenin expression (Fig. 3.5), confirming that Nkd acts at the level of Dvl. 
 
Analysis of the primary sequence of Nkd, and alignments from several species including 
humans and Drosophila (Fig. 3.2) highlighted two conserved regions that seemed attractive 
candidates for further study, namely the central EF-hand fold and C-terminal HRD. Mutations 
that cause misfolding or deletion (respectively) of either of these regions completely abrogate 
the ability of Nkd to reduce Wnt signalling (Fig. 3.6). Previous evidence had suggested that 
the EF-hand might constitute a binding site for Dvl on Nkd (Rousset et al., 2002). Indeed, our 
endogenous proximity labelling assays, as well as protein expression in vitro, confirm that this 
is the case, and mutations of the EF-hand which abrogate binding to Dvl also block the ability 
of Nkd to inhibit Wnt signalling in vivo (Fig. 3.7, 3.8). Interestingly, coIP assays between 
overexpressed proteins showed no clear difference between wt and 4A Nkd in binding to Dvl 
(data not shown). This could be because a weak secondary binding site (such as that 
reported immediately C-terminal to the EF-hand; Rousset et al., 2002) is sufficient for 
interaction at the high protein concentrations achieved during overexpression. 
 
Our data furthermore show that the central PDZ domain of Dvl constitutes the interaction site 
for Nkd, corroborating previous data (Rousset et al., 2001). NMR data show that Nkd binding 
causes chemical shifts in numerous PDZ domain residues, implying binding to a region much 
more extensive than the peptide binding cleft through which ligands usually interact with the 
PDZ (Fig. 3.8C; Gammons et al., 2016b). It is unclear whether this unusual mode of Nkd 
binding would be compatible or competitive with the binding of a peptide from another ligand 
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into the cleft, which could conceivably contribute to Nkd function, though this could easily be 
tested. Further biophysical characterization of this unusual interaction would be very 
interesting, not only from the point of view of understanding Nkd, but also to further appreciate 
the diverse range of interactions in which the Dvl PDZ domain appears able to participate. For 
example, using intermediate concentrations of EF-hand could allow peaks to be followed 
more closely and potentially identify key individual interacting residues within the PDZ, whilst 
an assignment of the Nkd EF-hand would be required to map the interacting region on the 
EF-hand. Miha Renko has purified a soluble, untagged EF-hand-PDZ complex, but no 
crystals have thus far been obtained from preliminary attempts at solving the structure. 
 
Intriguingly, SEC-MALS analysis of bacterially expressed Nkd1 EF-hand strongly suggests 
that it is dimeric (Fig. 3.8D). Since Nkd has only a single EF-hand, this suggests that it forms 
intermolecular dimers, as opposed to the intramolecular dimers formed by most EF-hands, 
which occur in tandem (Babu et al., 1988). Although this is unusual, it is not unprecedented: 
an isolated EF-hand in STIM1 forms a calcium-sensing dimer, whilst calpain contains no 
fewer than five EF-hand folds, and dimerises via mutual interaction of the fifth EF-hand 
(Huang et al., 2009b; Blanchard et al., 1997). Furthermore, each EF-hand dimer interacts with 
a single PDZ domain, implying that the stoichiometry of the Nkd:Dvl interaction is 2:1. This 
stoichiometry would permit a high concentration of Nkd to be established at Wnt 
signalosomes, which could be crucial to its function. 
 
Although the EF-hand has previously been suggested to bind several different cations, 
including Ca2+ (as is typical for EF-hand folds) and Zn2+ (Rousset et al., 2002), we found no 
evidence for this in our in vitro studies of Nkd. Treatment of Nkd1 EF-hand with high 
concentrations of EDTA or EGTA has no effect on folding in vitro, as observed during gel 
filtration, and does not disrupt the interaction of the EF-hand with the Dvl PDZ domain (Miha 
Renko, data not shown). However, these are preliminary experiments, and further studies 
using specialised mass spectrometry techniques might be required to answer the question of 
which, if any, metal cations are bound by Nkd. 
 
Overall, our data suggest that the EF-hand represents a targeting domain, which serves to 
recruit plasma membrane-localised Nkd to Wnt signalosomes via a direct interaction with Dvl. 
This interaction occurs with the Dvl PDZ domain, which is not required for signalosome 
assembly (Gammons et al., 2016b), suggesting that this interaction alone cannot serve to 






3.3.2 The Nkd HRD is a unique domain that forms unusual structures 
Having established a key role for the EF-hand in Nkd function, the second domain that we 
focused on was the highly unusual C-terminal HRD (histidine rich domain). Recall that the 
HRD is required for full inhibition of Wnt signalling by Nkd (Fig. 3.6). Given that Nkd can be 
recruited to Wnt signalosomes via its EF-hand, we were intrigued by the possibility that the 
HRD might serve to recruit an effector protein (or proteins) that could facilitate signalosome 
disassembly or otherwise inhibit canonical Wnt signalling. 
 
Surprisingly, I observed bands on Western blots corresponding to extremely high molecular 
weight (HMW) species of overexpressed wt Nkd, but never ΔHRD Nkd. This serendipitous 
observation suggested that the HRD might somehow promote the clustering or aggregation of 
Nkd molecules, which can indeed be observed using fluorescence microscopy (Fig. 3.9B). 
Positioning and/or cutting of the PDVF membrane used for blotting means that these bands 
had initially escaped notice. Although we were skeptical that these HMW species might be 
artefacts of gel running, they are clearly also present in solution and are highly stable, proving 
resistant to harsh treatments up to (and including) boiling in 20% SDS (Fig. 3.9C). Although 
unusual, the formation of stable HMW species is not unprecedented, having previously been 
observed for proteins that are modified by addition of C-terminal alanine/threonine (CAT) tails 
(Shen et al., 2015, Yonashiro et al., 2016), or those containing expanded polyglutamine 
(polyQ) tracts (Kim et al., 2002). As expected, mutation of histidine residues within the HRD 
abrogates the ability to form these species, and it will be essential to test such mutations in 
our in vivo assays of Nkd function. 
 
Data from our in vitro experiments give some clues as to the nature of these HMW species. 
Gel filtration analysis estimates the stoichiometry of these species to be variable, with a mean 
of around 16 Nkd moieties per cluster, a figure was corroborated by MALDI-TOF mass 
spectrometry. Boiling appears to reduce the clusters to a stable ‘core’ of 10 molecules. 
Although our preliminary attempts at structure solution have so far yielded no crystals or 
promising electron microscopy data, we speculate that this stable ‘core’ might be ring-shaped, 
as occurs in several other well-described aggregates (see for example Tran et al., 2016), and 
that further HRDs are then able to associate with this core. Although histidine residues are 
known to coordinate metal cations in many instances, addition of EDTA has no effect on HRD 
clustering either in vivo or in vitro, implying that such cations are not required for this process.  
 
Given that our data was collected with overexpressed Nkd, a crucial question is whether this 
‘histidine clustering’ effect occurs when Nkd is present at endogenous levels, seeing as it is 
expected to be concentration-dependent. We did not observe HMW species in gels when 
BirA*-tagged Nkd1 constructs were stably expressed in mammalian cells. However, in the 
context of the signalosome, where high local concentrations of Nkd are achieved as a result 
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of binding to polymerized Dvl, would seem to provide ideal conditions for the association of 
multiple Nkd HRDs to form clusters. Further experiments, perhaps employing super-resolution 
microscopy techniques, will be required to fully elucidate the structures formed by Nkd, and 
how they interact with the signalosome. Studies are also needed to determine the dynamicity 
of these clusters. Fluorescence recovery after photobleaching (FRAP) experiments have 
revealed that the puncta formed upon Dvl overexpression are highly dynamic (recovering 
within ~10 s), with Axin puncta being marginally less so (Schwarz-Romond et al., 2005; 
Schwarz-Romond et al., 2007b). On the basis of their stability in vitro, we might predict Nkd 
clusters to be much more long-lived if studied by the same method. This could have the effect 
of stabilising the entire signalosome, preventing the exchange of Dvl molecules, although it is 
difficult to predict what this might mean in terms of Wnt signal transduction. Alternatively, it 
could allow the stable recruitment of further factors to the signalosome. 
 
Intriguingly, the formation of HMW clusters by the Nkd HRD is pH dependent, being strongly 
disfavoured at pH values lower than around 6.3 (very close to mean pKa values for histidine 
residues within proteins; Edgcomb & Murphy, 2002). Protonation of histidine residues likely 
blocks the interaction of one positively charged HRD with another, suggesting that highly 
stable Nkd clusters could nonetheless be rapidly disassembled in a low pH environment, such 
as that found within the lysosome. Although speculative, this could have implications for Nkd 
function in signalosome disassembly.  
 
A final interesting question is whether this property of histidine-dependent clustering is a more 
general phenomenon. Relatively few proteins contain histidine rich regions, and these are 
rarely as pronounced at that of mammalian Nkd1. Multiple histidine residues are clearly 
required for formation of these species, but mutation of non-histidine residues also has a 
negative effect on clustering of Nkd1. Indeed, preliminary testing of a selection of 11 HRDs 
from other proteins, including Axin1 (carried out by Miha Renko; Fig. 3.11A) suggests that 
they will not cluster alone in the same fashion as Nkd, although it is notable that the Axin1 
HRD is able to associate with the Nkd HRD, forming clusters containing both proteins. This 
interaction does not, however, seem to compete with Axin’s interaction with Dvl or directly 
promote signalosome disassembly (Fig. 3.12). It will be interesting to test whether Drosophila 
Nkd is able to cluster in a similar fashion, as although it does contains a histidine-rich region, 
this is more extended, with a lower density of histidine residues. Further analysis is clearly 







3.3.3 Models for Naked-dependent switching of cytoplasmic Wnt signalling 
Given the requirement of the HRD for the ability of Nkd to inhibit canonical Wnt signalling, the 
unusual properties of this domain, and the lack of any obvious enzymatic (or other) activity 
within Nkd, I decided to search for interacting partners of Nkd using a proteomics approach, 
hypothesizing that hitherto unknown factors might be required in order for Nkd to promote 
signalosome disassembly or switching. Standard coIP-based methodologies failed to yield 
useful results (data not shown), but a screen using BioID proximity labelling successfully 
identified a number of interesting candidate interacting partners of the Nkd HRD (Fig. 3.14C), 
including multiple proteins involved in the autophagy pathway, and several implicated in the 
regulation of K63-linked polyUb chains, which were subsequently confirmed by other 
methods. Given the preliminary data presented in this chapter, I would thus like to present 
three models for mechanisms by which Nkd could catalyse signalosome switching, and hence 
to promote the cessation of canonical Wnt signalling (Fig. 3.17). Although these models 
remain highly speculative, they constitute a starting point for further studies to confirm or 
discount. 
 
Three proteins identified in the BioID screen that I focused on were the key autophagy 
receptors p62 and NBR1, and the associated adapter protein KEAP1. A mechanism whereby 
Nkd might promote the autophagic degradation of Dvl, through recruitment of these adapters, 
would be elegant and simple, particularly in light of the aggregation-prone nature of the HRD 
(Fig. 3.17A). Several reports have previously implicated p62 and autophagy in regulation of 
Dvl (Zhang et al., 2006; Gao et al., 2010). Although p62 contains a DIX-like PB1 domain, it 
cannot bind directly to Dvl (Ciara Metcalfe, PhD thesis). Instead, various proteins including 
Dapper1 and receptor for activated C kinase 1 (RACK1) have been proposed to provide the 
link between these components (Ma et al., 2015; Cheng et al., 2016). However, evidence 
from genetics would suggest that Nkd plays a far more widespread role in negative regulation 
of the Wnt pathway than either of these factors, and could represent the primary mechanism 
through which autophagy regulates Dvl. 
 
In many cases, including those already proposed to regulate Dvl, autophagy is directed by the 
assembly of ubiquitin on substrates, which serves to recruit autophagy receptors including 
p62 and NBR1 (Pankiv et al., 2007; Kirkin et al., 2009). However, our data suggest that Nkd is 
not heavily ubiquitylated in vivo, and indeed may not require this modification, given that 
protein aggregates appear to constitute prime targets for autophagic degradation (Khaminets 
et al., 2016). If this model turned out to be correct, it will be crucial to test which signalosome 
components are degraded, and whether there is any selectivity for Dvl in this process. Given 














Figure 3.17 Models for Naked function. 
(A) Nkd is localised to Wnt signalosomes via the interaction of the EF-hand with the Dvl PDZ 
domain. The 2:1 stoichiometry of this interaction, along with the polymerized nature of 
Dvl, creates a high local concentration of Nkd, permitting HRD-dependent clustering to 
occur. These clusters, which may also recruit Axin, are recognised by autophagy 
receptors such as p62 and earmarked for autophagy-mediated degradation. 
(B) Nkd is localised to signalosomes as in (A), but the HRD serves to recruit components of 
the ubiquitin system, including CYLD and N4BP1, which inhibit ubiquitylation of the DIX 
domain and could serve to thus block DIX-dependent polymerization (Tauriello et al., 
2010b). 
(C) Nkd is localised to canonical Wnt signalosomes, where it promotes the exchange of 
canonical Wnt signalling factors and receptors (including the key canonical co-receptor, 
LRP5/6) for those involved in non-canonical signalling. Details of how this switch might 




be sequestered within the autophagic membrane. It would then be interesting to test whether 
the acidic conditions found in the lysosome allow for disassembly of these clusters, as might 
be predicted by the pH-dependency of Nkd HRD aggregation (Fig. 3.10B). 
 
An alternative model for the role of Nkd is that it regulates the ubiquitylation status of Dvl (Fig. 
3.17B), through the concomitant recruitment of the deubiquitylase CYLD and N4BP1, an 
inhibitor of NEDD4-family E3 ubiquitin ligases such as ITCH (Oberst et al., 2007). Dvl is 
modified with non-degradative K63-linkages by a number of ligases (including ITCH; Wei et 
al., 2012), and CYLD has previously been implicated in Dvl regulation, having been shown to 
cleave these chain types from the Dvl1 DIX domain, promoting signalosome disassembly by 
abrogating DIX-dependent polymerization (Tauriello et al., 2010b). Importantly, this study 
could not demonstrate direct binding between Dvl and CYLD in vitro, suggesting that another 
factor, such as Nkd, may be required to in order to promote this interaction and permit 
deubiquitylation to occur. However, the effect of DIX ubiquitylation is residue-dependent, 
given that modification of Lysine-54 abrogates polymerization, whilst ubiquitylation of Lysine-
58 has no effect (Madrzak et al., 2015). It is important to note that these models for Nkd 
function are not mutually exclusive; indeed, given that K63-linked ubiquitin chains are a 
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primary signal for autophagy (Seibenhener et al., 2004), they may well be working in concert. 
Such a mechanism would require some complexity, however, given that the predicted effect 
of CYLD and N4BP1 recruitment to Dvl would be to remove ubiquitin, rather than add it. 
 
However, despite the simplicity and attractiveness of these two models, it is important to 
recognize that they are not immediately consistent with our data. Most principally, deletion of 
p62, NBR1, or the key autophagy mediator ATG5 using CRISPR/Cas9 does not appear to 
block the ability of Nkd to reduce Wnt signalling responses. Similarly, Nkd seems to function 
in the absence of CYLD or N4BP1 (Fig. 3.16). Whilst concerning, these experiments do not 
necessarily imply that these models are incorrect. For example, there may be redundancy 
between different components and pathways, particularly if Nkd is acting via multiple 
mechanisms. An overriding concern with all of these data is that overexpression of Nkd might 
mask a more subtle effects that the protein would have at endogenous levels, and it may be 
important to establish assays of Nkd function that do not rely on this in order to establish the 
true mechanism of Nkd function. One way to achieve this might be to generate cell lines in 
which Nkd1 and Nkd2 are deleted using CRISPR/Cas9. Wt or mutant Nkd constructs could 
then be stably reexpressed at near-endogenous level, as has been achieved for Dvl in our lab 
(Gammons et al., 2016b).  
 
It is certainly also possible that the models proposed are incorrect, and that we have not yet 
identified a key cofactor of Nkd. Another potential avenue for further study, which we have not 
touched upon in this chapter, is a potential role for Nkd in the endocytosis of Wnt receptors or 
other signalosome components. The Nkd HRD contains a C-terminal YHHF motif that 
constitutes a classical YXXΦ signal sequence for clathrin-mediated endocytosis (Olsen & 
Grose, 1998). The endocytic pathway can selectively deliver contents to lysosomes, and 
shares much of the machinery for degradation with the autophagy pathway (Lamb et al., 
2013), potentially providing an alternative route by which Nkd could promote the degradation 
of signalosome components. On the other hand, our BioID data also hints at a potential role 
for Nkd in controlling the switch between canonical and non-canonical Wnt outputs, as has 
previously been suggested (Yan et al., 2001; Fig. 3.17C). Although Nkd does not seem to 
direct PCP signalling in the context of the Drosophila wing (Zeng et al., 2000), this could be 
due to redundancy with another factor, such as Diego (Schwarz-Romond et al., 2002). 
Interestingly, the only other protein that appears to employ a folded domain to interact with 
the Dvl PDZ domain, in a similar fashion to Nkd, is diversin (the mammalian homolog of 
Diego), which acts to redirect Dvl such that canonical Wnt signalling is inhibited and the PCP 
pathway promoted (Jenny et al., 2005). Nkd could promote a similar ‘switching’ of Wnt 
signalosomes. Multiple Fz co-receptors implicated in non-canonical Wnt signalling were 
identified in the BioID screen, including VANGL1/2 and ROR2 (Murdoch et al., 2001; 
Takeuchi et al., 2000). Intriguingly, VANGL2 has also been identified as an interacting partner 
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of p62 (Puvirajesinghe et al., 2016). Further work will be required to validate these 
interactions, and improved biochemical tools to assay non-canonical signalling outputs 
needed to study a potential role for Nkd in redirecting the output of Wnt signalling towards 
these pathways.  
 
In conclusion, in this chapter I have presented initial results towards the understanding of the 
mechanistic basis of Nkd function. We have determined the biochemical properties of two key 
domains of Nkd, and identified a number of candidate proteins that could constitute key 
interactors of the Nkd HRD. Further work is now required to fully understand the role(s) of this 
enigmatic protein in terminating canonical Wnt signalling.  
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4. Materials & Methods 
 
Some passages in this chapter have been quoted verbatim, or adapted from, the Materials & 
Methods section of Flack et al., 2017.  
 
4.1 Key Resources Table 




α-GFP (rabbit) Sigma 
α-GFP (mouse) Sigma 
α-Flag (mouse) Sigma 
α-Flag (rabbit) Sigma 
α-HA (rat) Sigma 
α-HA (rabbit) Abcam 
α-Myc Santa Cruz Biotechnology 
α-active β-catenin (ABC) Cell Signaling Technologies  
α-β-catenin BD Transduction Laboratories 










α-Ub (FK2) Sigma 




α-CYLD Cell Signaling Technologies  
α-N4BP1 Abcam 
HRP conjugated Goat α-Mouse Santa Cruz Biotechnology 
HRP conjugated Goat α-Rabbit Santa Cruz Biotechnology 
HRP conjugated Goat α-Rat Santa Cruz Biotechnology 
HRP conjugated Goat α-Chicken Santa Cruz Biotechnology 
HRP conjugated Donkey α-Goat R&D Systems 
Alexa Fluor 488 conjugated Goat α-Rabbit Life Technologies 
Alexa Fluor 488 conjugated Goat α-Mouse Life Technologies 
Alexa Fluor 546 conjugated Goat α-Mouse Life Technologies 
Alexa Fluor 546 conjugated Goat α-Rat Life Technologies 
Alexa Fluor 647 conjugated Goat α-Mouse Life Technologies 
Alexa Fluor 647 conjugated Goat α-Guinea pig Invitrogen 
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α-Senseless Prof. Hugo J. Bellen 
α-Vestigial Prof. Sean B. Carroll  
α-Wingless DSHB 
α-Armadillo DSHB 
Chemicals, peptides and recombinant proteins 
Ni-NTA Agarose Qiagen 
α-FLAG M2 Affinity Gel Sigma 
EZview Red α-HA Affinity Gel Sigma 
GFP-trap_A Chromotek 
Glutathione Sepharose 4b GE Healthcare 
Dynabeads MyOne Streptavidin C1 Invitrogen 
Lipofectamine2000 Invitrogen 
Polyethylenimine, linear, MW25000 Polysciences 
EDTA-free Protease Inhibitor Cocktail Roche 
MG132 Sigma 
NMS-873 Cayman Chemical Co. 
CB-5083 Cayman Chemical Co. 
Cycloheximide Sigma 
Puromycin dihydrochloride Sigma 
Hygromycin B Sigma 
Tetracycline Sigma 
3xFLAG-Peptide Sigma 
L-Glutathione reduced Sigma 
VectaShield with DAPI Vector Laboratories 
Ubiquitin-activating enzyme E1 (UBE1A) Boston Biochem 
Ubiquitin-conjugating enzyme E2 (UBE2L3) Boston Biochem 
Ubiquitin Boston Biochem 
Methyl-ubiquitin Boston Biochem 
K6-only ubiquitin Boston Biochem 
K11-only ubiquitin Boston Biochem 
K27-only ubiquitin Boston Biochem 
K29-only ubiquitin Boston Biochem 
K33-only ubiquitin Boston Biochem 
K48-only ubiquitin Boston Biochem 
K63-only ubiquitin Boston Biochem 
Histone H2A (1-22) - GK(Biotin) AnaSpec Inc. 
Histone H3 (1-21) Biotinylated AnaSpec Inc. 
Histone H4 (1-23) - GGK(Biotin) AnaSpec Inc. 
Commercial assays/kits 
Dual-Luciferase Reporter Assay System Promega 
UbiCRest Deubiquitinase Enzyme Kit Boston Biochem 
RNeasy Mini Kit (RNA Purification) Qiagen 
iScript cDNA synthesis kit Biorad 







The following key parental plasmids were used during the course of these studies: 
Plasmid Source 
Flag-UBR5 Prof. Rina Rosin-Arbesfeld (Hay-Koren et al., 2011) 
GFP-UBR5 subcloned from Flag-UBR5 
GST-UBR5 HECT Bienz Lab, MRC-LMB 
GFP (empty vector) Bienz Lab, MRC-LMB 
Flag-GFP subcloned from GFP (empty vector) 
HA-GFP subcloned from GFP (empty vector) 
HA-β-catenin-Δ45 Bienz Lab, MRC-LMB (Morin et al., 1997) 
Myc-TLE3 Prof. Ethan Lee (Hanson et al., 2012) 
HA-TLE3 subcloned from Myc-TLE3 
Flag-TLE3 subcloned from Myc-TLE3 
VCP-GFP Prof. Nico Dantuma (Tresse et al., 2010) 
HA-PAIP2 Bienz Lab, MRC-LMB 
His-Ub Dr. Thomas Mund 
GST-HES1 Prof. Stefano Stifani 
SSDP-GFP Bienz Lab, MRC-LMB (Fiedler et al., 2015) 
LDB1-GFP Bienz Lab, MRC-LMB (Fiedler et al., 2015) 
GFP-TCF4 Bienz Lab, MRC-LMB 
GFP-Pygo1 Bienz Lab, MRC-LMB 
HA-Nkd1 Bienz Lab, MRC-LMB 
Flag-Nkd1 Bienz Lab, MRC-LMB 
Flag-Dvl2 Bienz Lab, MRC-LMB 
Lip-Dvl2 PDZ Bienz Lab, MRC-LMB 
Axin-GFP Bienz Lab, MRC-LMB 
GFP-p62 Randow Lab, MRC-LMB 
Flag-LC3C Randow Lab, MRC-LMB 
Luciferase-p62 Randow Lab, MRC-LMB 
Luciferase-NBR1 Randow Lab, MRC-LMB 
pcDNA5/FRT/TO van Breugel Lab, MRC-LMB 
pOG44 van Breugel Lab, MRC-LMB 
PX458 (Ran et al., 2013) 
PX459 (Ran et al., 2013) 
Super 8x TopFLASH (SuperTOP) (Veeman et el., 2003) 
CMV-Renilla  Promega (Cat #E2261) 
 
Cloning and mutagenesis of parental plasmid DNA to generate other constructs was carried 
out using standard PCR-based methods, using either KOD DNA polymerase (Merck Millipore) 








4.3 Drosophila strains and analysis  
All Drosophila analysis was performed by Juliusz Mieszczanek. The following strains of 
Drosophila melanogaster were used during the course of this study: 
Strain Source Identifier 
hydK7-19 Prof. Jessica E. Treisman FlyBase: FBal0144234 
groMB36 Prof. David Ish-Horowicz FlyBase: FBal0230454 
axinp Prof. Tetsu Akiyama FlyBase: FBal0097414 
UAS.SoxF Dr. Fernando Casares FlyBase: FBtp0051564 
pygoS123 Bloomington Drosophila Stock Centre FlyBase: FBal0146872 
UAS.ArmS10 Bloomington Drosophila Stock Centre FlyBase: FBtp0001723 
UAS.MamDN Prof. Sarah Bray FlyBase: FBtp0014588 
Vg-Gal4, UAS-flp; 
FRT82b GFP 
Bienz Laboratory, MRC-LMB (Miller et al., 2013) 
 
Double mutant Drosophila strains were generated from parental strains with standard 
techniques, and checked by complementation. 
 
Fly wings were dissected and mounted in 6:5 mixture of lactic acid:ethanol, and imaged with a 
Nikon Eclipse TE2000-E microscope. 
 
Wing disc clones were generated with vg.GAL4, UAS.flp; FRT82b GFP (also used for 
overexpression of UAS transgenes), as previously described (Miller et al., 2013). Wing discs 
were dissected from late third-instar larvae, fixed in phosphate-buffered saline (PBS) 
containing 4% formaldehyde, 0.1% Triton X-100 for 30 min and permeabilised in 0.1% Triton 
X-100 in PBS for 5x 5 min. Discs were blocked in blocking buffer (PBS supplemented with 
0.5% bovine serum albumin, 0.1% Tween-20) for 1 hr and incubated with primary antibodies 
in blocking buffer at 4 °C. Discs were washed in blocking buffer and incubated with secondary 
antibodies. Discs were embedded in VectaShield with DAPI mounting media, and single 
confocal images acquired at identical settings on a Zeiss LSM510 or LSM710 confocal 
microscope. 
 
4.4 Mammalian cell culture 
HEK293T, HEK293, HCT116, HeLa and COS-7 cells were cultured in DMEM (ThermoFisher 
Scientific), supplemented with 10% FBS (fetal bovine serum) at 37 °C in a humidified 
atmosphere with 5% CO2. No antibiotics were included in the media, and cell lines were 
regularly screened for Mycoplasma infection. 
 
For transfections, cells were plated 10-12 hrs prior to transfection in plates pre-treated with 
poly-L-lysine (Sigma). Cells were transfected with polyethylenimine (PEI) or Lipofectamine 
2000 according to the manufacturer’s instructions. 
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Wnt inductions were for 6 hrs, either with Wnt3a-conditioned media or 20 mM LiCl. L-cell 
conditioned media or 20 mM NaCl, respectively, were used as controls. Where noted, 10 µM 
MG132, 5 µM NMS-873, 2.5 µM CB-5083 or 50 µg mL-1 cycloheximide was added for the 
same time. 
 
4.5 CRISPR/Cas9 genome editing 
HEK293T or HCT116 KO cell lines were generated essentially as described (Ran et al., 
2013). The Optimized CRISPR Design tool (crispr.mit.edu) was used to design sgRNA-
encoding plasmid derivatives of pSpCas9(BB)-2A-GFP (PX458) for each gene to be targeted 
(see Appendix 1). Cells were selected for high expression of GFP by FACS 48 hrs post-
transfection, and individual clones expanded in 96-well plates. Clones were screened by 
Western blot analysis and subsequently by DNA sequencing (Appendix 1) to confirm the 
presence of frameshifting indels. To ensure consistency, multiple lines were isolated and 
sequenced for each gene being knocked out. MicroLYSIS-Plus (Microzone) was used as per 
the manufacturer’s instructions for sequencing of genomic DNA. 
 
For transient knockdowns, sgRNAs were cloned into pSpCas9(BB)-2A-Puro (PX459). 
Selection with puromycin was initiated 48 hrs post-transfection and carried out for 96 hr. Cells 
were left to recover for 72 hrs prior to seeding for experiments. 
 
4.6 Cell-based signalling assays 
For luciferase reporter (SuperTOP) assays, cells were lysed 20 hrs post-transfection with 
SuperTOP and CMV-Renilla (control) plasmids, and analysed with the Dual-Glo Luciferase 
Reporter Assay kit (Promega) according to the manufacturer’s protocol. Values were 
normalised to Renilla, and are shown as mean ± SEM relative to unstimulated controls (set to 
1) or to stimulated wt cells (set to 100%) for at least three independent experiments. 
 
4.7 Co-immunoprecipitation assays 
For coIP assays, cells were lysed 24-36 hrs post-transfection in lysis buffer (20 mM Tris-HCl 
pH 7.4, 200 mM NaCl, 10% glycerol, 5 mM NaF, 2 mM Na3VO4, 0.2% Triton X-100, protease 
inhibitor cocktail). Lysates were clarified by centrifugation (16,100x g, 10 min), and 
supernatants incubated with (Flag- or HA-) affinity gel or GFP-trap for 90 min at 4 °C. 
Subsequently, immunoprecipitates were washed 4x in lysis buffer and eluted by boiling in 
LDS (lithium dodecyl sulphate) sample buffer for 10 min. 
 
CoIP assays using biotinylated histone tail peptides were conducted in similar fashion, except 
that lysates were incubated with 1.5 µM biotinylated peptide for 45 min, prior to the addition of 
streptavidin dynabeads. 
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4.8 In vivo ubiquitylation assays 
Ni-NTA pull-down experiments to enrich proteins modified with His-ubiquitin were conducted 
in the same fashion as coIP assays, except that cells were lysed in urea buffer (8 M urea, 50 
mM Na2HPO4 pH 8.0, 300 mM NaCl, 2 mM N-ethylmaleimide (NEM), 5 mM chloroacetamide, 
0.5% NP40, 25 mM imidazole, protease inhibitor cocktail) and sonicated for 2x 10 sec with a 
Soniprep 150 plus sonicator (MSE) prior to addition of Ni-NTA agarose. Beads were washed 
6x in urea buffer and ubiquitylated proteins eluted by boiling in LDS sample buffer. 
 
4.9 “UbiCRest” deubiquitylation assays 
For UbiCRest assays (Hospenthal et al., 2015), the UbiCRest DUB Enzyme kit was used, 
following the manufacturer’s protocol. Briefly, immunoprecipitates of Flag-TLE3 or HA-Ub 
(generated as above) were washed twice and resuspended in ‘1X DUB reaction buffer’. DUBs 
were added and reactions incubated for 45 min at 37 °C (while rotating), and subsequently 
quenched by addition of LDS sample buffer. An aliquot of each reaction was resolved via 
SDS-PAGE and analysed by Western blotting. 
 
4.10 Immunofluorescence 
HeLa or COS-7 cells were fixed on coverslips for 10 min with 4% formaldehyde, and 
permeabilised for 5 min in 0.2% Triton X-100 in PBS. Cells were then blocked in 5% bovine 
serum albumin (BSA) in PBS, and incubated with primary antibodies. Cells were washed (in 
0.1% Triton X-100 in PBS) and incubated with secondary antibodies. Coverslips were washed 
and embedded with VectaShield with DAPI mounting media. Images were acquired at 
identical settings on a Zeiss LSM510 or LSM710 Confocal Microscope. 
 
4.11 Mass spectrometry 
For affinity purification of UBR5-associated proteins, 20x 175 cm2 flasks of HEK293T cells 
transfected with UBR5 or control baits were used for each experiment. Cells were lysed in 40 
mL lysis buffer (20 mM Tris-HCl pH 7.4, 10% glycerol, 100 mM NaCl, 5 mM NaF, 2 mM 
Na3PO4, 0.2% Triton X-100, protease inhibitor cocktail), and sonicated 10x 10 sec at 40% 
intensity with a Branson 250 Sonifier. Cell lysates were clarified by centrifugation (21,000x g, 
30 min, 4 °C) and incubated (while rotating) for 2 hrs with Flag affinity gel at 4 °C. 
Immunoprecipitates were washed 5x with lysis buffer, and subsequently eluted with lysis 
buffer supplemented with 250 mg mL-1 3xFlag-Peptide. Eluates were boiled in LDS sample 
buffer and resolved on 4-12% Bis-Tris SDS-polyacrylamide gels. These were stained with 
Imperial Protein Stain, and gel lanes cut into 1-2 mm slices.  
 
WD40 domain-associated proteins and post-translational modifications were affinity purified in 
the above fashion, except that 8x 175 cm2 flasks were used for transfection. 
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All mass spectrometry analysis was performed by the LMB Mass Spectrometry Facility. 
Briefly, peptides from in situ trypsin digestion were extracted in 2% formic acid/2% acetonitrile 
mix. Digests were analysed by nano-scale capillary LC-MS/MS using an Ultimate U3000 
HPLC and C18 Acclaim PepMap100 nanoViper (Thermo Scientific Dionex). LC-MS/MS data 
were searched against a protein database (UniProt KB) with the Mascot search engine 
program (Matrix Science). MS/MS data were validated using the Scaffold program (Proteome 
Software). 
 
4.12 BioID methodology 
BirA*(R118G) and Nkd1 coding sequences were subcloned into pcDNA5/FRT/TO to generate 
vectors for expression of BioID bait proteins. Stably transfected HEK293 cell lines inducibly 
expressing BioID baits were generated using the Flp-In system (ThermoFisher Scientific) 
according to the manufacturer’s protocol. Briefly, Flp-in HEK293 cells were transfected with a 
4:1 ratio of pOG44 recombinase:pcDNA5 bait plasmid, left to recover for 36 hrs and then 
selected with 250 µg/ml hygromycin B for at least 7 days. 
 
For large scale BioID experiments, cells were induced with 1 µg/ml tetracyline for 24 hr, and 
treated with 50 µM biotin for 12 hrs prior to lysis. BioID pulldowns were carried out using 
Streptavidin MyOne dynabeads (ThermoFisher) essentially as described (Roux et al., 2013), 
and biotinylated proteins eluted by boiling in LDS sample buffer. SDS-PAGE (for ‘BioIP’ 
experiments) and mass spectrometry analysis were carried out as above. 
 
4.13 Protein expression and purification 
All recombinant proteins were purified from BL21 (DE3) pRIL E. coli bacterial strains. Bacteria 
were grown in LB media supplemented with appropriate antibiotic to an OD600 of 
approximately 0.7 and induced by addition of 0.4 mM isopropyl-β-D-1-thiogalactopyranoside 
(IPTG). Proteins were expressed for 6 hrs at 37 °C or for 12 hrs at 22 °C. Cells were 
resuspended in lysis buffer (25 mM Tris-HCl pH 8.0, 200 mM NaCl, 10% glycerol, 5 mM β-
mercaptoethanol, 10 mg mL-1 DNase, protease inhibitor cocktail) and lysed by high-pressure 
homogenization with an Emulsiflex C-3. Lysates were clarified by ultracentrifugation 
(140,000x g, 30 min, 4 °C). His-tagged proteins were purified on Ni-NTA agarose beads 
(Qiagen) and washed 4x with lysis buffer (containing 20 mM imidazole) prior to elution (in 
lysis buffer contain 250 mM imidazole). 
 
For purification of GST-tagged proteins, lysates were mixed with glutathione Sepharose 4B. 
Beads were washed 7x with lysis buffer, including a high salt (500 mM NaCl) fourth wash, and 
GST-tagged protein eluted with 20 mM L-glutathione (reduced).  
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All proteins were purified by a final size exclusion chromatography step, and purity was 
assessed by SDS-PAGE prior to use in experiments. 
 
4.14 SEC-MALS 
SEC-MALS analysis was performed in collaboration with Chris Johnson and Miha Renko. 100 
µl Nkd EF-hand and/or Dvl2 PDZ samples were resolved on a Superdex S-200 analytical gel 
filtration column (GE Healthcare) in gel filtration buffer (150 mM NaCl, 25 mM!Na2HPO4, pH 
6.7) before light scattering and concentration determination using refractive index (RI) or UV 
absorbance in a standard SEC-MALS configuration (containing a Wyatt Heleos II 18 angle 
light scattering instrument coupled to a Wyatt Optilab rEX online RI detector). 
 
4.15 In vitro ubiquitylation assays 
In vitro ubiquitylation assays were carried out essentially as previously reported (Mund & 
Pelham, 2009). Assays were conducted in 20 µL format in buffer consisting of 25 mM Tris-
HCl pH 7.4, 10 mM MgCl2, 1 mM ATP, 200 ng UBE1A, 750 ng UBE2L3, 800 ng GST-
HECT2217-2799-wt or GST-HECT2217-2799-CS (each produced as above, Section 4.13), and 500 
ng ubiquitin (wt, methyl- or K-only mutant). Reactions were incubated for 2 hrs at 30 °C and 
quenched by the addition of LDS sample buffer. An aliquot of each reaction was resolved via 
SDS-PAGE and analysed by Western blotting. 
 
4.16 Protein NMR 
All NMR spectroscopy was performed in collaboration with Trevor Rutherford and Miha 
Renko. Nkd1 EF-hand and Dvl2 PDZ samples were prepared in NMR buffer (150 mM NaCl, 
25 mM! Na2HPO4, pH 7.4). Spectra were acquired on a Bruker Avance-3 spectrometer 
operating at 600 MHz and 25 °C.  
 
4.17 RT-qPCR 
RNA was extracted with the RNeasy mini kit and converted to cDNA using the iScript cDNA 
synthesis kit, as described in the manufacturer’s protocols. RT-qPCR reactions were run in 20 
µL, 96-well format on a Vii7 Real-Time PCR System (Applied Biosystems) using SYBR Select 
Mix with the primer pairs listed (Appendix 2). Values were normalised to PMM1 (Hanson et 
al., 2012), and are shown as mean ± SEM relative to unstimulated controls (set to 1) for at 
least three independent experiments. 
 
4.18 Quantitation and statistical analysis 
All error bars represent mean ± SEM for at least three independent experiments. Statistical 
significance was calculated using the Student’s t-test and denoted as follows in all cases: * = 
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Appendix 1 CRISPR/Cas9 genome editing 
Single-guide RNAs used for CRISPR/Cas9 genome editing 
Cell Line Gene Exon Targeted gRNA sequence 
HEK293T/
HCT116 UBR5 6 (G)CTGGAGCTCGAGATTCCCGC 
HEK293T HUWE1 5 GGACCGCTTCGATGGAATAC 
HEK293T TRIP12 3 (G)CTGACTCCGTGAACCGCCAG 
HEK293T HECTD1 3 (G)TATCTGCGGAATGTACCCGA 
HEK293T UBE3C 4 GCTACCTTGTCACAGTCCGG 
HEK293T XIAP 2 (G)TATCAGACACCATATACCCG 
HEK293T CTNNB1 3 GAAAAGCGGCTGTTAGTCAC 
HEK293T SQSTM1 3 (G)CGCTACACAAGTCGTAGTCT 
HEK293T NBR1 6 GTGGGGCTTCATCAACGACA 
HEK293T ATG5 2 (G)AACTTGTTTCACGCTATATC 
HEK293T CYLD 2 (G)CAGGACAGCCCACGTCTATT 
HEK293T N4BP1 1 (G)CGGCTAGGCTCACGCCAAAC 
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Genotyping primers for CRISPR/Cas9 genome editing 
Gene Exon  Primer sequence 
Fwd GATTGAGCCCGGGAGTTTTG 
Rev TCCATCTTCATCATCCCGGC UBR5 6 
Seq TGAGGCAGGAGGATCACTTC 
Fwd GCAGATCAAAACATGGAACATTGG 
Rev CTCTATGGAACTGTACAGATGCCG HUWE1 5 
Seq GTATGACAATGAACTACAGC 
Fwd AAGCTGCAGTTCATCATCTGCT 
Rev TTGCTAATTTGGCCTGTAATCCAGAA TRIP12 3 
Seq GCGCAGTGCTAGTCCAGACT 
Fwd GACTACAGGTGCCTGTCACC 
Rev ACTACCAGGAACTGAAGTGCAC HECTD1 3 
Seq ATATGATTTCTTTCACTACAG 
Fwd GAAGAAAGGCGAAGGTTGAAAAATGC 
Rev CACATCACCACATAGGTAACCTCTC UBE3C 4 
Seq CTACAATTCAACTGTGAGCA 
Fwd AAACTTGTGTACCTGCAGACA 
Rev CCGTGCTTCATAATCTGCCA XIAP 2 
Seq CTTTTGCTAATTTTCCAAGTGG 
Fwd GACAATGGCCATGTCCTACG 
Rev GGAAGGTGAAACACGGACAC SQSTM1 3 
Seq AGTCCATGTTCACTCTAG 
Fwd AAGAGACAGGCTGCAGTGAG 
Rev CTGCACTGCAGGATCCTCTG NBR1 6 
Seq GTTGTTGGATTTAATAAAGC 
Fwd GCAGTAGACTCTTCTGGGC 
Rev CCTTCTTTATGCTTATCTGTG ATG5 2 
Seq GCAATGAATATTACTGGC 
Fwd TGGACACCACGTTGCTGA 
Rev CCAAAGAATATTCCGGAGACTGT CYLD 2 
Seq CAATGAGTTCAGGCTTATG 
Fwd AAAGGGGCGGAGGGGTTC 




Appendix 2 RT-qPCR 
Primer pairs used for RT-qPCR analysis of endogenous gene expression 
Gene Primer sequence 
Fwd CTCCTAGTGGCACTGGCTTC PMM1 Rev GCAGGCTAGATCTCGT ACCG 
Fwd GCTGAGCGTGTCTCTCAACA NKD1 Rev AGGAGTGGATCGGGAGACAG 
Fwd CTGGTGCAAAGACATAGCCA AXIN2 Rev GTCCAGCAAAACTCTGAGGG 
Fwd TCGGACATAGGGACCCAGTT SP5 Rev CTGACGGTGGGAACGGTTTA 
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Appendix 3 – Bioinformatic analysis of histidine-rich domains 
Proteins from H. sapiens genome containing HRDs 
Protein HRD length 
Histidine 
residues  HRD sequence 
ERC2 13 12 HHHYHHHHHHHHH 
AXIN1 12 9 HHHRHVHHHVHH 
SORBS2 13 12 HHHHHHHHHHHRH 
CBL 11 8 HHHHHHHLSPH 
IQSEC2 13 11 HHHHHHHHHGHSH 
USP34 15 13 HHHHHHHHHHHHDGH 
NKD2 19 16 HEHHHHHEHHHHHHHHHFH 
NKD1 15 12 HEHHHHHEHHHHYHH 
SYNGAP1 10 10 HHHHHHHHHH 
RHOBTB2 20 12 HPEDHQGHSDQHHHHHHHHH 
EPB41L4B 14 9 HHHQHQHQHQHQHH 
SHANK1 23 14 HHHPPHHHHHHAPPPQPHHHHAH 
DLGAP3 19 14 HTSHHHHHHHHHHHHQSRH 
CPEB4 15 9 HHPHHPHFQHHHSQH 
BEAN1 15 12 HRHRHHRHHHHHHHH 
SIAH3 29 19 HPHHLSHHHCHHRHHHHLRHHAHPHHLHH 
CACNA1A 13 11 HRQHHHHHHHHHH 
CACNA1G 15 12 HHLVHHHHHHHHHYH 
CACNA1H 24 14 HTASVHHLVYHHHHHHHHHYHFSH 
SLC39A6 23 15 HHHHDYHHILHHHHHQNHHPHSH 
PRRT1 9 8 HHHHHHHYH 
VGLL3 20 15 HHHPHAHMHHRHRHHHHHHH 
CBX4 23 17 HPPSHHPHPHPHHHHHHHHHHHH 
CCNT1 25 13 HKEKHKTHPSNHHHHHNHHSHKHSH 
MAF 13 10 HHHHHHAAGHHHH 
ONECUT2 17 14 HHPHPHHHPHHHHHHHH 
HAND1 16 10 HHHHHHHPHPAHPMLH 
POU3F3 25 15 HHHHHHHHAHPHPPHPHHAQGPPHH 
YY1 16 13 HGHAGHHHHHHHHHHH 
OTX1 27 18 HHHHHPHAHHPLSQSSGHHHHHHHHHH 
HOXA1 10 10 HHHHHHHHHH 
MEOX2 17 15 HHRGHHHHHHHHHHHHH 
FOXG1 25 18 HHASHGHHNSHHPQHHHHHHHHHHH 
POU4F1 9 9 HHHHHHHHH 
POU4F2 15 13 HHHHHHHHHHHHQPH 
FOXF2 14 10 HAHPHHHHHHHVPH 
DYRK1A 21 17 HHHHGNSSHHHHHHHHHHHHH 
FAM76B 21 15 HHPKHHHHHHHHHHRHSSSHH 
FOXB2 27 21 HLHPHHHHHPHHHHHHHAAAHHHHHHH 
TAF2 12 9 HSDHHHHHHHEH 
VGLL2 24 11 HGHLHQGATEPWHHAHPHHAHPHH 
ARID1B 24 19 HQQHHHHHHAHHHHHHAHHLHHHH 
MAFA 25 19 HHHGAHHAAHHHHAAHHHHHHHHHH 







NR4A3 18 15 HHHHHHHHHHHHHHQQQH 
GATA6 10 10 HHHHHHHHHH 
CDX2 12 9 HPHHHPHHHPHH 
FOXC2 10 8 HHHQHHGHHH 
GSX2 16 12 HAHHHHHPPQHHHHHH 
PRDM13 12 11 HHHHHHAHHHHH 
CHD8 16 14 HHHHHHPHPHHHHHHH 
BMP2K 8 8 HHHHHHHH 
FAM120C 11 8 HHHPAHHFHHH 
ONECUT1 15 14 HHHHHHHHHHHPHHH 
ZNF281 8 8 HHHHHHHH 
MAFB 14 11 HHHHHHHHPHPHHA 
ZIC3 11 11 HHHHHHHHHHH 
ZIC2 9 9 HHHHHHHHH 
TSC22D1 23 15 HPHHLHHHHQIHHGHHLQHGHHH 
SKOR2 21 15 HSAQTHPHHHHHPHHHHHHHH 
RNF111 16 11 HGHHFQHHHHHHHTPH 
NUFIP2 40 23 HHHSHHHPHHHPQQQQQQPHHHHHYYFYNHSHNHHHHHHH 
NLK 28 18 HHHHHHHHLPHLPPPHLHHHHHPQHHLH 
FOXA2 11 8 HHHSHHHHQPH 
NCAN 19 13 HRMRRHHHHHQHHHQHHHH 







SEPP1 14 9 HYHHEHHHNHGHQH 
BTBD11 10 8 HHHHHHHALH 
HRCT1 43 23 HHHRHPGHVSHVPNVGLHHHHHPRHTPHHLHHHHHPHRHHPRH 
PRICKLE3 13 10 HHHHNHHHHHNRH 
C21orf58 8 8 HHHHHHHH 
SKIDA1 30 20 HHHHHHHHHHHHHHHRAQPPQQSHHPPHHH 
RBM33 13 9 HPPQHQHHHHHHH 
LRCH1 16 12 HPLHHPHHHHHHHQHH 
 
